1848636	31	43	Debrisochina	CHEMICALENTITY	D003647
1848636	103	120	beta- 2 recettore	GENEORGENEPRODUCT	154
1848636	171	182	metoprololo	CHEMICALENTITY	D008790
1848636	284	295	metoprololo	CHEMICALENTITY	D008790
1848636	363	375	debrisochina	CHEMICALENTITY	D003647
1848636	407	416	sparteine	CHEMICALENTITY	D013034
1848636	633	653	beta-1 adrenocettore	GENEORGENEPRODUCT	153
1848636	724	735	metoprololo	CHEMICALENTITY	D008790
1848636	843	863	beta-2 adrenocettore	GENEORGENEPRODUCT	154
1848636	907	918	metoprololo	CHEMICALENTITY	D008790
1848636	1007	1018	metoprololo	CHEMICALENTITY	D008790
1848636	1053	1064	terbutalina	CHEMICALENTITY	D013726
1848636	1117	1128	ipokaliemia	DISEASEORPHENOTYPICFEATURE	D007008
1848636	1245	1256	metoprololo	CHEMICALENTITY	D008790
1848636	1403	1414	metoprololo	CHEMICALENTITY	D008790
1848636	1562	1573	terbutalina	CHEMICALENTITY	D013726
1848636	1710	1721	metoprololo	CHEMICALENTITY	D008790
1848636	1860	1871	terbutalina	CHEMICALENTITY	D013726
1848636	1971	1979	potassio	CHEMICALENTITY	D011188
1848636	2012	2023	terbutalina	CHEMICALENTITY	D013726
1848636	2056	2068	metoprololo 	CHEMICALENTITY	D008790
1848636	2128	2151	alfa-idrossimetoprololo	CHEMICALENTITY	C029504
1848636	2254	2265	metoprololo	CHEMICALENTITY	D008790
1848636	2306	2317	metoprololo	CHEMICALENTITY	D008790
1848636	2370	2381	terbutalina	CHEMICALENTITY	D013726
1848636	2492	2503	metoprololo	CHEMICALENTITY	D008790
1848636	2535	2558	alfa-idrossimetoprololo	CHEMICALENTITY	C029504
1848636	2701	2712	metoprololo	CHEMICALENTITY	D008790
1848636	2772	2783	metoprololo	CHEMICALENTITY	D008790
2491010	62	70	pazienti	ORGANISMTAXON	9606
2491010	165	213	Gene della distrofia muscolare di Duchenne (DMD)	GENEORGENEPRODUCT	1756
2491010	296	327	Distrofia muscolare di Duchenne	DISEASEORPHENOTYPICFEATURE	D020388
2491010	373	376	DMD	DISEASEORPHENOTYPICFEATURE	D020388
2491010	422	451	Distrofia muscolare di Becker	DISEASEORPHENOTYPICFEATURE	D020388
2491010	497	500	BMD	DISEASEORPHENOTYPICFEATURE	D020388
2491010	622	625	DMD	GENEORGENEPRODUCT	1756
2491010	890	898	pazienti	ORGANISMTAXON	9606
2491010	955	965	distrofina	GENEORGENEPRODUCT	1 756
2491010	1237	1245	pazienti	ORGANISMTAXON	9606
2491010	1354	1362	pazienti	ORGANISMTAXON	9606
2491010	1472	1475	DMD	DISEASEORPHENOTYPICFEATURE	D020388
2491010	1520	1523	BMD	DISEASEORPHENOTYPICFEATURE	D020388
2491010	1677	1680	BMD	DISEASEORPHENOTYPICFEATURE	D020388
2491010	1708	1716	pazienti	ORGANISMTAXON	9606
2491010	1762	1770	paziente	ORGANISMTAXON	9606
2491010	1905	1908	DMD	DISEASEORPHENOTYPICFEATURE	D020388
2491010	1937	1945	pazienti	ORGANISMTAXON	9606
2491010	1986	1994	pazienti	ORGANISMTAXON	9606
2491010	2042	2046	 BMD	DISEASEORPHENOTYPICFEATURE	D020388
2491010	2074	2082	paziente	ORGANISMTAXON	9606
8829135	31	42	Nefiracetam	CHEMICALENTITY	C058876
8829135	75	82	DM-9384	CHEMICALENTITY	C058876
8829135	123	133	apomorfina	CHEMICALENTITY	D001058
8829135	188	195	amnesia	DISEASEORPHENOTYPICFEATURE	D000647
8829135	327	338	Nefiracetam	CHEMICALENTITY	C058876
8829135	383	394	pirrolidone	CHEMICALENTITY	D011760
8829135	448	459	scopolamina	CHEMICALENTITY	D012601
8829135	511	573	deficit di consolidamento dell'apprendimento e post-formazione	DISEASEORPHENOTYPICFEATURE	D007859
8829135	615	625	apomorfina	CHEMICALENTITY	D001058
8829135	836	847	nefiracetam	CHEMICALENTITY	C058876
8829135	905	912	amnesia	DISEASEORPHENOTYPICFEATURE	D000647
8829135	955	978	agonismo dopaminergico 	CHEMICALENTITY	D018491
8829135	1075	1086	nefiracetam	CHEMICALENTITY	C058876
8829135	1130	1140	apomorfina	CHEMICALENTITY	D001058
8829135	1348	1359	nefiracetam	CHEMICALENTITY	C058876
8829135	1393	1403	apomorfina	CHEMICALENTITY	D001058
8829135	1526	1534	amnesico	DISEASEORPHENOTYPICFEATURE	D000647
8829135	1600	1611	nefiracetam	CHEMICALENTITY	C058876
8829135	1706	1713	amnesia	DISEASEORPHENOTYPICFEATURE	D000647
8829135	1763	1773	apomorfina	CHEMICALENTITY	D001058
8829135	1952	1963	nefiracetam	CHEMICALENTITY	C058876
8829135	2056	2059	3H 	CHEMICALENTITY	D014316
8829135	2091	2100	SCH 23390	CHEMICALENTITY	C534628
8829135	2135	2137	3H	CHEMICALENTITY	D014316
8829135	2170	2179	spiperone	CHEMICALENTITY	D013134
8829135	2237	2269	Recettore della dopamina D1 o D2	GENEORGENEPRODUCT	1812,1813
8829135	2338	2349	nefiracetam	CHEMICALENTITY	C058876
9672936	31	40	Pethidina	CHEMICALENTITY	D008614
9672936	94	99	crisi	DISEASEORPHENOTYPICFEATURE	D012640
9672936	165	173	petidina	CHEMICALENTITY	D008614
9672936	221	242	dolore postoperatorio	DISEASEORPHENOTYPICFEATURE	D010149
9672936	356	364	petidina	CHEMICALENTITY	D008614
9672936	403	411	paziente	ORGANISMTAXON	9606
9672936	526	547	dolore postoperatorio	DISEASEORPHENOTYPICFEATURE	D010149
9672936	647	656	sequestro	DISEASEORPHENOTYPICFEATURE	D012640
9672936	696	704	petidina	CHEMICALENTITY	D008614
9672936	743	754	norpetidina	CHEMICALENTITY	C002752
9672936	975	984	tossicità	DISEASEORPHENOTYPICFEATURE	D064420
9672936	1070	1078	petidina	CHEMICALENTITY	D008614
9672936	1162	1170	petidina	CHEMICALENTITY	D008614
9672936	1204	1215	norpetidina	CHEMICALENTITY	C002752
9672936	1268	1276	petidina	CHEMICALENTITY	D008614
9672936	1352	1376	analgesia postoperatoria	DISEASEORPHENOTYPICFEATURE	D010149
15000256	102	106	FMR1	GENEORGENEPRODUCT	2332
15000256	154	171	bambini autistici	DISEASEORPHENOTYPICFEATURE	D001321
15000256	217	234	ritardati mentali	DISEASEORPHENOTYPICFEATURE	D008607
15000256	299	323	Sindrome dell'X fragile 	DISEASEORPHENOTYPICFEATURE	D005600
15000256	399	414	ritardo mentale	DISEASEORPHENOTYPICFEATURE	D008607
15000256	455	466	 i pazienti	ORGANISMTAXON	9606
15000256	514	537	sindrome dell'X fragile	DISEASEORPHENOTYPICFEATURE	D005600
15000256	608	615	autismo	DISEASEORPHENOTYPICFEATURE	D001321
15000256	757	761	FMR1	GENEORGENEPRODUCT	2332
15000256	817	825	pazienti	ORGANISMTAXON	9606
15000256	955	959	FMR1	GENEORGE NEPRODUCT	2332
15000256	1031	1040	autistico	DISEASEORPHENOTYPICFEATURE	D001321
15000256	1086	1104	ritardato mentale 	DISEASEORPHENOTYPICFEATURE	D008607
15000256	1314	1322	pazienti	ORGANISMTAXON	9606
15000256	1380	1388	paziente	ORGANISMTAXON	9606
15000256	1504	1530	 da A a C a nucleotide 879	SEQUENCEVARIANT	RS782013865
15000256	1867	1871	FMR1	GENEORGENEPRODUCT	2332
15000256	1943	1950	autismo	DISEASEORPHENOTYPICFEATURE	D001321
15000256	1996	2011	ritardo mentale	DISEASEORPHENOTYPICFEATURE	D008607
15000256	2053	2061	pazienti	ORGANISMTAXON	9606
15036754	31	44	Organofosfato	CHEMICALENTITY	D010755
15036754	96	107	convulsioni	DISEASEORPHENOTYPICFEATURE	D012640
15036754	169	190	danni neuropatologici	DISEASEORPHENOTYPICFEATURE	D004194
15036754	228	241	organofosforo	CHEMICALENTITY	D010755
15036754	274	276	OP	CHEMICALENTITY	D010755
15036754	315	339	diisopropilfluorofosfato	CHEMICALENTITY	D007531
15036754	372	375	DFP	CHEMICALENTITY	D007531
15036754	409	414	sarin	CHEMICALENTITY	D012524
15036754	448	453	soman	CHEMICALENTITY	D012999
15036754	515	534	acetilcolinesterasi	GENEORGENEPRODUCT	83817
15036754	569	574	AChEs	GENEORGENEPRODUCT	83817
15036754	610	631	butirrilcolinesterasi	GENEORGENEPRODUCT	65036
15036754	665	670	BChEs	GENEORGENEPRODUCT	65036
15036754	719	728	tossicità	DISEASEORPHENOTYPICFEATURE	D064420
15036754	769	771	OP	CHEMICALENTITY	D010755
15036754	854	859	AChEs	GENEORGENEPRODUCT	83817
15036754	937	949	acetilcolina	CHEMICALENTITY	D000109
15036754	983	986	ACh	CHEMICALENTITY	D000109
15036754	1132	1135	DFP	CHEMICALENTITY	D007531
15036754	1256	1261	ratti	ORGANISMTAXON	10116
15036754	1293	1298	ratti	ORGANISMTAXON	10116
15036754	1346	1350	AChE	GENEORGENEPRODUCT	83817
15036754	1396	1418	pralidossima-2-cloruro	CHEMICALENTITY	D011220
15036754	1451	1455	2PAM	CHEMICALENTITY	D011220
15036754	1538	1546	diazepam	CHEMICALENTITY	D003975
15036754	1609	1633	Recettore A(1)-adenosina	GENEORGENEPRODUCT	29290
15036754	1675	1701	N(6)-ciclopentil adenosina	CHEMICALENTITY	C048599
15036754	1734	1737	CPA	CHEMICALENTITY	C048599
15036754	1802	1816	Recettore NMDA	GENEORGENEPRODUCT	24408
15036754	1860	1879	dizocilpina maleato	CHEMICALENTITY	D016291
15036754	1915	1937	MK801 idrogeno maleato	CHEMICALENTITY	D016291
15036754	2047	2063	atropina solfato	CHEMICALENTITY	D001285
15036754	2194	2197	DFP	CHEMICALENTITY	D007531
15036754	2240	2245	ratti	ORGANISMTAXON	10116
15036754	2289	2305	atropina solfato	CHEMICALENTITY	D001285
15036754	2370	2382	olio d'oliva	CHEMICALENTITY	D000069463
15036754	2441	2444	DFP	CHEMICALENTITY	D007531
15036754	2499	2504	ratti	ORGANISMTAXON	10116
15036754	2597	2600	DFP	CHEMICALENTITY	D007531
15036754	2633	2638	ratti	ORGANISMTAXON	10116
15036754	2683	2686	DFP	CHEMICALENTITY	D007531
15036754	2719	2727	atropina	CHEMICALENTITY	 D001285
15036754	2777	2779	OP	CHEMICALENTITY	D010755
15036754	2834	2843	tossicità	DISEASEORPHENOTYPICFEATURE	D064420
15036754	2889	2892	CPA	CHEMICALENTITY	C048599
15036754	2925	2933	diazepam	CHEMICALENTITY	D003975
15036754	2968	2972	2PAM	CHEMICALENTITY	D011220
15036754	3046	3049	DFP	CHEMICALENTITY	D007531
15036754	3081	3089	atropina	CHEMICALENTITY	D001285
15036754	3222	3235	avvelenamento	DISEASEORPHENOTYPICFEATURE	D011041
15036754	3268	3276	Atropina	CHEMICALENTITY	D001285
15036754	3308	3313	MK801	CHEMICALENTITY	D016291
15036754	3394	3397	DFP	CHEMICALENTITY	D007531
15036754	3441	3450	tossicità	DISEASEORPHENOTYPICFEATURE	D064420
15036754	3499	3502	CPA	CHEMICALENTITY	C048599
15036754	3535	3543	diazepam	CHEMICALENTITY	D003975
15036754	3578	3582	2PAM	CHEMICALENTITY	D011220
15036754	3634	3642	atropina	CHEMICALENTITY	D001285
15036754	3732	3745	avvelenamento	DISEASEORPHENOTYPICFEATURE	D011041
15036754	3809	3818	tossicità	DISEASEORPHENOTYPICFEATURE	D064420
15036754	3853	3856	DFP	CHEMICALENTITY	D007531
15036754	3888	3891	rat	ORGANISMTAXON	10116
15111599	31	40	CRYBA3/A1	GENEORGENEPRODUCT	1411
15111599	131	180	cataratta nucleare congenita autosomica dominante	DISEASEORPHENOTYPICFEATURE	 C565137
15111599	267	283	difetto genetico	DISEASEORPHENOTYPICFEATURE	D030342
15111599	342	370	cataratta nucleare congenita	DISEASEORPHENOTYPICFEATURE	C565137
15111599	721	730	cataratta	DISEASEORPHENOTYPICFEATURE	D002386
15111599	1179	1208	cataratta nucleare congenita 	DISEASEORPHENOTYPICFEATURE	C565137
15111599	1412	1421	CRYBA3/A1	GENEORGENEPRODUCT	1411
15111599	1506	1527	cancellazione di 3 bp	SEQUENCEVARIANT	C|DEL||3
15111599	1580	1589	279delGAG	SEQUENCEVARIANT	C|DEL|279|GAG
15111599	1662	1685	delezione di glicina-91	SEQUENCEVARIANT	P|DEL|91|G
15111599	2006	2014	DeltaG91	SEQUENCEVARIANT	P|DEL|91|G
15111599	2049	2058	CRYBA3/A1	GENEORGENEPRODUCT	1411
15111599	2120	2169	cataratta nucleare congenita autosomica dominante	DISEASEORPHENOTYPICFEATURE	C565137
15111599	2331	2349	cataratta zonulare	DISEASEORPHENOTYPICFEATURE	C535342
15130900	43	72	Cancro della vescica urinaria	DISEASEORPHENOTYPICFEATURE	D001749
15130900	119	143	Granulomatosi di Wegener	DISEASEORPHENOTYPICFEATURE	D014890
15130900	199	213	ciclofosfamide	CHEMICALENTITY	D003520
15130900	308	329	 cancro della vescica	DISEASEORPHENOTYPICFEATURE	D001749
15130900	385	399	ciclofosfamide	CHEMICALENTITY	D003520
15130900	431	439	pazienti	ORGANISMTAXON	9606
15130900	487	511	Granulomatosi di Wegener	DISEASEORPHENOTYPICFEATURE	D014890
15130900	574	584	Ricoverata	ORGANISMTAXON	9606
15130900	640	648	pazienti	ORGANISMTAXON	9606
15130900	696	720	Granulomatosi di Wegener	DISEASEORPHENOTYPICFEATURE	D014890
15130900	847	853	Cancro	DISEASEORPHENOTYPICFEATURE	D009369
15130900	961	981	cancro della vescica	DISEASEORPHENOTYPICFEATURE	D001749
15130900	1156	1170	ciclofosfamide	CHEMICALENTITY	D003520
15130900	1216	1237	cancro della vescica 	DISEASEORPHENOTYPICFEATURE	D001749
15130900	1374	1394	cancro della vescica	DISEASEORPHENOTYPICFEATURE	D001749
15130900	1443	1467	granulomatosi di Wegener	DISEASEORPHENOTYPICFEATURE	D014890
15130900	1554	1574	cancro della vescica	DISEASEORPHENOTYPICFEATURE	D001749
15130900	1647	1671	granulomatosi di Wegener	DISEASEORPHENOTYPICFEATURE	D014890
15130900	1771	1785	ciclofosfamide	CHEMICALENTITY	D003520
15130900	1925	1945	cancro della vescica	DISEASEORPHENOTYPICFEATURE	D001749
15130900	2022	2036	ciclofosfamide	CHEMICALENTITY	D003520
15130900	2295	2315	cancro della vescica	DISEASEORPHENOTYPICFEATURE	D001749
15130900	2420	2444	granulomatosi di Wegener	DISEASEORPHENOTYPICFEATURE	D014890
15130900	2504	2524	cancro della vescica	DISEASEORPHENOTYPICFEATURE	D001749
15130900	2660	2684	Granulomatosi di Wegener	DISEASEORPHENOTYPICFEATURE	D014890
15130900	2783	2797	ciclofosfamide	CHEMICALENTITY	D003520
15130900	2857	2877	cancro della vescica	DISEASEORPHENOTYPICFEATURE	D001749
15130900	3042	3066	granulomatosi di Wegener	DISEASEORPHENOTYPICFEATURE	D014890
15233872	62	82	tintura di Crataegus	CHEMICALENTITY	C007145
15233872	117	132	isoproterenolo 	CHEMICALENTITY	D007545
15233872	184	205	infarto del miocardio	DISEASEORPHENOTYPICFEATURE	D009203
15233872	237	242	ratti	ORGANISMTAXON	10116
15233872	276	296	Tintura di Crataegus	CHEMICALENTITY	C007145
15233872	329	332	TCR	CHEMICALENTITY	C007145
15233872	370	415	estratto alcolico delle bacche di biancospino	CHEMICALENTITY	C007145
15233872	448	467	Crataegus oxycantha	CHEMICALENTITY	C007145
15233872	618	621	TCR	CHEMICALENTITY	C007145
15233872	668	686	infarto miocardico	DISEASEORPHENOTYPICFEATURE	D009203
15233872	743	748	ratti	ORGANISMTAXON	10116
15233872	802	805	TCR	CHEMICALENTITY	C007145
15233872	947	953	lipidi	CHEMICALENTITY	D008055
15233872	1047	1061	isoproterenolo	CHEMICALENTITY	D007545
15233872	1099	1104	ratti	ORGANISMTAXON	 10116
15233872	1192	1195	TCR	CHEMICALENTITY	C007145
15233872	1259	1273	isoproterenolo	CHEMICALENTITY	D007545
15233872	1382	1385	ADP	CHEMICALENTITY	D000244
15233872	1427	1435	ossigeno	CHEMICALENTITY	D010100
15233872	1509	1512	TCR	CHEMICALENTITY	C007145
15233872	1598	1612	isoproterenolo	CHEMICALENTITY	D007545
15233872	1645	1648	rat	ORGANISMTAXON	10116
15233872	1734	1737	TCR	CHEMICALENTITY	C007145
15233872	1825	1839	isoproterenolo	CHEMICALENTITY	D007545
15233872	1871	1874	rat	ORGANISMTAXON	10116
15459975	86	90	SSH1	GENEORGENEPRODUCT	54434
15459975	138	185	porocheratosi attinica superficiale disseminata	DISEASEORPHENOTYPICFEATURE	 D017499
15459975	230	277	Porocheratosi attinica superficiale disseminata	DISEASEORPHENOTYPICFEATURE	D017499
15459975	322	326	DSAP	DISEASEORPHENOTYPICFEATURE	D017499
15459975	426	458	disturbo della cheratinizzazione	DISEASEORPHENOTYPICFEATURE	D007642
15459975	540	560	lesioni cheratosiche	DISEASEORPHENOTYPICFEATURE	D007642
15459975	718	722	DSAP	DISEASEORPHENOTYPICFEATURE	D017499
15459975	1141	1151	p.Ser63Asn	SEQUENCEVARIANT	P|SUB|S|63|N
15459975	1187	1191	SSH1	GENEORGENEPRODUCT	54434
15459975	1274	1289	p.Ser19CysfsX24	SEQUENCEVARIANT	P|FS|S|19|C|24
15459975	1368	1372	SSH1	GENEORGENEPRODUCT	54434
15459975	1461	1476	p.Pro27ProfsX54	SEQUENCEVARIANT	P|FS|P|63|P|54
15459975	1583	1587	DSAP	DISEASEORPHENOTYPICFEATURE	D017499
15459975	1621	1625	SSH1	GENEORGENEPRODUCT	54434
15459975	1901	1905	DSAP	DISEASEORPHENOTYPICFEATURE	D017499
15464247	44	61	interleuchina 12B	GENEORGENEPRODUCT	3593
15464247	94	99	IL12B	GENEORGENEPRODUCT	3593
15464247	209	242	infezione da virus dell'epatite C	DISEASEORPHENOTYPICFEATURE	D006526
15464247	297	313	Interleuchina-12	GENEORGENEPRODUCT	3593
15464247	346	351	IL-12	GENEORGENEPRODUCT	3593
15464247	505	521	infezione da HCV	DISEASEORPHENOTYPICFEATURE	D006526
15464247	588	593	IL12B	GENEORGENEPRODUCT	3593
15464247	666	696	4 bp inserimento/cancellazione	SEQUENCEVARIANT	C|INDEL||4
15464247	751	759	1188-A/C	SEQUENCEVARIANT	C |SUB|A|1188|C
15464247	831	836	IL-12	GENEORGENEPRODUCT	3593
15464247	918	934	Infezione da HCV	DISEASEORPHENOTYPICFEATURE	D0065 26
15464247	1029	1032	HCV	ORGANISMTAXON	11103
15464247	1094	1105	HCV infetto	DISEASEORPHENOTYPICFEATURE	D006526
15464247	1133	1141	pazienti	ORGANISMTAXON	9606
15464247	1195	1200	IL12B	GENEORGENEPRODUCT	3593
15464247	1329	1344	oligonucleotide	CHEMICALENTITY	D009841
15464247	1492	1497	IL12B	GENEORGENEPRODUCT	3593
15464247	1635	1657	HCV genotipo 1-infetto	DISEASEORPHENOTYPICFEATURE	D006526
15464247	1685	1693	pazienti	ORGANISMTAXON	9606
15464247	1753	1760	viremia	DISEASEORPHENOTYPICFEATURE	D014766
15464247	1804	1809	IL12B	GENEORGENEPRODUCT	3593
15464247	1858	1864	1188-C	SEQUENCEVARIANT	C |ALLELE|C|1188
15464247	2154	2159	IL12B	GENEORGENEPRODUCT	3593
15464247	2207	2213	1188-C	SEQUENCEVARIANT	C|ALLELE|C|1188
15464247	2476	2481	IL12B	GENEORGENEPRODUCT	3593
15464247	2540	2556	infezione da HCV	DISEASEORPHENOTYPICFEATURE	D006526
15485686	42	47	SCN5A	GENEORGENEPRODUCT	6331
15485686	144	165	sindrome del QT lungo	DISEASEORPHENOTYPICFEATURE	 D008133
15485686	235	246	tachicardia	DISEASEORPHENOTYPICFEATURE	D013610
15485686	290	301	bradicardia	DISEASEORPHENOTYPICFEATURE	D001919
15485686	367	388	sindrome del QT lungo	DISEASEORPHENOTYPICFEATURE	D008133
15485686	433	437	LQTS	DISEASEORPHENOTYPICFEATURE	D008133
15485686	599	607	paziente	ORGANISMTAXON	9606
15485686	655	666	bradicardia	DISEASEORPHENOTYPICFEATURE	D001919
15485686	723	747	blocco atrioventricolare	DISEASEORPHENOTYPICFEATURE	D054537
15485686	793	817	tachicardia ventricolare	DISEASEORPHENOTYPICFEATURE	D017180
15485686	985	1009	blocco atrioventricolare	DISEASEORPHENOTYPICFEATURE	D054537
15485686	1081	1090	lidocaina	CHEMICALENTITY	D008012
15485686	1173	1183	mexiletina	CHEMICALENTITY	D008801
15485686	1253	1277	tachicardia ventricolare	DISEASEORPHENOTYPICFEATURE	D017180
15485686	1363	1367	LQTS	DISEASEORPHENOTYPICFEATURE	D008133
15485686	1470	1479	 Na(v)1.5	GENEORGENEPRODUCT	6331
15485686	1527	1532	sodio	CHEMICALENTITY	D012964
15485686	1593	1628	G-->Una sostituzione al codone 1763	SEQUENCEVARIANT	C|SUB|G |CODON1763|A
15485686	1685	1720	valina (GTG) in una metionina (ATG)	SEQUENCEVARIANT	P|SUB|V||M
15485686	1985	1999	tetrodotossina	CHEMICALENTITY	D013779
15485686	2056	2090	corrente resistente alla lidocaina	CHEMICALENTITY	D008012
15485686	2385	2391	V1764M	SEQUENCEVARIANT	P|SUB|V|1764|M
15485686	2458	2464	I1762A	SEQUENCEVARIANT	P|SUB|I|1762|A
15485686	2643	2651	Na(v)1.5	GENEORGENEPRODUCT	6331
15485686	2691	2698	V1763M 	SEQUENCEVARIANT	P|SUB|V|1763|M
15485686	2888	2892	LQTS	DISEASEORPHENOTYPICFEATURE	D008133
15485686	2985	2992	aritmie	DISEASEORPHENOTYPICFEATURE	D001145
15485686	3045	3054	lidocaina	CHEMICALENTITY	D008012
15485686	3089	3100	messiletina	CHEMICALENTITY	D008801
15668505	37	42	BRCA2	GENEORGENEPRODUCT	675
15668505	117	146	 carcinoma mammario e ovarico	DISEASEORPHENOTYPICFEATURE	D001943,D010051
15668505	215	220	BRCA1	GENEORGENEPRODUCT	672
15668505	333	338	N372H	SEQUENCEVARIANT	RS144848
15668505	378	383	BRCA2	GENEORGENEPRODUCT	675
15668505	526	550	cancro al seno e ovarico	DISEASEORPHENOTYPICFEATURE	D001943,D010051
15668505	628	634	cancro	DISEASEORPHENOTYPICFEATURE	D009369
15668505	705	710	N372H	SEQUENCEVARIANT	RS144848
15668505	816	824	203G > A	SEQUENCEVARIANT	G |SUB|G|203|A
15668505	860	865	BRCA2	GENEORGENEPRODUCT	675
15668505	935	962	cancro al seno o alle ovaie	DISEASEORPHENOTYPICFEATURE	D001943,D010051
15668505	1031	1036	BRCA1	GENEORGENEPRODUCT	672
15668505	1087	1092	donne	ORGANISMTAXON	9606
15668505	1173	1178	BRCA1	GENEORGENEPRODUCT	672
15668505	1239	1244	BRCA2	GENEORGENEPRODUCT	675
15668505	1567	1581	cancro al seno	DISEASEORPHENOTYPICFEATURE	D001943
15668505	1626	1631	BRCA1	GENEORGENEPRODUCT	672
15668505	1760	1774	cancro ovarico	DISEASEORPHENOTYPICFEATURE	D010051
15668505	1860	1865	N372H	SEQUENCEVARIANT	RS144848
15668505	1993	1997	203A	SEQUENCEVARIANT	G|ALLELE|A|203
15668505	2276	2281	N372H	SEQUENCEVARIANT	RS144848
15668505	2336	2341	BRCA1	GENEORGENEPRODUCT	672
15668505	2479	2485	cancro	DISEASEORPHENOTYPICFEATURE	D009369
15668505	2519	2524	BRCA1	GENEORGENEPRODUCT	672
15668505	2647	2652	N372H	SEQUENCEVARIANT	RS144848
15673851	50	79	recettori N-metil-D-aspartato	GENEORGENEPRODUCT	24408
15673851	189	196	morfina	CHEMICALENTITY	D009020
15673851	287	315	ischemia del midollo spinale	DISEASEORPHENOTYPICFEATURE	D020760
15673851	444	480	recettori N-metil-d-aspartato (NMDA)	GENEORGENEPRODUCT	24408
15673851	531	538	morfina	CHEMICALENTITY	D009020
15673851	616	634	occlusione aortica	DISEASEORPHENOTYPICFEATURE	D001157
15673851	666	672	 ratti	ORGANISMTAXON	10116
15673851	717	745	Ischemia del midollo spinale	DISEASEORPHENOTYPICFEATURE	D020760
15673851	808	826	occlusione aortica	DISEASEORPHENOTYPICFEATURE	D001157
15673851	1009	1016	morfina	CHEMICALENTITY	D009020
15673851	1128	1135	morfina	CHEMICALENTITY	D009020
15673851	1489	1495	MK-801	CHEMICALENTITY	D016291
15673851	1593	1600	morfina	CHEMICALENTITY	 D009020
15673851	1655	1674	paraparesi spastica	DISEASEORPHENOTYPICFEATURE	D020336
15673851	1715	1722	morfina	CHEMICALENTITY	D009020
15673851	1806	1816	glutammato	CHEMICALENTITY	D018698
15673851	1967	1973	MK-801	CHEMICALENTITY	D016291
15673851	2079	2086	morfina	CHEMICALENTITY	D009020
15673851	2138	2157	paraparesi spastica	DISEASEORPHENOTYPICFEATURE	D020336
15673851	2244	2251	morfina	CHEMICALENTITY	D009020
15673851	2302	2321	paraparesi spastica	DISEASEORPHENOTYPICFEATURE	D020336
15673851	2388	2398	glutammato	CHEMICALENTITY	D018698
15673851	2469	2483	recettore NMDA	GENEORGENEPRODUCT	24408
15673851	2531	2539	oppioidi	CHEMICALENTITY	D000701
15673851	2598	2610	neurotossici	DISEASEORPHENOTYPICFEATURE	D020258
15673851	2671	2699	ischemia del midollo spinale	DISEASEORPHENOTYPICFEATURE	D020760
15673851	2740	2754	Recettore NMDA	GENEORGENEPRODUCT	24408
15811908	43	57	Feocromocitoma	DISEASEORPHENOTYPICFEATURE	D010673
15811908	107	118	amisulpride	CHEMICALENTITY	D000077582
15811908	152	160	tiapride	CHEMICALENTITY	D063325
15811908	248	262	feocromocitoma	DISEASEORPHENOTYPICFEATURE	D010673
15811908	296	304	paziente	ORGANISMTAXON	9606
15811908	345	353	paziente	ORGANISMTAXON	9606
15811908	388	399	amisulpride	CHEMICALENTITY	D000077582
15811908	433	441	tiapride	CHEMICALENTITY	D063325
15811908	493	497	uomo	ORGANISMTAXON	9606
15811908	573	585	ipertensione	DISEASEORPHENOTYPICFEATURE	D006973
15811908	633	645	mal di testa	DISEASEORPHENOTYPICFEATURE	D006261
15811908	691	697	vomito	DISEASEORPHENOTYPICFEATURE	D014839
15811908	760	771	amisulpride	CHEMICALENTITY	D000077582
15811908	812	820	tiapride	CHEMICALENTITY	D063325
15811908	914	922	paziente	ORGANISMTAXON	9606
15811908	986	997	nicardipina	CHEMICALENTITY	D009529
15811908	1031	1056	trattamento con verapamil	CHEMICALENTITY	D014700
15811908	1223	1237	feocromocitoma	DISEASEORPHENOTYPICFEATURE	D010673
15811908	1327	1341	feocromocitoma	DISEASEORPHENOTYPICFEATURE	D010673
15811908	1407	1434	farmaci a base di benzamide	CHEMICALENTITY	D001549
15811908	1644	1655	ipertensiva	DISEASEORPHENOTYPICFEATURE	D006973
15811908	1692	1703	amisulpride	CHEMICALENTITY	D000077582
15811908	1737	1745	tiapride	CHEMICALENTITY	D063325
15811908	1856	1867	amisulpride	CHEMICALENTITY	D000077582
15811908	1902	1910	tiapride	CHEMICALENTITY	D063325
15811908	1971	1982	ipertensiva	DISEASEORPHENOTYPICFEATURE	D006973
15811908	2016	2024	paziente	ORGANISMTAXON	9606
15811908	2072	2086	feocromocitoma	DISEASEORPHENOTYPICFEATURE	D010673
15811908	2225	2233	tiapride	CHEMICALENTITY	D063325
15811908	2270	2281	amisulpride	CHEMICALENTITY	D000077582
15818664	59	84	condrocalcinosi sporadica	DISEASEORPHENOTYPICFEATURE	D002805
15818664	226	230	ANKH	GENEORGENEPRODUCT	56172
15818664	304	308	ANKH	GENEORGENEPRODUCT	56172
15818664	379	401	pirofosfato inorganico	CHEMICALENTITY	D043564
15818664	480	484	ANKH	GENEORGENEPRODUCT	56172
15818664	587	611	 pirofosfato inorganico 	CHEMICALENTITY	D043564
15818664	644	647	PPi	CHEMICALENTITY	D043564
15818664	717	763	condrocalcinosi familiare autosomica dominante	DISEASEORPHENOTYPICFEATURE	D002805
15818664	861	865	ANKH	GENEORGENEPRODUCT	56172
15818664	936	951	condrocalcinosi	DISEASEORPHENOT YPICFEATURE	D002805
15818664	993	997	ANKH	GENEORGENEPRODUCT	56172
15818664	1148	1163	condrocalcinosi	DISEASEORPHENOTYPICFEATURE	D002805
15818664	1198	1206	pazienti	ORGANISMTAXON	9606
15818664	1254	1269	condrocalcinosi	DISEASEORPHENOTYPICFEATURE	D002805
15818664	1598	1603	umano	ORGANISMTAXON	9606
15818664	1725	1750	condrocalcinosi sporadica	DISEASEORPHENOTYPICFEATURE	D002805
15818664	1806	1812	G-to-A	SEQUENCEVARIANT	C|SUB|G||A
15818664	1863	1867	ANKH	GENEORGENEPRODUCT	56172
15818664	2186	2223	condrocalcinosi familiare e sporadica	DISEASEORPHENOTYPICFEATURE	D002805
15818664	2263	2278	+14 bp da C a T	SEQUENCEVARIANT	C|SUB| C|14|T
15818664	2328	2344	Eliminazione GAG	SEQUENCEVARIANT	C|DEL||GAG
15818664	2426	2451	condrocalcinosi familiare	DISEASEORPHENOTYPICFEATURE	D002805
15818664	2497	2523	143- bp mutazione da T a C	SEQUENCEVARIANT	C|SUB|T|143|C
15818664	2582	2586	ANKH	GENEORGENEPRODUCT	56172
15818664	2632	2637	ANKH 	GENEORGENEPRODUCT	56172
15818664	2745	2749	ANKH	GENEORGENEPRODUCT	56172
15818664	2790	2794	ANKH	GENEORGENEPRODUCT	56172
15818664	2882	2885	PPi	CHEMICALENTITY	D043564
15818664	2998	3002	ANKH	GENEORGENEPRODUCT	56172
15818664	3085	3088	PPi	CHEMICALENTITY	D043564
15818664	3148	3158	ipertrofia	DISEASEORPHENOTYPICFEATURE	D006984
15818664	3201	3220	tipo di collagene X	GENEORGENEPRODUCT	1300
15818664	3297	3322	condrocalcinosi sporadica	DISEASEORPHENOTYPICFEATURE	D002805
15818664	3444	3448	ANKH	GENEORGENEPRODUCT	56172
15818664	3530	3534	ANKH	GENEORGENEPRODUCT	56172
15818664	3584	3587	PPi	CHEMICALENTITY	D043564
15818664	3669	3673	ANKH	GENEORGENEPRODUCT	56172
15818664	3729	3744	condrocalcinosi	DISEASEORPHENOTYPICFEATURE	D002805
15818664	3848	3851	PPi	CHEMICALENTITY	D043564
15818664	3908	3918	ipertrofia	DISEASEORPHENOTYPICFEATURE	D006984
15820770	31	61	proteina legante la vitamina D	GENEORGENEPRODUCT	2638
15820770	134	138	IA-2	GENEORGENEPRODUCT	5798
15820770	199	216	diabete di tipo 1	DISEASEORPHENOTYPICFEATURE	D003922
15820770	261	294	La proteina legante la vitamina D	GENEORGENEPRODUCT	2638
15820770	327	330	DBP	GENEORGENEPRODUCT	2638
15820770	415	426	1.25(OH)2D3	CHEMICALENTITY	D002117
15820770	557	560	DBP	GENEORGENEPRODUCT	2638
15820770	642	733	GAT-->La sostituzione GAG sostituisce l'acido aspartico con acido glutammico nel codone 416	SEQUENCEVARIANT	P|SUB|D| 416|E
15820770	775	815	ACG-->la sostituzione AAG nel codone 420	SEQUENCEVARIANT	P|SUB|T|420|K
15820770	875	894	treonina per lisina	SEQUENCEVARIANT	P |SUB|T||K
15820770	946	949	DBP	GENEORGENEPRODUCT	2638
15820770	1020	1031	1.25(OH)2D3	CHEMICALENTITY	D002117
15820770	1084	1087	DBP	GENEORGENEPRODUCT	2638
15820770	1140	1157	diabete di tipo 1	DISEASEORPHENOTYPICFEATURE	D003922
15820770	1302	1305	DBP	GENEORGENEPRODUCT	2638
15820770	1397	1411	tipo 1 diabete	DISEASEORPHENOTYPICFEATURE	D003922
15820770	1517	1525	pazienti	ORGANISMTAXON	9606
15820770	1632	1635	DBP	GENEORGENEPRODUCT	2638
15820770	1730	1733	DBP	GENEORGENEPRODUCT	2638
15820770	1970	1979	diabetici	DISEASEORPHENOTYPICFEATURE	D003920
15820770	2024	2040	IA rilevabile -2	GENEORGENEPRODUCT	5798
15820770	2110	2113	DBP	GENEORGENEPRODUCT	2638
15820770	2228	2233	GAD65	GENEORGENEPRODUCT	2572
15820770	2342	2352	vitamina D	CHEMICALENTITY	D014807
15820770	2423	2440	diabete di tipo 1	DISEASEORPHENOTYPICFEATURE	D003922
15824163	51	55	BRAF	GENEORGENEPRODUCT	673
15824163	104	112	melanoma	DISEASEORPHENOTYPICFEATURE	D008545
15824163	156	160	nevo	DISEASEORPHENOTYPICFEATURE	D009506
15824163	238	242	BRAF	GENEORGENEPRODUCT	673
15824163	317	335	tumori di melanoma	DISEASEORPHENOTYPICFEATURE	D008545
15824163	390	394	nevi	DISEASEORPHENOTYPICFEATURE	D009506
15824163	461	465	BRAF	GENEORGENEPRODUCT	673
15824163	576	584	melanoma	DISEASEORPHENOTYPICFEATURE	D008545
15824163	674	678	BRAF	GENEORGENEPRODUCT	673
15824163	752	770	melanoma sporadico	DISEASEORPHENOTYPICFEATURE	D008545
15824163	801	807	uomini	ORGANISMTAXON	9606
15824163	878	882	BRAF	GENEORGENEPRODUCT	673
15824163	992	996	nevo	DISEASEORPHENOTYPICFEATURE	D009506
15824163	1040	1063	sensibilità al melanoma	DISEASEORPHENOTYPICFEATURE	D008545
15824163	1375	1393	melanoma familiare	DISEASEORPHENOTYPICFEATURE	D008545
15824163	1428	1433	BRAF 	GENEORGENEPRODUCT	673
15824163	1597	1601	BRAF	GENEORGENEPRODUCT	673
15824163	1679	1688	rs1639679	SEQUENCEVARIANT	RS1639679
15824163	1766	1774	melanoma	DISEASEORPHENOTYPICFEATURE	D008545
15824163	1880	1884	BRAF	GENEORGENEPRODUCT	673
15824163	1943	1951	melanoma	DISEASEORPHENOTYPICFEATURE	D008545
15824163	2353	2357	BRAF	GENEORGENEPRODUCT	673
15824163	2477	2481	BRAF	GENEORGENEPRODUCT	673
15824163	2562	2570	melanoma	DISEASEORPHENOTYPICFEATURE	D008545
15824163	2776	2780	BRAF	GENEORGENEPRODUCT	673
15824163	2869	2874	 nevi	DISEASEORPHENOTYPICFEATURE	D009506
15987266	32	67	Proteina associata alla crescita 43	GENEORGENEPRODUCT	29423
15987266	166	176	epilettico	DISEASEORPHENOTYPICFEATURE	D004827
15987266	205	210	ratti	ORGANISMTAXON	10116
15987266	255	267	cicloesimide	CHEMICALENTITY	D003513
15987266	308	313	GAP43	GENEORGENEPRODUCT	29423
15987266	476	486	epilessia 	DISEASEORPHENOTYPICFEATURE	D004827
15987266	545	550	GAP43	GENEORGENEPRODUCT	29423
15987266	596	601	GAP43	GENEORGENEPRODUCT	29423
15987266	732	737	GAP43	GENEORGENEPRODUCT	29423
15987266	828	833	ratti	ORGANISMTAXON	10116
15987266	888	904	stato epilettico	DISEASEORPHENOTYPICFEATURE	D013226
15987266	947	959	 pilocarpina	CHEMICALENTITY	D010862
15987266	992	996	Pilo	CHEMICALENTITY	D010862
15987266	1067	1079	cicloesimide	CHEMICALENTITY	D003513
15987266	1112	1115	CHX	CHEMICALENTITY	D003513
15987266	1194	1197	CHX	CHEMICALENTITY	D003513
15987266	1271	1275	Pilo	CHEMICALENTITY	D010862
15987266	1322	1327	ratti	ORGANISMTAXON	10116
15987266	1370	1374	Pilo	CHEMICALENTITY	D010862
15987266	1463	1466	CHX	CHEMICALENTITY	D003513
15987266	1605	1610	GAP43	GENEORGENEPRODUCT	29423
15987266	1742	1747	GAP43	GENEORGENEPRODUCT	29423
15987266	1795	1799	Pilo	CHEMICALENTITY	D010862
15987266	1832	1835	CHX	CHEMICALENTITY	D003513
15987266	1867	1871	Pilo	CHEMICALENTITY	D010862
15987266	1975	1980	GAP43	GENEORGENEPRODUCT	29423
15987266	2043	2046	CHX	CHEMICALENTITY	D003513
15987266	2078	2082	Pilo	CHEMICALENTITY	D010862
15987266	2222	2226	Pilo	CHEMICALENTITY	D010862
15987266	2333	2336	CHX	CHEMICALENTITY	D003513
15987266	2368	2372	Pilo	CHEMICALENTITY	D010862
15987266	2421	2426	GAP43	GENEORGENEPRODUCT	29423
15987266	2588	2593	GAP43	GENEORGENEPRODUCT	29423
15987266	2665	2669	Pilo	CHEMICALENTITY	D010862
15987266	2901	2907	GAP-43	GENEORGENEPRODUCT	29423
16046395	67	72	umano	ORGANISMTAXON	9606
16046395	104	126	recettore mu oppioide 	GENEORGENEPRODUCT	4988
16046395	159	164	OPRM1	GENEORGENEPRODUCT	4988
16046395	223	228	A118G	SEQUENCEVARIANT	RS1799971
16046395	320	341	recettore mu oppioide	GENEORGENEPRODUCT	4988
16046395	374	379	OPRM1	GENEORGENEPRODUCT	4988
16046395	453	459	dolore	DISEASEORPHENOTYPICFEATURE	D010146
16046395	538	543	OPRM1	GENEORGENEPRODUCT	4988
16046395	632	649	tossicodipendenza	DISEASEORPHENOTYPICFEATURE	D019966
16046395	740	745	A118G	SEQUENCEVARIANT	RS1799971
16046395	810	814	N40D	SEQUENCEVARIANT	RS1799971
16046395	964	969	OPRM1	GENEORGENEPRODUCT	4988
16046395	1000	1005	umano	ORGANISMTAXON	9606
16046395	1080	1085	A118G	SEQUENCEVARIANT	RS1799971
16046395	1186	1190	A118	SEQUENCEVARIANT	RS1799971
16046395	1271	1275	G118	SEQUENCEVARIANT	RS1799971
16046395	1327	1341	Criceto cinese	ORGANISMTAXON	10029
16046395	1453	1458	OPRM1	GENEORGENEPRODUCT	100770962
16046395	1503	1561	adenosina, guanosina, citidina e timidina in posizione 118	SEQUENCEVARIANT	RS1799971
16046395	1657	1662	OPRM1	GENEORGENEPRODUCT	100770962
16046395	1697	1701	G118	SEQUENCEVARIANT	RS1799971
16046395	1767	1772	OPRM1	GENEORGENEPRODUCT	100770962
16046395	1947	1961	actinomicina D	CHEMICALENTITY	D003609
16046395	2087	2099	 Alleli A118	SEQUENCEVARIANT	RS1799971
16046395	2136	2140	G118	SEQUENCEVARIANT	RS1799971
16046395	2282	2287	OPRM1	GENEORGENEPRODUCT	100770962
16046395	2322	2326	G118	SEQUENCEVARIANT	RS1799971
16046395	2565	2582	tossicodipendenza	DISEASEORPHENOTYPICFEATURE	D019966
16112787	118	129	vancomicina	CHEMICALENTITY	D014640
16112787	182	196	nefrotossicità	DISEASEORPHENOTYPICFEATURE	D007674
16112787	243	253	erdosteina	CHEMICALENTITY	C048498
16112787	336	347	vancomicina	CHEMICALENTITY	D014640
16112787	380	383	VCM	CHEMICALENTITY	D014640
16112787	472	501	specie reattive dell'ossigeno	CHEMICALENTITY	D017382
16112787	534	537	ROS	CHEMICALENTITY	D017382
16112787	593	603	erdosteina	CHEMICALENTITY	C048498
16112787	673	686	antiossidante	CHEMICALENTITY	D000975
16112787	768	771	VCM	CHEMICALENTITY	D014640
16112787	823	844	compromissione renale	DISEASEORPHENOTYPICFEATURE	D007674
16112787	876	881	ratti	ORGANISMTAXON	10116
16112787	911	916	Ratti	ORGANISMTAXON	10116
16112787	987	990	VCM	CHEMICALENTITY	D014640
16112787	1025	1028	VCM	CHEMICALENTITY	D014640
16112787	1064	1074	erdosteina	CHEMICALENTITY	C048498
16112787	1107	1110	VCM	CHEMICALENTITY	D014640
16112787	1245	1255	Erdosteine	CHEMICALENTITY	C048498
16112787	1324	1327	VCM	CHEMICALENTITY	D014640
16112787	1389	1394	ratti	ORGANISMTAXON	10116
16112787	1475	1489	malondialdeide	CHEMICALENTITY	D008315
16112787	1522	1525	MDA	CHEMICALENTITY	D008315
16112787	1571	1603	N-acetil- beta-d-glucosaminidasi	GENEORGENEPRODUCT	154968
16112787	1638	1641	NAG	GENEORGENEPRODUCT	154968
16112787	1699	1723	lesione tubulare renale 	DISEASEORPHENOTYPICFEATURE	D007674
16112787	1780	1801	superossido dismutasi	CHEMICALENTITY	D013482
16112787	1834	1837	SOD	CHEMICALENTITY	D013482
16112787	1873	1881	catalasi	GENEORGENEPRODUCT	24248
16112787	1915	1918	CAT	GENEORGENEPRODUCT	24248
16112787	1952	1962	Erdosteina	CHEMICALENTITY	C048498
16112787	2031	2034	VCM	CHEMICALENTITY	D014640
16112787	2134	2137	MDA	CHEMICALENTITY	D008315
16112787	2173	2176	NAG	GENEORGENEPRODUCT	154968
16112787	2232	2236	SOD 	CHEMICALENTITY	D013482
16112787	2286	2289	CAT	GENEORGENEPRODUCT	24248
16112787	2360	2363	VCM	CHEMICALENTITY	D014640
16112787	2404	2414	Erdosteine	CHEMICALENTITY	C048498
16112787	2491	2494	VCM	CHEMICALENTITY	D014640
16112787	2549	2563	nefrotossicità	DISEASEORPHENOTYPICFEATURE	D007674
16112787	2711	2718	atrofia	DISEASEORPHENOTYPICFEATURE	D001284
16112787	2763	2776	desquamazione	DISEASEORPHENOTYPICFEATURE	D012871
16112787	2822	2829	necrosi	DISEASEORPHENOTYPICFEATURE	D009336
16112787	2864	2867	VCM	CHEMICALENTITY	D014640
16112787	2910	2914	rats	ORGANISMTAXON	10116
16112787	2998	3008	erdosteine	CHEMICALENTITY	C048498
16112787	3041	3051	Erdosteine	CHEMICALENTITY	C048498
16112787	3225	3228	VCM	CHEMICALENTITY	D014640
16112787	3283	3297	nefrotossicità	DISEASEORPHENOTYPICFEATURE	D007674
16112787	3374	3384	erdosteina	CHEMICALENTITY	C048498
16112787	3426	3429	VCM	CHEMICALENTITY	D014640
16112787	3482	3494	danno renale	DISEASEORPHENOTYPICFEATURE	D007674
16116131	87	97	discinesie	DISEASEORPHENOTYPICFEATURE	D004409
16116131	145	166	Malattia di Parkinson	DISEASEORPHENOTYPICFEATURE	D010300
16116131	249	257	levodopa	CHEMICALENTITY	D007980
16116131	312	322	discinesia	DISEASEORPHENOTYPICFEATURE	D004409
16116131	490	498	pazienti	ORGANISMTAXON	9606
16116131	548	569	Malattia di Parkinson	DISEASEORPHENOTYPICFEATURE	D010300
16116131	734	745	discinetico	DISEASEORPHENOTYPICFEATURE	D004409
16116131	794	804	apomorfina	CHEMICALENTITY	D001058
16116131	913	942	discinesia indotta da farmaci	DISEASEORPHENOTYPICFEATURE	D004409
16186368	64	95	Distrofia cristallina di Bietti	DISEASEORPHENOTYPICFEATURE	C535440
16186368	123	131	pazienti	ORGANISMTAXON	9606
16186368	179	185	CYP4V2	GENEORGENEPRODUCT	285440
16186368	240	246	CYP4V2	GENEORGENEPRODUCT	285440
16186368	326	340	citocromo P450	GENEORGENEPRODUCT	285440
16186368	425	434	 pazienti	ORGANISMTAXON	9606
16186368	482	513	Distrofia cristallina di Bietti	DISEASEORPHENOTYPICFEATURE	C535440
16186368	558	561	BCD	DISEASEORPHENOTYPICFEATURE	C535440
16186368	694	697	BCD	DISEASEORPHENOTYPICFEATURE	C535440
16186368	725	733	pazienti	ORGANISMTAXON	9606
16186368	821	829	pazienti	ORGANISMTAXON	9606
16186368	877	881	BCD 	DISEASEORPHENOTYPICFEATURE	C535440
16186368	988	994	CYP4V2	GENEORGENEPRODUCT	285440
16186368	1065	1073	pazienti	ORGANISMTAXON	9606
16186368	1217	1225	pazienti	ORGANISMTAXON	9606
16186368	1472	1477	S482X	SEQUENCEVARIANT	RS146494374
16186368	1516	1521	K386T	SEQUENCEVARIANT	RS199476200
16186368	1591	1599	pazienti	ORGANISMTAXON	9606
16186368	1688	1693	15-bp	SEQUENCEVARIANT	C|DEL||15
16186368	1805	1813	pazienti	ORGANISMTAXON	9606
16186368	1850	1858	pazienti	ORGANISMTAXON	9606
16186368	1962	1970	pazienti	ORGANISMTAXON	9606
16186368	2132	2140	pazienti	ORGANISMTAXON	 9606
16186368	2276	2284	pazienti	ORGANISMTAXON	9606
16186368	2562	2568	CYP4V2	GENEORGENEPRODUCT	285440
16186368	2626	2629	BCD	DISEASEORPHENOTYPICFEATURE	C535440
16186368	2747	2752	15-bp	SEQUENCEVARIANT	C|DEL||15
16252083	52	82	riparazione del disadattamento	GENEORGENEPRODUCT	4436
16252083	119	125	HMSH2 	GENEORGENEPRODUCT	4436
16252083	172	186	cancro al seno	DISEASEORPHENOTYPICFEATURE	D001943
16252083	417	434	inizio del cancro	DISEASEORPHENOTYPICFEATURE	D009369
16252083	586	599	carcinogenesi	DISEASEORPHENOTYPICFEATURE	D063646
16252083	690	714	riparazione del mismatch	GENEORGENEPRODUCT	4436
16252083	747	750	MMR	GENEORGENEPRODUCT	4436
16252083	821	843	cancro del colon-retto	DISEASEORPHENOTYPICFEATURE	D015179
16252083	924	938	cancro al seno	DISEASEORPHENOTYPICFEATURE	D001943
16252083	971	976	hMSH2	GENEORGENEPRODUCT	4436
16252083	1041	1044	MMR	GENEORGENEPRODUCT	4436
16252083	1177	1182	hMSH2	GENEORGENEPRODUCT	4436
16252083	1222	1261	A - -> Transizione G alla posizione 127	SEQUENCEVARIANT	RS17217772
16252083	1311	1349	Asn --> Sostituzione Ser al codone 127	SEQUENCEVARIANT	RS17217772
16252083	1390	1399	Asn127Ser	SEQUENCEVARIANT	RS17217772
16252083	1453	1494	G --> Una transizione alla posizione 1032	SEQUENCEVARIANT	RS4987188
16252083	1547	1579	Gly --> Asp cambia al codone 322	SEQUENCEVARIANT	RS4987188
16252083	1618	1627	Gly322Asp	SEQUENCEVARIANT	RS4987188
16252083	1687	1701	cancro al seno	DISEASEORPHENOTYPICFEATURE	D001943
16252083	1755	1761	cancro	DISEASEORPHENOTYPICFEATURE	D009369
16252083	1904	1918	cancro al seno	DISEASEORPHENOTYPICFEATURE	D001943
16252083	1946	1954	pazienti	ORGANISMTAXON	9606
16252083	1988	1993	donne	ORGANISMTAXON	9606
16252083	2258	2272	cancro al seno	DISEASEORPHENOTYPICFEATURE	D001943
16252083	2351	2357	tumore	DISEASEORPHENOTYPICFEATURE	D009369
16252083	2475	2489	cancro al seno	DISEASEORPHENOTYPICFEATURE	D001943
16252083	2550	2559	Gly322Asp	SEQUENCEVARIANT	RS4987188
16252083	2695	2698	MMR	GENEORGENEPRODUCT	4436
16252083	2770	2792	carcinogenesi mammaria	DISEASEORPHENOTYPICFEATURE	D001943
16252083	2836	2845	Gly322Asp	SEQUENCEVARIANT	RS4987188
16252083	2899	2904	hMSH2	GENEORGENEPRODUCT	4436
16252083	2999	3013	cancro al seno	DISEASEORPHENOTYPICFEATURE	D001943
16330669	175	218	linfoma cutaneo primario a grandi cellule B	DISEASEORPHENOTYPICFEATURE	D016403
16330669	331	375	linfoma cutaneo primitivo a grandi cellule B	DISEASEORPHENOTYPICFEATURE	D016403
16330669	420	426	PCLBCL	DISEASEORPHENOTYPICFEATURE	D016403
16330669	456	464	PAZIENTI	ORGANISMTAXON	9606
16330669	534	542	pazienti	ORGANISMTAXON	9606
16330669	591	597	PCLBCL	DISEASEORPHENOTYPICFEATURE	D016403
16330669	659	707	linfoma primitivo del centro follicolare cutaneo	DISEASEORPHENOTYPICFEATURE	D008224
16330669	753	758	PCFCL	DISEASEORPHENOTYPICFEATURE	D008224
16330669	813	819	PCLBCL	DISEASEORPHENOTYPICFEATURE	D016403
16330669	980	986	Cancro	DISEASEORPHENOTYPICFEATURE	D009369
16330669	1255	1260	PCFCL	DISEASEORPHENOTYPICFEATURE	D008224
16330669	1449	1454	c-REL	GENEORGENEPRODUCT	5966
16330669	1485	1493	pazienti	ORGANISMTAXON	9606
16330669	1564	1570	PCLBCL	DISEASEORPHENOTYPICFEATURE	D016403
16330669	1731	1736	BCL-2	GENEORGENEPRODUCT	596
16330669	1771	1776	MALT1	GENEORGENEPRODUCT	10892
16330669	1904	1910	CDKN2A	GENEORGENEPRODUCT	1029
16330669	1943	1949	CDKN2B	GENEORGENEPRODUCT	1030
16330669	1985	1990	NSG-x	GENEORGENEPRODUCT	27099
16330669	2091	2099	pazienti	ORGANISMTAXON	9606
16330669	2147	2153	PCLBCL	DISEASEORPHENOTYPICFEATURE	D016403
16330669	2214	2222	pazienti	ORGANISMTAXON	9606
16330669	2270	2275	PCFCL	DISEASEORPHENOTYPICFEATURE	D008224
16330669	2369	2375	CDKN2A	GENEORGENEPRODUCT	1029
16330669	2444	2450	PCLBCL	DISEASEORPHENOTYPICFEATURE	D016403
16330669	2494	2502	paziente	ORGANISMTAXON	9606
16330669	2561	2569	paziente	ORGANISMTAXON	9606
16330669	2635	2643	pazienti	ORGANISMTAXON	9606
16330669	2691	2696	PCFCL	DISEASEORPHENOTYPICFEATURE	D008224
16330669	2756	2762	PCLBCL	DISEASEORPHENOTYPICFEATURE	D016403
16330669	2806	2814	pazienti	ORGANISMTAXON	9606
16330669	2903	2909	CDKN2A	GENEORGENEPRODUCT	1029
16330669	2976	2983	linfoma	DISEASEORPHENOTYPICFEATURE	D008223
16330669	3126	3131	PCFCL	DISEASEORPHENOTYPICFEATURE	D008224
16330669	3177	3183	PCLBCL	DISEASEORPHENOTYPICFEATURE	D016403
16330669	3347	3353	CDKN2A	GENEORGENEPRODUCT	1029
16330669	3517	3524	PCLBCL 	DISEASEORPHENOTYPICFEATURE	D016403
16428827	31	39	Daidzein	CHEMICALENTITY	C004742
16428827	78	102	colina acetiltransferasi	GENEORGENEPRODUCT	1103
16428827	202	209	amnesia	DISEASEORPHENOTYPICFEATURE	D000647
16428827	254	278	colina acetiltransferasi	GENEORGENEPRODUCT	1103
16428827	311	315	ChAT	GENEORGENEPRODUCT	1103
16428827	440	452	acetilcolina	CHEMICALENTITY	D000109
16428827	485	488	ACh	CHEMICALENTITY	D000109
16428827	577	598	Malattia di Alzheimer	DISEASEORPHENOTYPICFEATURE	D000544
16428827	643	645	AD	DISEASEORPHENOTYPICFEATURE	D000544
16428827	692	694	AD	DISEASEORPHENOTYPICFEATURE	D000544
16428827	728	751	Gli estratti metanolici	CHEMICALENTITY	D000432
16428827	858	862	ChAT	GENEORGENEPRODUCT	1103
16428827	1019	1027	daidzein	CHEMICALENTITY	C004742
16428827	1060	1085	4',7-diidrossi-isoflavone	CHEMICALENTITY	C004742
16428827	1147	1155	daidzein	CHEMICALENTITY	C004742
16428827	1215	1226	scopolamine	CHEMICALENTITY	D012601
16428827	1287	1330	disturbi dell'apprendimento e della memoria	DISEASEORPHENOTYPICFEATURE	D007859|D008569
16428827	1430	1438	daidzein	CHEMICALENTITY	C004742
16428827	1498	1502	topi	ORGANISMTAXON	10090
16428827	1584	1595	scopolamina	CHEMICALENTITY	D012601
16428827	1650	1657	amnesia	DISEASEORPHENOTYPICFEATURE	D000647
16428827	1756	1767	scopolamina	CHEMICALENTITY	D012601
16428827	1799	1803	topi	ORGANISMTAXON	10090
16428827	1959	1963	topi	ORGANISMTAXON	10090
16428827	2008	2016	daidzein	CHEMICALENTITY	C004742
16428827	2059	2086	le iniezioni di scopolamina	CHEMICALENTITY	D012601
16428827	2286	2294	daidzein	CHEMICALENTITY	C004742
16428827	2374	2386	acetilcolina	CHEMICALENTITY	D000109
16428827	2424	2428	Chat	GENEORGENEPRODUCT	12647
16428827	2496	2507	scopolamina	CHEMICALENTITY	D012601
16428827	2559	2566	amnesia	DISEASEORPHENOTYPICFEATURE	D000647
16629641	69	75	anemia	DISEASEORPHENOTYPICFEATURE	D000740
16629641	106	114	pazienti	ORGANISMTAXON	9606
16629641	158	189	infetto da virus dell'epatite C	DISEASEORPHENOTYPICFEATURE	D006526
16629641	234	277	L'infezione cronica da virus dell'epatite C	DISEASEORPHENOTYPICFEATURE	D019698
16629641	307	310	HCV	ORGANISMTAXON	11103
16629641	372	379	cirrosi	DISEASEORPHENOTYPICFEATURE	D005355
16629641	424	448	carcinoma epatocellulare	DISEASEORPHENOTYPICFEATURE	D006528
16629641	495	534	 malattia epatica allo stadio terminale	DISEASEORPHENOTYPICFEATURE	D058625
16629641	613	629	infezione da HCV	DISEASEORPHENOTYPICFEATURE	D006526
16629641	694	714	interferone pegilato	GENEORGENEPRODUCT	3439
16629641	748	758	ribavirina	CHEMICALENTITY	D012254
16629641	875	883	pazienti	ORGANISMTAXON	9606
16629641	985	1001	anemia emolitica	DISEASEORPHENOTYPICFEATURE	D000743
16629641	1034	1065	Le concentrazioni di emoglobina	GENEORGENEPRODUCT	3039
16629641	1136	1146	ribavirina	CHEMICALENTITY	D012254
16629641	1202	1209	emolisi	DISEASEORPHENOTYPICFEATURE	D006461
16629641	1263	1269	anemia	DISEASEORPHENOTYPICFEATURE	D000740
16629641	1326	1334	pazienti	ORGANISMTAXON	 9606
16629641	1382	1398	infezione da HCV	DISEASEORPHENOTYPICFEATURE	D006526
16629641	1495	1529	 disturbi renali o cardiovascolari	DISEASEORPHENOTYPICFEATURE	D002318,D007674
16629641	1587	1593	anemia	DISEASEORPHENOTYPICFEATURE	D000740
16629641	1765	1775	ribavirina	CHEMICALENTITY	D012254
16629641	1831	1837	anemia	DISEASEORPHENOTYPICFEATURE	D000740
16629641	2021	2026	umano	ORGANISMTAXON	9606
16629641	2058	2072	eritropoietina	GENEORGENEPRODUCT	2056
16629641	2136	2146	ribavirina	CHEMICALENTITY	D012254
16629641	2200	2206	anemia	DISEASEORPHENOTYPICFEATURE	D000740
16629641	2278	2288	Viramidina	CHEMICALENTITY	C026956
16629641	2355	2365	ribavirina	CHEMICALENTITY	D012254
16629641	2455	2465	ribavirina	CHEMICALENTITY	D012254
16629641	2533	2549	anemia emolitica	DISEASEORPHENOTYPICFEATURE	D000743
16629641	2580	2588	pazienti	ORGANISMTAXON	9606
16629641	2636	2653	epatite cronica C	DISEASEORPHENOTYPICFEATURE	D019698
16731636	40	54	isoproterenolo	CHEMICALENTITY	D007545
16731636	106	125	ipertrofia cardiaca	DISEASEORPHENOTYPICFEATURE	D006332
16731636	157	162	ratti	ORGANISMTAXON	10116
16731636	226	242	angiotensinogeno	GENEORGENEPRODUCT	24179
16731636	351	357	renina	GENEORGENEPRODUCT	24715
16731636	390	402	angiotensina	GENEORGENEPRODUCT	24179
16731636	638	654	beta-adrenergico	GENEORGENEPRODUCT	24925
16731636	689	696	beta-AR	GENEORGENEPRODUCT	24925
16731636	738	752	isoproterenolo	CHEMICALENTITY	D007545
16731636	785	788	Iso	CHEMICALENTITY	D007545
16731636	841	846	ratti	ORGANISMTAXON	10116
16731636	898	914	angiotensinogeno	GENEORGENEPRODUCT	24179
16731636	971	974	Iso	CHEMICALENTITY	D007545
16731636	1174	1179	ratti	ORGANISMTAXON	10116
16731636	1224	1237	Ipertrofia VS	DISEASEORPHENOTYPICFEATURE	D006332
16731636	1280	1283	Iso	CHEMICALENTITY	D007545
16731636	1378	1383	ratti	ORGANISMTAXON	10116
16731636	1519	1532	ipertrofia VS	DISEASEORPHENOTYPICFEATURE	D006332
16731636	1568	1572	rats	ORGANISMTAXON	10116
16731636	1663	1670	beta-AR	GENEORGENEPRODUCT	24925
16731636	1728	1745	beta-AR chinasi-1	GENEORGENEPRODUCT	25238
16731636	1811	1816	ratti	ORGANISMTAXON	10116
16731636	1921	1928	beta-AR	GENEORGENEPRODUCT	24925
16731636	1960	1971	metoprololo	CHEMICALENTITY	D008790
16731636	2013	2017	rats	ORGANISMTAXON	10116
16731636	2104	2108	rats	ORGANISMTAXON	10116
16731636	2221	2229	atropina	CHEMICALENTITY	D001285
16731636	2360	2367	beta-AR	GENEORGENEPRODUCT	24925
16731636	2462	2472	ipertrofia	DISEASEORPHENOTYPICFEATURE	D006984
16820346	34	47	Atorvastatina	CHEMICALENTITY	D000069059
16820346	101	113	desametasone	CHEMICALENTITY	D003907
16820346	161	174	antiossidante	CHEMICALENTITY	D000975
16820346	220	233	atorvastatina	CHEMICALENTITY	D000069059
16820346	270	276	atorva	CHEMICALENTITY	 D000069059
16820346	312	324	desametasone	CHEMICALENTITY	D003907
16820346	357	360	dex	CHEMICALENTITY	D003907
16820346	413	425	ipertensione	DISEASEORPHENOTYPICFEATURE	D006973
16820346	480	485	ratti	ORGANISMTAXON	10116
16820346	539	545	atorva	CHEMICALENTITY	D000069059
16820346	628	631	Dex	CHEMICALENTITY	D003907
16820346	756	767	superossido	CHEMICALENTITY	D013481
16820346	854	857	dex	CHEMICALENTITY	D003907
16820346	956	962	atorva	CHEMICALENTITY	D000069059
16820346	996	999	dex	CHEMICALENTITY	D003907
16820346	1147	1150	dex	CHEMICALENTITY	D003907
16820346	1199	1205	Atorva	CHEMICALENTITY	D000069059
16820346	1247	1250	dex	CHEMICALENTITY	D003907
16820346	1303	1315	ipertensione	DISEASEORPHENOTYPICFEATURE	D006973
16820346	1418	1429	superossido	CHEMICALENTITY	D013481
16820346	1477	1480	dex	CHEMICALENTITY	D003907
16820346	1531	1537	atorva	CHEMICALENTITY	D000069059
16820346	1571	1574	dex	CHEMICALENTITY	D003907
16820346	1627	1634	nitrato	CHEMICALENTITY	D009566
16820346	1666	1673	nitrito	CHEMICALENTITY	D009573
16820346	1707	1710	NOx	CHEMICALENTITY	D009589
16820346	1762	1765	dex	CHEMICALENTITY	D003907
16820346	1803	1808	ratti	ORGANISMTAXON	10116
16820346	1849	1854	ratti	ORGANISMTAXON	10116
16820346	1991	1997	Atorva	CHEMICALENTITY	D000069059
16820346	2061	2064	NOx	CHEMICALENTITY	D009589
16820346	2130	2143	atorvastatina	CHEMICALENTITY	D000069059
16820346	2200	2212	desametasone	CHEMICALENTITY	D003907
16820346	2265	2277	ipertensione	DISEASEORPHENOTYPICFEATURE	D006973
16820346	2310	2313	rat	ORGANISMTAXON	10116
16840830	60	64	MEN1	GENEORGENEPRODUCT	4221
16840830	125	155	neoplasia endocrina multipla-1	DISEASEORPHENOTYPICFEATURE	 D018761
16840830	200	241	La neoplasia endocrina multipla di tipo 1	DISEASEORPHENOTYPICFEATURE	D018761
16840830	286	290	MEN1	DISEASEORPHENOTYPICFEATURE	D018761
16840830	382	429	adenomi endocrini e ipofisari enteropancreatici	DISEASEORPHENOTYPICFEATURE	C535650,D010911
16840830	492	496	MEN1	GENEORGENEPRODUCT	4221
16840830	561	565	MEN1	GENEORGENEPRODUCT	4221
16840830	626	630	MEN1	GENEORGENEPRODUCT	4221
16840830	704	712	paziente	ORGANISMTAXON	9606
16840830	767	794	iperparatiroidismo primario	DISEASEORPHENOTYPICFEATURE	D049950
16840830	839	843	PHPT	DISEASEORPHENOTYPICFEATURE	D049950
16840830	895	907	prolattinoma	DISEASEORPHENOTYPICFEATURE	D015175
16840830	977	981	PHPT	DISEASEORPHENOTYPICFEATURE	D049950
16840830	1019	1027	paziente	ORGANISMTAXON	9606
16840830	1087	1092	donna	ORGANISMTAXON	9606
16840830	1176	1184	paziente	ORGANISMTAXON	9606
16840830	1254	1260	dolore	DISEASEORPHENOTYPICFEATURE	D010146
16840830	1315	1322	diarrea	DISEASEORPHENOTYPICFEATURE	D003967
16840830	1460	1501	tumore a cellule delle isole pancreatiche	DISEASEORPHENOTYPICFEATURE	D007516
16840830	1581	1593	prolattinoma	DISEASEORPHENOTYPICFEATURE	D015175
16840830	1660	1664	MEN1	GENEORGENEPRODUCT	4221
16840830	1784	1792	paziente	ORGANISMTAXON	9606
16840830	1891	1935	A to G transizione al codone 557 (AAG-->GAG)	SEQUENCEVARIANT	P|SUB|K|557|E
16840830	1984	1988	MEN1	GENEORGENEPRODUCT	4221
16840830	2060	2086	lisina da acido glutammico	SEQUENCEVARIANT	P|SUB|K||E
16840830	2131	2139	paziente	ORGANISMTAXON	9606
16840830	2236	2273	a codone 418 dell'esone 9 (GAC-->TAT)	SEQUENCEVARIANT	P|SUB|D|418|Y
16840830	2347	2375	acido aspartico con tirosina	SEQUENCEVARIANT	P|SUB|D||Y
16840830	2481	2485	MEN1	GENEORGENEPRODUCT	4221
16844102	42	57	alfa-tocoferolo	CHEMICALENTITY	D024502
16844102	91	103	deferoxamina	CHEMICALENTITY	D003676
16844102	138	151	metanfetamine	CHEMICALENTITY	D008694
16844102	203	217	neurotossicità	DISEASEORPHENOTYPICFEATURE	D020258
16844102	250	263	Metamfetamina	CHEMICALENTITY	D008694
16844102	296	298	MA	CHEMICALENTITY	D008694
16844102	340	353	dopaminergico	CHEMICALENTITY	 D004298
16844102	397	411	neurotossicità	DISEASEORPHENOTYPICFEATURE	D020258
16844102	557	572	alfa-tocoferolo	CHEMICALENTITY	D024502
16844102	605	613	alpha-TC	CHEMICALENTITY	D024502
16844102	664	693	specie reattive dell'ossigeno	CHEMICALENTITY	D017382
16844102	727	739	deferoxamina	CHEMICALENTITY	D003676
16844102	773	776	DFO	CHEMICALENTITY	D003676
16844102	823	828	ferro	CHEMICALENTITY	D007501
16844102	866	868	MA	CHEMICALENTITY	 D008694
16844102	923	937	neurotossicità	DISEASEORPHENOTYPICFEATURE	D020258
16844102	976	981	ratti	ORGANISMTAXON	10116
16844102	1037	1039	MA	CHEMICALENTITY	D008694
16844102	1115	1118	rat	ORGANISMTAXON	10116
16844102	1162	1169	alfa-TC	CHEMICALENTITY	D024502
16844102	1291	1293	MA	CHEMICALENTITY	D008694
16844102	1327	1330	DFO	CHEMICALENTITY	D003676
16844102	1433	1435	MA	CHEMICALENTITY	D008694
16844102	1489	1497	dopamina	CHEMICALENTITY	D004298
16844102	1530	1532	DA	CHEMICALENTITY	D004298
16844102	1567	1577	serotonina	CHEMICALENTITY	D012701
16844102	1691	1693	MA	CHEMICALENTITY	D008694
16844102	1773	1781	alpha-TC	CHEMICALENTITY	D024502
16844102	1815	1818	DFO	CHEMICALENTITY	D003676
16844102	1866	1874	alpha-TC	CHEMICALENTITY	D024502
16844102	1908	1911	DFO	CHEMICALENTITY	D003676
16844102	1963	1965	MA	CHEMICALENTITY	D008694
16844102	2020	2030	ipertermia	DISEASEORPHENOTYPICFEATURE	D005334
16844102	2125	2130	lipid	CHEMICALENTITY	D008055
16844102	2221	2231	glutatione	CHEMICALENTITY	D005978
16844102	2281	2283	MA	CHEMICALENTITY	D008694
16844102	2321	2326	ratti	ORGANISMTAXON	10116
16844102	2419	2427	alpha-TC	CHEMICALENTITY	D024502
16844102	2461	2464	DFO	CHEMICALENTITY	D003676
16844102	2516	2524	alpha-TC	CHEMICALENTITY	D024502
16844102	2558	2561	DFO	CHEMICALENTITY	D003676
16844102	2608	2610	MA	CHEMICALENTITY	D008694
16844102	2665	2680	danno neuronale	DISEASEORPHENOTYPICFEATURE	D009422
16849419	75	82	SLC34A3	GENEORGENEPRODUCT	142680
16849419	126	180	ereditaria rachitismo ipofosfatemico con ipercalciuria	DISEASEORPHENOTYPICFEATURE	C562793
16849419	235	292	Il rachitismo ipofosfatemico ereditario con ipercalciuria	DISEASEORPHENOTYPICFEATURE	C562793
16849419	337	341	HHRH	DISEASEORPHENOTYPICFEATURE	C562793
16849419	397	416	disturbo metabolico	DISEASEORPHENOTYPICFEATURE	D008659
16849419	479	492	ipofosfatemia	DISEASEORPHENOTYPICFEATURE	D017674
16849419	539	549	rachitismo	DISEASEORPHENOTYPICFEATURE	 D012279
16849419	593	605	osteomalacia	DISEASEORPHENOTYPICFEATURE	D010018
16849419	657	682	1,25-diidrossivitamina D 	CHEMICALENTITY	C097949
16849419	715	728	1,25-(OH)(2)D	CHEMICALENTITY	C097949
16849419	788	801	ipercalciuria	DISEASEORPHENOTYPICFEATURE	D053565
16849419	908	915	SLC34A3	GENEORGENEPRODUCT	142680
16849419	967	993	sodio-fosfato di tipo IIc 	GENEORGENEPRODUCT	142680
16849419	1075	1079	HHRH	DISEASEORPHENOTYPICFEATURE	C562793
16849419	1211	1218	SLC34A3	GENEORGENEPRODUCT	142680
16849419	1327	1335	PAZIENTI	ORGANISMTAXON	9606
16849419	1462	1466	HHRH	DISEASEORPHENOTYPICFEATURE	C562793
16849419	1585	1601	101-bp delezione	SEQUENCEVARIANT	C|DEL||101
16849419	1678	1685	SLC34A3	GENEORGENEPRODUCT	142680
16849419	1842	1846	HHRH	DISEASEORPHENOTYPICFEATURE	C562793
16849419	1917	1935	85-bp di delezione	SEQUENCEVARIANT	C|DEL||85
16849419	2006	2012	G-to-A	SEQUENCEVARIANT	C|SUB|G||A
16849419	2361	2365	HHRH	DISEASEORPHENOTYPICFEATURE	C562793
16849419	2443	2450	SLC34A3	GENEORGENEPRODUCT	142680
16849419	2677	2684	SLC34A3	GENEORGENEPRODUCT	142680
16970763	50	53	NDP	GENEORGENEPRODUCT	4693
16970763	111	130	 Malattia di Norrie	DISEASEORPHENOTYPICFEATURE	C537849
16970763	178	216	vitreoretinopatia essudativa familiare	DISEASEORPHENOTYPICFEATURE	D000080345
16970763	262	287	retinopatia del prematuro	DISEASEORPHENOTYPICFEATURE	D012178
16970763	402	420	Malattia di Norrie	DISEASEORPHENOTYPICFEATURE	C537849
16970763	453	456	NDP	GENEORGENEPRODUCT	4693
16970763	526	563	malattie retiniche Malattia di Norrie	DISEASEORPHENOTYPICFEATURE	C537849
16970763	611	663	Vitreoretinopatia essudativa familiare legata all'X 	DISEASEORPHENOTYPICFEATURE	D000080345
16970763	711	715	FEVR	DISEASEORPHENOTYPICFEATURE	D000080345
16970763	761	782	Malattia del mantello	DISEASEORPHENOTYPICFEATURE	D058456
16970763	828	853	retinopatia del prematuro	DISEASEORPHENOTYPICFEATURE	D012178
16970763	898	902	RO P	DISEASEORPHENOTYPICFEATURE	D012178
16970763	987	1001	FEVR di Norrie	DISEASEORPHENOTYPICFEATURE	C537849
16970763	1050	1071	Malattia del mantello	DISEASEORPHENOTYPICFEATURE	D058456
16970763	1119	1122	ROP	DISEASEORPHENOTYPICFEATURE	D012178
16970763	1150	1158	pazienti	ORGANISMTAXON	9606
16970763	1359	1362	NDP	GENEORGENEPRODUCT	4693
16970763	1793	1796	NDP	GENEORGENEPRODUCT	4693
16970763	1836	1846	 Leu103Val	SEQUENCEVARIANT	P|SUB|L|103|V
16970763	1899	1903	FEVR	DISEASEORPHENOTYPICFEATURE	D000080345
16970763	1931	1939	paziente	ORGANISMTAXON	9606
16970763	1979	1987	His43Arg	SEQUENCEVARIANT	P|SUB|H|43|R
16970763	2054	2072	Malattia di Norrie	DISEASEORPHENOTYPICFEATURE	C537849
16970763	2100	2108	pazienti	ORGANISMTAXON	9606
16970763	2183	2188	14-bp	SEQUENCEVARIANT	C|DEL||14
16970763	2353	2356	ROP	DISEASEORPHENOTYPICFEATURE	D012178
16970763	2415	2420	14-bp	SEQUENCEVARIANT	C|DEL||14
16970763	2545	2556	Norrie-FEVR	DISEASEORPHENOTYPICFEATURE	C537849
16970763	2639	2657	Malattia di Norrie	DISEASEORPHENOTYPICFEATURE	C537849
16970763	2705	2712	sordità	DISEASEORPHENOTYPICFEATURE	D003638
16970763	2758	2773	ritardo mentale	DISEASEORPHENOTYPICFEATURE	D008607
16970763	2905	2908	NDP	GENEORGENEPRODUCT	4693
16970763	3000	3018	Malattia di Norrie	DISEASEORPHENOTYPICFEATURE	 C537849
16970763	3079	3083	FEVR	DISEASEORPHENOTYPICFEATURE	D000080345
16970763	3209	3212	ROP	DISEASEORPHENOTYPICFEATURE	D012178
16970763	3333	3344	prematurità	DISEASEORPHENOTYPICFEATURE	 D007235
16970763	3393	3401	ossigeno	CHEMICALENTITY	D010100
16970763	3472	3490	distacco di retina	DISEASEORPHENOTYPICFEATURE	D012163
16970763	3587	3605	Malattia di Norrie	DISEASEORPHENOTYPICFEATURE	C537849
17003923	110	144	tromboembolismo venoso e arterioso	DISEASEORPHENOTYPICFEATURE	D054556
17003923	285	309	malattie cardiovascolari	DISEASEORPHENOTYPICFEATURE	D002318
17003923	916	944	ipercoagulabilità ereditaria	DISEASEORPHENOTYPICFEATURE	D019851
17003923	1124	1146	trombofilia ereditaria	DISEASEORPHENOTYPICFEATURE	C540694
17003923	1360	1369	fattore V	GENEORGENEPRODUCT	2153
17003923	1409	1416	1691G>A	SEQUENCEVARIANT	C|SUB|G|1691|A
17003923	1449	1465	fattore V Leiden	GENEORGENEPRODUCT	2153
17003923	1499	1508	fattore V	GENEORGENEPRODUCT	2153
17003923	1549	1556	4070A>G	SEQUENCEVARIANT	C|SUB|A|4070|G
17003923	1589	1598	fattore V	GENEORGENEPRODUCT	2153
17003923	1646	1657	fattore VII	GENEORGENEPRODUCT	2155
17003923	1696	1705	Arg353Gln	SEQUENCEVARIANT	P|SUB|R|353|Q
17003923	1738	1750	fattore XIII	GENEORGENEPRODUCT	2162
17003923	1788	1796	Val34Leu	SEQUENCEVARIANT	P|SUB|V|34|L
17003923	1830	1846	beta-fibrinogeno	GENEORGENEPRODUCT	2244
17003923	1927	1938	protrombina	GENEORGENEPRODUCT	2147
17003923	1979	1987	20210G>A	SEQUENCEVARIANT	C|SUB|G|20210|A
17003923	2052	2093	inibitore della via del fattore tissutale	GENEORGENEPRODUCT	7035
17003923	2132	2138	536C>T	SEQUENCEVARIANT	C|SUB|C|536|T
17003923	2171	2185	trombomodulina	GENEORGENEPRODUCT	7056
17003923	2225	2231	127G>A	SEQUENCEVARIANT	C|SUB|G|127|A
17003923	2288	2327	enzima di conversione dell'angiotensina	GENEORGENEPRODUCT	1636
17003923	2402	2435	proteasi attivante il fattore VII	GENEORGENEPRODUCT	3026
17003923	2476	2483	1601G>A	SEQUENCEVARIANT	C|SUB|G|1601|A
17003923	2516	2520	FSAP	GENEORGENEPRODUCT	3026
17003923	2564	2609	inibitore dell'attivatore del plasminogeno 1 	GENEORGENEPRODUCT	5054
17003923	2647	2676	675 inserimento/cancellazione	SEQUENCEVARIANT	C|INDEL|675|
17003923	2718	2755	attivatore del plasminogeno tissutale	GENEORGENEPRODUCT	5327
17003923	2900	2924	malattie tromboemboliche	DISEASEORPHENOTYPICFEATURE	D013923
17003923	2959	3001	apolipoproteina E2/E3/E4, glicoproteina Ia	GENEORGENEPRODUCT	22915
17003923	3040	3046	807C>T	SEQUENCEVARIANT	C|SUB|C|807|T
17003923	3079	3111	metilentetraidrofolato reduttasi	GENEORGENEPRODUCT	4524
17003923	3150	3156	677C>T	SEQUENCEVARIANT	C|SUB|C|677|T
17003923	3233	3249	glicoproteina Ia	GENEORGENEPRODUCT	22915
17003923	3288	3294	807C>T	SEQUENCEVARIANT	C|SUB|C|807|T
17059986	66	73	SLC12A3	GENEORGENEPRODUCT	6559
17059986	129	150	 Sindrome di Gitelman	DISEASEORPHENOTYPICFEATURE	D053579
17059986	196	232	ipertensione intracranica idiopatica	DISEASEORPHENOTYPICFEATURE	D011559
17059986	298	319	Sindrome di Gitelman 	DISEASEORPHENOTYPICFEATURE	D053579
17059986	364	366	GS	DISEASEORPHENOTYPICFEATURE	D053579
17059986	462	481	ritardo di crescita	DISEASEORPHENOTYPICFEATURE	D006130
17059986	526	545	alcalosi metabolica	DISEASEORPHENOTYPICFEATURE	D000471
17059986	590	604	ipomagnesiemia	DISEASEORPHENOTYPICFEATURE	C537153
17059986	650	661	ipokaliemia	DISEASEORPHENOTYPICFEATURE	D007008
17059986	735	771	ipertensione intracranica idiopatica	DISEASEORPHENOTYPICFEATURE	D011559
17059986	820	856	ipertensione intracranica idiopatica	DISEASEORPHENOTYPICFEATURE	D011559
17059986	905	927	papilledema bilaterale	DISEASEORPHENOTYPICFEATURE	D010211
17059986	973	992	pseudotumor cerebri	DISEASEORPHENOTYPICFEATURE	D01155 9
17059986	1031	1039	paziente	ORGANISMTAXON	9606
17059986	1129	1162	malformazioni cavernose cerebrali	DISEASEORPHENOTYPICFEATURE	D002543
17059986	1298	1317	sindrome di Bartter	DISEASEORPHENOTYPICFEATURE	D001477
17059986	1459	1466	SLC12A3	GENEORGENEPRODUCT	6559
17059986	1524	1572	serina di leucina in posizione amminoacidica 555	SEQUENCEVARIANT	RS148038173
17059986	1610	1621	p.Ser555Leu	SEQUENCEVARIANT	RS148038173
17059986	1672	1705	transizione da guanina a citosina	SEQUENCEVARIANT	C |SUB|G||C
17059986	1881	1883	GS	DISEASEORPHENOTYPICFEATURE	D053579
17059986	2341	2349	potassio	CHEMICALENTITY	D011188
17059986	2383	2391	magnesio	CHEMICALENTITY	D008274
17059986	2566	2585	sindrome di Bartter	DISEASEORPHENOTYPICFEATURE	D001477
17059986	2629	2631	GS	DISEASEORPHENOTYPICFEATURE	D053579
17059986	2680	2699	pseudotumor cerebri	DISEASEORPHENOTYPICFEATURE	D011559
17059986	2793	2816	anomalie elettrolitiche	DISEASEORPHENOTYPICFEATURE	D014883
17059986	2864	2889	aldosteronismo secondario	DISEASEORPHENOTYPICFEATURE	D001477
17059986	2955	2991	ipertensione intracranica idiopatica	DISEASEORPHENOTYPICFEATURE	D011559
17059986	3108	3110	GS	DISEASEORPHENOTYPICFEATURE	D053579
17059986	3259	3282	cavernomatosi familiare	DISEASEORPHENOTYPICFEATURE	D006392
17059986	3328	3330	GS	DISEASEORPHENOTYPICFEATURE	D053579
17166870	51	59	endoglin	GENEORGENEPRODUCT	2022
17166870	125	143	sistemico sclerosi	DISEASEORPHENOTYPICFEATURE	D012595
17166870	201	233	ipertensione arteriosa polmonare	DISEASEORPHENOTYPICFEATURE	D000081029
17166870	278	296	Sclerosi sistemica	DISEASEORPHENOTYPICFEATURE	D012595
17166870	341	344	SSc	DISEASEORPHENOTYPICFEATURE	D012595
17166870	445	460	microangiopatia	DISEASEORPHENOTYPICFEATURE	D057049
17166870	520	528	Endoglin	GENEORGENEPRODUCT	2022
17166870	566	569	ENG	GENEORGENEPRODUCT	2022
17166870	629	642	glicoproteina	GENEORGENEPRODUCT	351
17166870	718	755	fattore di crescita trasformante-beta	GENEORGENEPRODUCT	7040
17166870	789	797	TGF-beta	GENEORGENEPRODUCT	7040
17166870	903	923	Inserimento a 6 basi	SEQUENCEVARIANT	C|INS||6
17166870	973	978	6bINS	SEQUENCEVARIANT	C|INS||6
17166870	1014	1017	ENG	GENEORGENEPRODUCT	2022
17166870	1178	1183	6bINS	SEQUENCEVARIANT	C|INS||6
17166870	1232	1255	complicazione vascolare	DISEASEORPHENOTYPICFEATURE	D014652
17166870	1302	1334	ipertensione arteriosa polmonare	DISEASEORPHENOTYPICFEATURE	D000081029
17166870	1382	1385	PAH	DISEASEORPHENOTYPICFEATURE	D000081029
17166870	1434	1437	SSc	DISEASEORPHENOTYPICFEATURE	D012595
17166870	1543	1546	SSc	DISEASEORPHENOTYPICFEATURE	D012595
17166870	1620	1623	PAH	DISEASEORPHENOTYPICFEATURE	D000081029
17166870	1717	1725	pazienti	ORGANISMTAXON	9606
17166870	1773	1785	osteoartrosi	DISEASEORPHENOTYPICFEATURE	D010003
17166870	2107	2112	6bINS	SEQUENCEVARIANT	C|INS||6
17166870	2159	2162	SSc	DISEASEORPHENOTYPICFEATURE	D012595
17166870	2190	2198	pazienti	ORGANISMTAXON	9606
17166870	2249	2252	PAH	DISEASEORPHENOTYPICFEATURE	D000081029
17166870	2441	2444	SSc	DISEASEORPHENOTYPICFEATURE	D012595
17166870	2473	2481	pazienti	ORGANISMTAXON	9606
17166870	2534	2537	PAH	DISEASEORPHENOTYPICFEATURE	D000081029
17166870	2671	2676	6bINS	SEQUENCEVARIANT	C|INS||6
17166870	2744	2747	SSc	DISEASEORPHENOTYPICFEATURE	D012595
17166870	2775	2783	pazienti	ORGANISMTAXON	9606
17166870	2834	2837	PAH	DISEASEORPHENOTYPICFEATURE	D000081029
17166870	2956	2961	6bINS	SEQUENCEVARIANT	C|INS||6
17166870	3020	3023	SSc	DISEASEORPHENOTYPICFEATURE	D012595
17166870	3051	3059	pazienti	ORGANISMTAXON	9606
17166870	3118	3121	PAH	DISEASEORPHENOTYPICFEATURE	D000081029
17166870	3184	3187	ITA	GENEORGENEPRODUCT	2022
17166870	3252	3275	complicazione vascolare	DISEASEORPHENOTYPICFEATURE	D014652
17166870	3322	3326	 SSc	DISEASEORPHENOTYPICFEATURE	D012595
17491223	121	131	dobutamina	CHEMICALENTITY	D004280
17491223	183	202	ischemia miocardica	DISEASEORPHENOTYPICFEATURE	D017202
17491223	313	323	dobutamina	CHEMICALENTITY	D004280
17491223	375	394	ischemia miocardica	DISEASEORPHENOTYPICFEATURE	D017202
17491223	667	678	dobutamina 	CHEMICALENTITY	D004280
17491223	730	749	ischemia miocardica	DISEASEORPHENOTYPICFEATURE	D017202
17491223	951	959	ischemia	DISEASEORPHENOTYPICFEATURE	D007511
17491223	1031	1039	pazienti	ORGANISMTAXON	9606
17491223	1100	1110	dobutamina	CHEMICALENTITY	D004280
17491223	1267	1277	dobutamina	CHEMICALENTITY	D004280
17491223	1319	1327	pazienti	ORGANISMTAXON	9606
17491223	1409	1417	ischemia	DISEASEORPHENOTYPICFEATURE	D007511
17491223	1524	1534	dobutamina	CHEMICALENTITY	D004280
17491223	2241	2261	ischemia miocardica 	DISEASEORPHENOTYPICFEATURE	D017202
17491223	2307	2315	pazienti	ORGANISMTAXON	9606
17511042	72	93	parassitosi delirante	DISEASEORPHENOTYPICFEATURE	D063726
17511042	144	161	epatite cronica C	DISEASEORPHENOTYPICFEATURE	D019698
17511042	189	197	paziente	ORGANISMTAXON	9606
17511042	237	265	interferone pegilato alfa-2b	GENEORGENEPRODUCT	3440
17511042	299	325	trattamento con ribavirina	CHEMICALENTITY	D012254
17511042	396	413	epatite cronica C	DISEASEORPHENOTYPICFEATURE	D019698
17511042	441	449	pazienti	ORGANISMTAXON	9606
17511042	486	497	interferone	GENEORGENEPRODUCT	3440
17511042	531	541	ribavirina	CHEMICALENTITY	D012254
17511042	631	639	pazienti	ORGANISMTAXON	9606
17511042	694	705	depressione	DISEASEORPHENOTYPICFEATURE	D003866
17511042	751	759	pazienti	ORGANISMTAXON	9606
17511042	813	820	psicosi	DISEASEORPHENOTYPICFEATURE	D011605
17511042	904	925	parassitosi psicogena	DISEASEORPHENOTYPICFEATURE	D063726
17511042	981	992	interferone	GENEORGENEPRODUCT	3440
17511042	1087	1092	donna	ORGANISMTAXON	9606
17511042	1169	1190	parassitosi delirante	DISEASEORPHENOTYPICFEATURE	D063726
17511042	1249	1277	interferone pegilato alfa-2b	GENEORGENEPRODUCT	3440
17511042	1323	1333	ribavirina	CHEMICALENTITY	D012254
17511042	1544	1572	interferone pegilato alfa-2b	GENEORGENEPRODUCT	3440
17562951	68	76	Pazienti	ORGANISMTAXON	9606
17562951	166	175	contrasto	CHEMICALENTITY	D003287
17562951	227	237	nefropatia	DISEASEORPHENOTYPICFEATURE	D007674
17562951	269	277	pazienti	ORGANISMTAXON	9606
17562951	325	353	insufficienza renale cronica	DISEASEORPHENOTYPICFEATURE	D051436
17562951	479	497	mezzo di contrasto	CHEMICALENTITY	D003287
17562951	529	538	iopamidol	CHEMICALENTITY	D007479
17562951	601	619	mezzo di contrasto	CHEMICALENTITY	D003287
17562951	651	660	iodixanol	CHEMICALENTITY	C044834
17562951	691	699	pazienti	ORGANISMTAXON	9606
17562951	850	860	iopamidolo	CHEMICALENTITY	D007479
17562951	894	903	iodixanol	CHEMICALENTITY	C044834
17562951	934	942	pazienti	ORGANISMTAXON	9606
17562951	990	1013	malattia renale cronica	DISEASEORPHENOTYPICFEATURE	D051436
17562951	1203	1213	creatinina	CHEMICALENTITY	D003404
17562951	1246	1249	SCr	CHEMICALENTITY	D003404
17562951	1452	1455	SCr	CHEMICALENTITY	D003404
17562951	1587	1590	SCr	CHEMICALENTITY	D003404
17562951	1756	1759	SCr	CHEMICALENTITY	D003404
17562951	1795	1803	pazienti	ORGANISMTAXON	9606
17562951	1836	1845	contrasto	CHEMICALENTITY	D003287
17562951	1910	1925	diabete mellito	DISEASEORPHENOTYPICFEATURE	D003920
17562951	1965	1981	N-acetilcisteina	CHEMICALENTITY	D000111
17562951	2035	2038	SCr	CHEMICALENTITY	 D003404
17562951	2151	2154	SCr	CHEMICALENTITY	D003404
17562951	2241	2249	pazienti	ORGANISMTAXON	9606
17562951	2287	2296	iopamidol	CHEMICALENTITY	D007479
17562951	2342	2350	pazienti	ORGANISMTAXON	9606
17562951	2388	2397	iodixanol	CHEMICALENTITY	C044834
17562951	2455	2458	SCr	CHEMICALENTITY	D003404
17562951	2564	2572	pazienti	ORGANISMTAXON	9606
17562951	2620	2627	diabete	DISEASEORPHENOTYPICFEATURE	D003920
17562951	2661	2664	SCr	CHEMICALENTITY	D003404
17562951	2736	2744	pazienti	ORGANISMTAXON	9606
17562951	2782	2791	iopamidol	CHEMICALENTITY	D007479
17562951	2837	2845	pazienti	ORGANISMTAXON	9606
17562951	2883	2892	iodixanol	CHEMICALENTITY	C044834
17562951	2941	2944	SCr	CHEMICALENTITY	D003404
17562951	3062	3065	SCr	CHEMICALENTITY	D003404
17562951	3141	3150	iopamidol	CHEMICALENTITY	D007479
17562951	3190	3198	pazienti	ORGANISMTAXON	9606
17562951	3287	3295	pazienti	ORGANISMTAXON	9606
17562951	3343	3350	diabete	DISEASEORPHENOTYPICFEATURE	D003920
17562951	3469	3478	contrasto	CHEMICALENTITY	D003287
17562951	3530	3540	nefropatia	DISEASEORPHENOTYPICFEATURE	D007674
17562951	3684	3694	iopamidolo	CHEMICALENTITY	D007479
17562951	3728	3737	iodixanol	CHEMICALENTITY	C044834
17562951	3767	3775	pazienti	ORGANISMTAXON	9606
17562951	3848	3863	diabete mellito	DISEASEORPHENOTYPICFEATURE	D003920
17879945	31	40	Estrogeno	CHEMICALENTITY	D004967
17879945	81	102	estere di colesterolo	CHEMICALENTITY	D002788
17879945	231	240	ritonavir	CHEMICALENTITY	D019438
17879945	288	291	HIV	ORGANISMTAXON	11676
17879945	432	441	ritonavir	CHEMICALENTITY	D019438
17879945	573	596	aterosclerosi prematura	DISEASEORPHENOTYPICFEATURE	D050197
17879945	668	677	ritonavir	CHEMICALENTITY	D019438
17879945	744	767	lesione aterosclerotica	DISEASEORPHENOTYPICFEATURE	D050197
17879945	820	824	topi	ORGANISMTAXON	10090
17879945	894	898	topi	ORGANISMTAXON	10090
17879945	1009	1018	ritonavir	CHEMICALENTITY	D019438
17879945	1063	1085	estere del colesterolo	CHEMICALENTITY	D002788
17879945	1265	1276	colesterolo	CHEMICALENTITY	D002784
17879945	1394	1403	ritonavir	CHEMICALENTITY	D019438
17879945	1483	1488	umano	ORGANISMTAXON	9606
17879945	1749	1766	17beta-estradiolo	CHEMICALENTITY	D004958
17879945	1800	1802	E2	CHEMICALENTITY	D004958
17879945	1843	1855	progesterone	CHEMICALENTITY	D011374
17879945	1905	1912	etanolo	CHEMICALENTITY	D000431
17879945	1997	2006	ritonavir	CHEMICALENTITY	D019438
17879945	2132	2137	lipid	CHEMICALENTITY	D008055
17879945	2201	2203	E2	CHEMICALENTITY	D004958
17879945	2262	2284	esteri del colesterolo	CHEMICALENTITY	D002788
17879945	2336	2345	ritonavir	CHEMICALENTITY	D019438
17879945	2390	2399	Ritonavir	CHEMICALENTITY	D019438
17879945	2482	2486	CD36	GENEORGENEPRODUCT	948
17879945	2591	2600	ritonavir	CHEMICALENTITY	D019438
17879945	2682	2691	PPARgamma	GENEORGENEPRODUCT	5468
17879945	2814	2818	CD36	GENEORGENEPRODUCT	948
17879945	2870	2872	E2	CHEMICALENTITY	D004958
17879945	2976	2978	E2	CHEMICALENTITY	D004958
17879945	3055	3059	CD36	GENEORGENEPRODUCT	948
17879945	3187	3189	E2	CHEMICALENTITY	D004958
17879945	3246	3250	CD36	GENEORGENEPRODUCT	948
17879945	3395	3417	estere del colesterolo	CHEMICALENTITY	D002788
17879945	3462	3471	ritonavir	CHEMICALENTITY	D019438
17935240	77	109	Retinite pigmentosa legata all'X	DISEASEORPHENOTYPICFEATURE	D012174
17935240	230	234	RPGR	GENEORGENEPRODUCT	6103
17935240	318	350	Retinite pigmentosa legata all'X	DISEASEORPHENOTYPICFEATURE	D012174
17935240	395	399	XLRP	DISEASEORPHENOTYPICFEATURE	D012174
17935240	536	540	XLRP	DISEASEORPHENOTYPICFEATURE	D012174
17935240	607	609	RP	DISEASEORPHENOTYPICFEATURE	D012174
17935240	815	819	RPGR	GENEORGENEPRODUCT	6103
17935240	1290	1298	pazienti	ORGANISMTAXON	9606
17935240	1713	1718	donna	ORGANISMTAXON	9606
17935240	1803	1807	RPGR	GENEORGENEPRODUCT	6103
17935240	1939	1943	XLRP	DISEASEORPHENOTYPICFEATURE	D012174
17935240	2058	2060	RP	DISEASEORPHENOTYPICFEATURE	D012174
17935240	2086	2088	RP	DISEASEORPHENOTYPICFEATURE	D012174
18179903	55	61	CHRNA1	GENEORGENEPRODUCT	1134
18179903	94	100	CHRNB1	GENEORGENEPRODUCT	1140
18179903	133	138	CHRND	GENEORGENEPRODUCT	1144
18179903	172	177	RAPSN	GENEORGENEPRODUCT	5913
18179903	229	258	sindrome da pterigio multiplo	DISEASEORPHENOTYPICFEATURE	C537377
18179903	302	317	acinesia fetale	DISEASEORPHENOTYPICFEATURE	C536647
18179903	346	354	pazienti	ORGANISMTAXON	9606
18179903	399	428	Sindromi multiple di pterigio	DISEASEORPHENOTYPICFEATURE	C537377
18179903	473	476	MPS	DISEASEORPHENOTYPICFEATURE	C537377
18179903	549	567	anomalie congenite	DISEASEORPHENOTYPICFEATURE	D000013
18179903	684	706	contratture articolari	DISEASEORPHENOTYPICFEATURE	D003286
18179903	751	763	artrogriposi	DISEASEORPHENOTYPICFEATURE	D001176
18179903	809	812	MPS	DISEASEORPHENOTYPICFEATURE	C537377
18179903	1052	1105	subunità g del recettore embrionale dell'acetilcolina	GENEORGENEPRODUCT	1146
18179903	1138	1143	CHRNG	GENEORGENEPRODUCT	1146
18179903	1226	1229	MPS	DISEASEORPHENOTYPICFEATURE	C537377
18179903	1319	1334	acinesia fetale	DISEASEORPHENOTYPICFEATURE	C536647
18179903	1496	1499	MPS	DISEASEORPHENOTYPICFEATURE	C537377
18179903	1543	1558	acinesia fetale	DISEASEORPHENOTYPICFEATURE	C536647
18179903	1650	1653	MPS	DISEASEORPHENOTYPICFEATURE	C537377
18179903	1697	1712	acinesia fetale	DISEASEORPHENOTYPICFEATURE	C536647
18179903	1760	1765	CHRNG	GENEORGENEPRODUCT	1146
18179903	1818	1824	CHRNA1	GENEORGENEPRODUCT	1134
18179903	1858	1864	CHRNB1	GENEORGENEPRODUCT	1140
18179903	1897	1902	CHRND	GENEORGENEPRODUCT	1144
18179903	1936	1948	 geni rapsyn	GENEORGENEPRODUCT	5913
18179903	1981	1986	RAPSN	GENEORGENEPRODUCT	5913
18179903	2023	2029	CHRNA1	GENEORGENEPRODUCT	1134
18179903	2062	2068	CHRNB1	GENEORGENEPRODUCT	1140
18179903	2103	2108	CHRND	GENEORGENEPRODUCT	 1144
18179903	2198	2203	RAPSN	GENEORGENEPRODUCT	5913
18179903	2395	2422	sequenza di acinesia fetale	DISEASEORPHENOTYPICFEATURE	C536647
18179903	2501	2506	RAPSN	GENEORGENEPRODUCT	5913
18179903	2553	2572	miastenia congenita	DISEASEORPHENOTYPICFEATURE	D020294
18179903	2703	2709	rapsyn	GENEORGENEPRODUCT	5913
18179903	2765	2784	miastenia congenita	DISEASEORPHENOTYPICFEATURE	D020294
18179903	2899	2914	acinesia fetale	DISEASEORPHENOTYPICFEATURE	C536647
18257781	64	68	PKD1	GENEORGENEPRODUCT	5310
18257781	113	126	Variante PKD2	GENEORGENEPRODUCT	5311
18257781	201	251	malattia del rene policistico autosomico dominante	DISEASEORPHENOTYPICFEATURE	D007690
18257781	308	345	Rene policistico autosomico dominante	DISEASEORPHENOTYPICFEATURE	 D007690
18257781	390	395	ADPKD	DISEASEORPHENOTYPICFEATURE	D007690
18257781	460	473	policistine 1	GENEORGENEPRODUCT	5310
18257781	506	509	PC1	GENEORGENEPRODUCT	5310
18257781	547	550	PC2	GENEORGENEPRODUCT	5311
18257781	608	623	malattie renali	DISEASEORPHENOTYPICFEATURE	D007674
18257781	774	779	ADPKD	DISEASEORPHENOTYPICFEATURE	D007690
18257781	807	815	pazienti	ORGANISMTAXON	9606
18257781	969	977	paziente	ORGANISMTAXON	9606
18257781	1055	1066	c.1445T > G	SEQUENCEVARIANT	RS75762896
18257781	1191	1248	 alla cisteina idrofila polare nell'esone 6 al codone 482	SEQUENCEVARIANT	RS75762896
18257781	1286	1293	p.F482C	SEQUENCEVARIANT	RS75762896
18257781	1335	1339	PKD2	GENEORGENEPRODUCT	5311
18257781	1385	1389	PKD1	GENEORGENEPRODUCT	5310
18257781	1546	1550	PKD2	GENEORGENEPRODUCT	5311
18257781	1716	1720	PKD1	GENEORGENEPRODUCT	5310
18257781	1790	1794	PKD2	GENEORGENEPRODUCT	5311
18257781	1895	1903	paziente	ORGANISMTAXON	9606
18257781	2036	2044	paziente	ORGANISMTAXON	9606
18257781	2298	2302	PKD2	GENEORGENEPRODUCT	18764
18257781	2331	2335	topo	ORGANISMTAXON	10090
18257781	2521	2528	p.F482C	SEQUENCEVARIANT	RS75762896
18257781	2606	2619	policistina-2	GENEORGENEPRODUCT	5311
18257781	2736	2744	paziente	ORGANISMTAXON	9606
18257781	2792	2797	ADPKD	DISEASEORPHENOTYPICFEATURE	D007690
18257781	2872	2876	PKD1	GENEORGENEPRODUCT	5310
18257781	2944	2948	PKD2	GENEORGENEPRODUCT	5311
18399341	289	300	ipotensione	DISEASEORPHENOTYPICFEATURE	D007022
18399341	669	677	pazienti	ORGANISMTAXON	9606
18399341	788	798	I pazienti	ORGANISMTAXON	9606
18399341	1008	1016	pazienti	ORGANISMTAXON	9606
18399341	1095	1106	bupivacaina	CHEMICALENTITY	D002045
18399341	1172	1182	I pazienti	ORGANISMTAXON	9606
18399341	1502	1510	ossigeno	CHEMICALENTITY	D010100
18399341	1595	1603	pazienti	ORGANISMTAXON	9606
18399341	1732	1743	ipotensione	DISEASEORPHENOTYPICFEATURE	D007022
18399341	1797	1805	pazienti	ORGANISMTAXON	9606
18399341	1916	1939	infusione di epinefrina	CHEMICALENTITY	D004837
18399341	2005	2016	ipotensione	DISEASEORPHENOTYPICFEATURE	D007022
18399341	2045	2055	I pazienti	ORGANISMTAXON	9606
18399341	2313	2321	ossigeno	CHEMICALENTITY	D010100
18399341	2660	2668	ossigeno	CHEMICALENTITY	D010100
18439803	48	73	N-(2-propilpentanoil)urea	CHEMICALENTITY	C108761
18439803	159	170	pilocarpina	CHEMICALENTITY	D010862
18439803	225	230	crisi	DISEASEORPHENOTYPICFEATURE	D012640
18439803	262	268	 ratti	ORGANISMTAXON	10116
18439803	443	453	glutammato	CHEMICALENTITY	D018698
18439803	487	496	aspartato	CHEMICALENTITY	D001224
18439803	529	536	glicina	CHEMICALENTITY	D005998
18439803	570	574	GABA	CHEMICALENTITY	D005680
18439803	610	635	N-(2-propilpentanoil)urea	CHEMICALENTITY	C108761
18439803	668	671	VPU	CHEMICALENTITY	C108761
18439803	743	758	acido valproico	CHEMICALENTITY	D014635
18439803	791	794	VPA	CHEMICALENTITY	D014635
18439803	828	831	VPU	CHEMICALENTITY	C108761
18439803	882	885	VPA	CHEMICALENTITY	D014635
18439803	992	997	ratti	ORGANISMTAXON	10116
18439803	1036	1047	pilocarpina	CHEMICALENTITY	D010862
18439803	1100	1111	convulsioni	DISEASEORPHENOTYPICFEATURE	D012640
18439803	1179	1182	VPA	CHEMICALENTITY	D014635
18439803	1313	1324	pilocarpina	CHEMICALENTITY	D010862
18439803	1408	1419	 glutammato	CHEMICALENTITY	D018698
18439803	1453	1462	aspartato	CHEMICALENTITY	D001224
18439803	1565	1572	glicina	CHEMICALENTITY	D005998
18439803	1606	1610	GABA	CHEMICALENTITY	D005680
18439803	1662	1665	VPU	CHEMICALENTITY	C108761
18439803	1716	1719	VPA	CHEMICALENTITY	D014635
18439803	1791	1802	pilocarpina	CHEMICALENTITY	D010862
18439803	1856	1866	glutammato	CHEMICALENTITY	D018698
18439803	1900	1909	aspartato	CHEMICALENTITY	D001224
18439803	2031	2035	GABA	CHEMICALENTITY	D005680
18439803	2069	2076	glicina	CHEMICALENTITY	D005998
18439803	2157	2167	glutammato	CHEMICALENTITY	D018698
18439803	2201	2210	aspartato	CHEMICALENTITY	D001224
18439803	2279	2282	VPU	CHEMICALENTITY	C108761
18439803	2316	2319	VPA	CHEMICALENTITY	D014635
18439803	2388	2391	VPA	CHEMICALENTITY	D014635
18439803	2423	2434	pilocarpina	CHEMICALENTITY	D010862
18439803	2489	2500	convulsioni	DISEASEORPHENOTYPICFEATURE	D012640
18439803	2672	2682	glutammato	CHEMICALENTITY	D018698
18439803	2716	2725	aspartato	CHEMICALENTITY	D001224
18439803	2773	2776	VPA	CHEMICALENTITY	D014635
18439803	2825	2828	VPU	CHEMICALENTITY	C108761
18439803	2891	2902	pilocarpina	CHEMICALENTITY	D010862
18439803	2953	2963	glutammato	CHEMICALENTITY	D018698
18439803	2998	3007	aspartato	CHEMICALENTITY	D001224
18439803	3130	3141	pilocarpina	CHEMICALENTITY	D010862
18439803	3194	3205	convulsioni	DISEASEORPHENOTYPICFEATURE	D012640
18441470	43	76	Blocco atrioventricolare completo	DISEASEORPHENOTYPICFEATURE	D054537
18441470	121	126	litio	CHEMICALENTITY	D008094
18441470	179	211	Disfunzione del nodo senoatriale	DISEASEORPHENOTYPICFEATURE	D012804
18441470	300	331	effetti cardiovascolari avversi	DISEASEORPHENOTYPICFEATURE	D018376
18441470	366	371	litio	CHEMICALENTITY	D008094
18441470	435	473	blocco atrioventricolare (AV) completo	DISEASEORPHENOTYPICFEATURE	D054537
18441470	521	539	attacchi sincopali	DISEASEORPHENOTYPICFEATURE	D013575
18441470	607	612	litio	CHEMICALENTITY	D008094
18441470	715	720	litio	CHEMICALENTITY	D008094
18441470	837	855	attacchi sincopali	DISEASEORPHENOTYPICFEATURE	D013575
18441470	889	897	Il litio	CHEMICALENTITY	D008094
18441470	981	989	pazienti	ORGANISMTAXON	9606
18503483	43	53	tacrolimus	CHEMICALENTITY	D016559
18503483	107	124	neurite brachiale	DISEASEORPHENOTYPICFEATURE	D020968
18503483	181	191	everolimus	CHEMICALENTITY	D000068338
18503483	315	318	TAC	CHEMICALENTITY	D016559
18503483	470	487	La neurotossicità	DISEASEORPHENOTYPICFEATURE	D020258
18503483	594	607	encefalopatia	DISEASEORPHENOTYPICFEATURE	D001927
18503483	652	664	mal di testa	DISEASEORPHENOTYPICFEATURE	D006261
18503483	711	722	convulsioni	DISEASEORPHENOTYPICFEATURE	D012640
18503483	769	788	deficit neurologici	DISEASEORPHENOTYPICFEATURE	D009461
18503483	1076	1083	mielite	DISEASEORPHENOTYPICFEATURE	D009187
18503483	1139	1158	plessite brachiale 	DISEASEORPHENOTYPICFEATURE	D020968
18503483	1241	1244	TAC	CHEMICALENTITY	D016559
18503483	1341	1358	metilprednisolone	CHEMICALENTITY	D008775
18503483	1491	1494	TAC	CHEMICALENTITY	D016559
18503483	1591	1601	everolimus	CHEMICALENTITY	D000068338
18507837	139	153	cancro al seno	DISEASEORPHENOTYPICFEATURE	D001943
18507837	377	391	cancro al seno	DISEASEORPHENOTYPICFEATURE	D001943
18507837	753	758	CCND1	GENEORGENEPRODUCT	595
18507837	790	796	CCND2 	GENEORGENEPRODUCT	894
18507837	828	833	CCND3	GENEORGENEPRODUCT	896
18507837	865	870	CCNE1	GENEORGENEPRODUCT	898
18507837	904	914	CDK2 [p33]	GENEORGENEPRODUCT	1017
18507837	947	951	CDK4	GENEORGENEPRODUCT	1019
18507837	985	989	CDK6	GENEORGENEPRODUCT	 1021
18507837	1022	1028	CDKN1A	GENEORGENEPRODUCT	1026
18507837	1061	1064	p21	GENEORGENEPRODUCT	1026
18507837	1097	1101	Cip1	GENEORGENEPRODUCT	1026
18507837	1135	1141	CDKN1B	GENEORGENEPRODUCT	1027
18507837	1175	1184	p27, Kip1	GENEORGENEPRODUCT	1027
18507837	1218	1224	CDKN2A	GENEORGENEPRODUCT	1029
18507837	1257	1260	p16	GENEORGENEPRODUCT	1029
18507837	1294	1300	CDKN2B	GENEORGENEPRODUCT	1030
18507837	1333	1336	p15	GENEORGENEPRODUCT	1030
18507837	1371	1377	CDKN2C	GENEORGENEPRODUCT	1031
18507837	1410	1413	p18	GENEORGENEPRODUCT	1031
18507837	1448	1455	 CDKN2D	GENEORGENEPRODUCT	1032
18507837	1488	1491	p19	GENEORGENEPRODUCT	1029
18507837	1541	1546	donne	ORGANISMTAXON	9606
18507837	1607	1634	carcinoma mammario invasivo	DISEASEORPHENOTYPICFEATURE	D001943
18507837	1769	1790	tumore della mammella	DISEASEORPHENOTYPICFEATURE	D001943
18507837	1856	1861	donne	ORGANISMTAXON	9606
18507837	2238	2247	rs2479717	SEQUENCEVARIANT	RS2479717
18507837	2330	2336	 morte	DISEASEORPHENOTYPICFEATURE	D003643
18507837	2539	2546	 tumore	DISEASEORPHENOTYPICFEATURE	D009369
18507837	2686	2691	CCND3	GENEORGENEPRODUCT	896
18507837	2723	2727	BYSL	GENEORGENEPRODUCT	705
18507837	2761	2765	TRFP	GENEORGENEPRODUCT	55031
18507837	2799	2804	USP49	GENEORGENEPRODUCT	25862
18507837	2839	2846	C6ofr49	GENEORGENEPRODUCT	29964
18507837	2880	2884	FRS3	GENEORGENEPRODUCT	10817
18507837	2918	2921	PGC	GENEORGENEPRODUCT	5225
18507837	3058	3072	tumori mammari	DISEASEORPHENOTYPICFEATURE	D001943
18507837	3227	3234	C6orf49	GENEORGENEPRODUCT	29964
18507837	3318	3332	cancro al seno	DISEASEORPHENOTYPICFEATURE	D001943
18507837	3442	3447	CCND3	GENEORGENEPRODUCT	896
18507837	3482	3491	rs2479717	SEQUENCEVARIANT	RS2479717
18507837	3615	3629	cancro al seno	DISEASEORPHENOTYPICFEATURE	D001943
18991055	66	73	SLC30A8	GENEORGENEPRODUCT	169026
18991055	106	110	HHEX	GENEORGENEPRODUCT	3087
18991055	148	156	CDKN2A/B	GENEORGENEPRODUCT	1029,1030
18991055	190	197	IGF2BP2	GENEORGENEPRODUCT	10644
18991055	231	234	FTO	GENEORGENEPRODUCT	79068
18991055	267	271	WFS1	GENEORGENEPRODUCT	7466
18991055	306	312	CDKAL1	GENEORGENEPRODUCT	 54901
18991055	345	350	KCNQ1	GENEORGENEPRODUCT	3784
18991055	396	413	diabete di tipo 2	DISEASEORPHENOTYPICFEATURE	D003924
18991055	640	665	diabete mellito di tipo 2	DISEASEORPHENOTYPICFEATURE	D003924
18991055	710	714	T2DM	DISEASEORPHENOTYPICFEATURE	D003924
18991055	832	839	SLC30A8	GENEORGENEPRODUCT	169026
18991055	872	876	HHEX	GENEORGENEPRODUCT	3087
18991055	914	922	CDKN2A/B	GENEORGENEPRODUCT	1029,1030
18991055	956	963	IGF2BP2	GENEORGENEPRODUCT	10644
18991055	998	1001	FTO	GENEORGENEPRODUCT	79068
18991055	1034	1038	WFS1	GENEORGENEPRODUCT	7466
18991055	1072	1079	CDKAL1 	GENEORGENEPRODUCT	54901
18991055	1113	1118	KCNQ1	GENEORGENEPRODUCT	3784
18991055	1178	1182	T2DM	DISEASEORPHENOTYPICFEATURE	D003924
18991055	1323	1331	pazienti	ORGANISMTAXON	9606
18991055	1379	1383	T2DM	DISEASEORPHENOTYPICFEATURE	D003924
18991055	1447	1456	diabetici	DISEASEORPHENOTYPICFEATURE	D003920
18991055	1515	1525	rs13266634	SEQUENCEVARIANT	RS13266634
18991055	1561	1570	rs1111875	SEQUENCEVARIANT	RS1111875
18991055	1608	1618	rs10811661	SEQUENCEVARIANT	 RS10811661
18991055	1654	1663	rs4402960	SEQUENCEVARIANT	RS4402960
18991055	1700	1709	rs8050136	SEQUENCEVARIANT	RS8050136
18991055	1744	1752	rs734312	SEQUENCEVARIANT	RS734312
18991055	1788	1797	rs7754840	SEQUENCEVARIANT	RS7754840
18991055	1835	1844	rs2237892	SEQUENCEVARIANT	 RS2237892
18991055	1954	1962	glucosio	CHEMICALENTITY	D005947
18991055	2000	2008	pazienti	ORGANISMTAXON	9606
18991055	2114	2120	CDKAL1	GENEORGENEPRODUCT	54901
18991055	2156	2165	rs7754840	SEQUENCEVARIANT	RS7754840
18991055	2283	2292	rs1111875	SEQUENCEVARIANT	RS1111875
18991055	2378	2382	HHEX	GENEORGENEPRODUCT	3087
18991055	2434	2444	rs10811661	SEQUENCEVARIANT	RS10811661
18991055	2534	2542	CDKN2A/B	GENEORGENEPRODUCT	1029,1030
18991055	2595	2604	rs2237892	SEQUENCEVARIANT	RS2237892
18991055	2682	2687	KCNQ1	GENEORGENEPRODUCT	3784
18991055	2774	2778	T2DM	DISEASEORPHENOTYPICFEATURE	D003924
18991055	2815	2825	Rs13266634	SEQUENCEVARIANT	RS13266634
18991055	2905	2912	SLC30A8	GENEORGENEPRODUCT	169026
18991055	3011	3015	T2DM	DISEASEORPHENOTYPICFEATURE	D003924
18991055	3067	3074	IGF2BP2	GENEORGENEPRODUCT	10644
18991055	3108	3111	FTO	GENEORGENEPRODUCT	79068
18991055	3145	3149	WFS1	GENEORGENEPRODUCT	7466
18991055	3255	3258	HEX	GENEORGENEPRODUCT	3087
18991055	3296	3304	CDKN2A/B	GENEORGENEPRODUCT	1029,1030
18991055	3338	3344	CDKAL1	GENEORGENEPRODUCT	54901
18991055	3377	3382	KCNQ1	GENEORGENEPRODUCT	3784
18991055	3419	3426	SLC30A8	GENEORGENEPRODUCT	169026
18991055	3495	3499	T2DM	DISEASEORPHENOTYPICFEATURE	D003924
19207031	31	52	Ormone della crescita	GENEORGENEPRODUCT	2688
19207031	104	139	deficit dell'ormone della crescita 	DISEASEORPHENOTYPICFEATURE	D004393
19207031	216	221	IGF-1	GENEORGENEPRODUCT	3479
19207031	396	401	IGF-1	GENEORGENEPRODUCT	3479
19207031	470	475	IGF-1	GENEORGENEPRODUCT	3479
19207031	568	573	IGF-1	GENEORGENEPRODUCT	3479
19207031	674	695	ormone della crescita	GENEORGENEPRODUCT	2688
19207031	728	730	GH	GENEORGENEPRODUCT	2688
19207031	825	827	GH	GENEORGENEPRODUCT	2688
19207031	880	893	deficit di GH	DISEASEORPHENOTYPICFEATURE	D004393
19207031	921	929	pazienti	ORGANISMTAXON	9606
19207031	1033	1038	IGF-1	GENEORGENEPRODUCT	3479
19207031	1088	1090	GH	GENEORGENEPRODUCT	2688
19207031	1142	1154	Gh-deficient	DISEASEORPHENOTYPICFEATURE	D004393
19207031	1190	1198	pazienti	ORGANISMTAXON	9606
19207031	1242	1250	pazienti	ORGANISMTAXON	9606
19207031	1317	1323	uomini	ORGANISMTAXON	9606
19207031	1355	1360	donne	ORGANISMTAXON	9606
19207031	1483	1496	deficit di GH	DISEASEORPHENOTYPICFEATURE	D004393
19207031	1541	1544	GHD	DISEASEORPHENOTYPICFEATURE	D004393
19207031	1692	1700	Pazienti	ORGANISMTAXON	9606
19207031	1747	1749	GH	GENEORGENEPRODUCT	2688
19207031	1842	1844	GH	GENEORGENEPRODUCT	2688
19207031	1904	1909	IGF-1	GENEORGENEPRODUCT	3479
19207031	1942	1944	GH	GENEORGENEPRODUCT	2688
19207031	2009	2014	IGF-1	GENEORGENEPRODUCT	3479
19207031	2062	2067	IGF-1	GENEORGENEPRODUCT	3479
19207031	2139	2144	IGF-1	GENEORGENEPRODUCT	3479
19207031	2176	2178	GH	GENEORGENEPRODUCT	2688
19207031	2307	2316	rs1019731	SEQUENCEVARIANT	RS1019731
19207031	2397	2402	IGF-1	GENEORGENEPRODUCT	3479
19207031	2523	2525	GH	GENEORGENEPRODUCT	2688
19207031	2563	2587	 Concentrazioni di IGF-1	GENEORGENEPRODUCT	3479
19207031	2620	2625	IGF-1	GENEORGENEPRODUCT	3479
19207031	2663	2669	IGF-1 	GENEORGENEPRODUCT	3479
19207031	2701	2703	GH	GENEORGENEPRODUCT	2688
19207031	2825	2830	IGF-1	GENEORGENEPRODUCT	3479
19207031	2924	2926	GH	GENEORGENEPRODUCT	2688
19207031	2973	2976	GHD	DISEASEORPHENOTYPICFEATURE	D004393
19207031	3052	3057	IGF-1	GENEORGENEPRODUCT	3479
19207031	3147	3149	GH	GENEORGENEPRODUCT	2688
19207031	3181	3184	IGF	GENEORGENEPRODUCT	3479
19207031	3256	3258	GH	GENEORGENEPRODUCT	2688
19208385	43	74	Osteogenesi imperfetta tipo III	DISEASEORPHENOTYPICFEATURE	C536044
19208385	122	144	emorragia intracranica	DISEASEORPHENOTYPICFEATURE	D020300
19208385	190	204	brachidattilia	DISEASEORPHENOTYPICFEATURE	D059327
19208385	275	281	COL1A2	GENEORGENEPRODUCT	1278
19208385	326	348	Osteogenesi imperfetta	DISEASEORPHENOTYPICFEATURE	D010013
19208385	393	395	OI	DISEASEORPHENOTYPICFEATURE	D010013
19208385	458	472	disturbo osseo	DISEASEORPHENOTYPICFEATURE	D001847
19208385	534	542	fratture	DISEASEORPHENOTYPICFEATURE	D050723
19208385	591	597	trauma	DISEASEORPHENOTYPICFEATURE	D014947
19208385	642	664	Emorragia intracranica	DISEASEORPHENOTYPICFEATURE	D020300
19208385	750	752	OI	DISEASEORPHENOTYPICFEATURE	D010013
19208385	781	789	pazienti	ORGANISMTAXON	9606
19208385	838	846	pazienti	ORGANISMTAXON	9606
19208385	951	962	OI tipo III	DISEASEORPHENOTYPICFEATURE	 C536044
19208385	1022	1044	emorragia intracranica	DISEASEORPHENOTYPICFEATURE	D020300
19208385	1104	1119	brachidattilia 	DISEASEORPHENOTYPICFEATURE	D059327
19208385	1165	1186	ipoplasia dell'unghia	DISEASEORPHENOTYPICFEATURE	D009260
19208385	1231	1239	pazienti	ORGANISMTAXON	9606
19208385	1284	1286	OI	DISEASEORPHENOTYPICFEATURE	D010013
19208385	1397	1403	COL1A2	GENEORGENEPRODUCT	1278
19208385	1517	1540	collagene tipo I alfa 2	GENEORGENEPRODUCT	1278
19208385	1661	1687	collagene di tipo I alfa 2	GENEORGENEPRODUCT	1278
19208385	1764	1792	anormale sviluppo degli arti	DISEASEORPHENOTYPICFEATURE	D009140
19208385	1838	1860	emorragia intracranica	DISEASEORPHENOTYPICFEATURE	D020300
19276632	58	63	FOXF2	GENEORGENEPRODUCT	2295
19276632	94	102	pazienti	ORGANISMTAXON	9606
19276632	150	182	disturbi dello sviluppo sessuale	DISEASEORPHENOTYPICFEATURE	D012734
19276632	227	230	DSD	DISEASEORPHENOTYPICFEATURE	D012734
19276632	295	307	palatoschisi	DISEASEORPHENOTYPICFEATURE	D002972
19276632	369	409	disturbi della differenziazione sessuale	DISEASEORPHENOTYPICFEATURE	D012734
19276632	465	474	androgeno	CHEMICALENTITY	D000728
19276632	527	536	androgeno	CHEMICALENTITY	D000728
19276632	676	681	umani	ORGANISMTAXON	9606
19276632	780	785	FOXF2	GENEORGENEPRODUCT	2295
19276632	837	842	umano	ORGANISMTAXON	9606
19276632	894	899	Foxf2	GENEORGENEPRODUCT	14238
19276632	941	945	topi	ORGANISMTAXON	10090
19276632	1002	1014	palatoschisi	DISEASEORPHENOTYPICFEATURE	D002972
19276632	1079	1111	ipoplasia del tubercolo genitale	DISEASEORPHENOTYPICFEATURE	C537540
19276632	1163	1168	umani	ORGANISMTAXON	9606
19276632	1216	1248	disturbi dello sviluppo sessuale	DISEASEORPHENOTYPICFEATURE	D012734
19276632	1294	1297	DSD	DISEASEORPHENOTYPICFEATURE	D012734
19276632	1362	1374	palatoschisi	DISEASEORPHENOTYPICFEATURE	D002972
19276632	1437	1447	Gene FOXF2	GENEORGENEPRODUCT	2295
19276632	1513	1516	DSD	DISEASEORPHENOTYPICFEATURE	D012734
19276632	1562	1574	palatoschisi	DISEASEORPHENOTYPICFEATURE	D002972
19276632	1653	1656	DSD	DISEASEORPHENOTYPICFEATURE	D012734
19276632	1768	1773	FOXF2	GENEORGENEPRODUCT	2295
19276632	2018	2026	paziente	ORGANISMTAXON	9606
19276632	2116	2135	duplicazione di GCC	SEQUENCEVARIANT	C |DUP||GCC|
19276632	2378	2386	pazienti	ORGANISMTAXON	9606
19276632	2460	2468	c.262G>A	SEQUENCEVARIANT	RS72667003
19276632	2521	2529	Ala88Thr	SEQUENCEVARIANT	RS72667003
19276632	2635	2644	c.1272C>T	SEQUENCEVARIANT	RS61753348
19276632	2681	2690	Ser424Ser	SEQUENCEVARIANT	RS61753348
19276632	2729	2738	c.1284T>C	SEQUENCEVARIANT	RS2293783
19276632	2774	2783	Tyr428Tyr	SEQUENCEVARIANT	RS2293783
19276632	2904	2912	pazienti	ORGANISMTAXON	9606
19276632	3206	3211	FOXF2	GENEORGENEPRODUCT	2295
19353688	148	153	PCDH9	GENEORGENEPRODUCT	5101
19353688	223	262	neuropatia uditiva autosomica dominante	DISEASEORPHENOTYPICFEATURE	C563790
19353688	307	312	AUNA1	DISEASEORPHENOTYPICFEATURE	C563790
19353688	942	949	sordità	DISEASEORPHENOTYPICFEATURE	D003638
19353688	994	1011	stenosi duodenale	DISEASEORPHENOTYPICFEATURE	C535720
19353688	1057	1096	ritardo dello sviluppo e della crescita	DISEASEORPHENOTYPICFEATURE	D002658
19353688	1141	1160	anomalie vertebrali	DISEASEORPHENOTYPICFEATURE	C535781
19353688	1207	1227	dismorfismi facciali	DISEASEORPHENOTYPICFEATURE	 D019465
19353688	1308	1319	dismorfismi	DISEASEORPHENOTYPICFEATURE	D019465
19353688	1387	1392	AUNA1	DISEASEORPHENOTYPICFEATURE	C563790
19353688	1436	1443	sordità	DISEASEORPHENOTYPICFEATURE	D003638
19353688	1512	1517	PCDH9	GENEORGENEPRODUCT	5101
19353688	1550	1565	protocaderina-9	GENEORGENEPRODUCT	5101
19353688	1617	1622	PCDH9	GENEORGENEPRODUCT	5101
19353688	1707	1714	sordità	DISEASEORPHENOTYPICFEATURE	D003638
19353688	1883	1888	AUNA1	DISEASEORPHENOTYPICFEATURE	C563790
19353688	1934	1939	PCDH9	GENEORGENEPRODUCT	5101
19353688	2099	2104	AUNA1	DISEASEORPHENOTYPICFEATURE	C563790
19353688	2171	2190	paziente monosomico	ORGANISMTAXON	9606
19353688	2277	2282	AUNA1	DISEASEORPHENOTYPICFEATURE	C563790
19353688	2326	2333	sordità	DISEASEORPHENOTYPICFEATURE	D003638
19353688	2419	2426	sordità	DISEASEORPHENOTYPICFEATURE	D003638
19353688	2507	2514	sordità	DISEASEORPHENOTYPICFEATURE	D003638
19353688	2578	2583	PCHD9	GENEORGENEPRODUCT	5101
19394258	50	55	DGUOK	GENEORGENEPRODUCT	1716
19394258	121	180	epatocerebrale sindrome da deplezione del DNA mitocondriale	DISEASEORPHENOTYPICFEATURE	C580039
19394258	225	265	Deficit di deossiguanosina chinasi (dGK)	DISEASEORPHENOTYPICFEATURE	C580039
19394258	334	366	deplezione del DNA mitocondriale	DISEASEORPHENOTYPICFEATURE	C580039
19394258	518	523	DGUOK	GENEORGENEPRODUCT	1716
19394258	622	627	DGUOK	GENEORGENEPRODUCT	1716
19394258	655	663	pazienti	ORGANISMTAXON	9606
19394258	729	734	DGUOK	GENEORGENEPRODUCT	1716
19394258	846	854	pazienti	ORGANISMTAXON	9606
19394258	967	1000	deficit della catena respiratoria	DISEASEORPHENOTYPICFEATURE	 combinate D028361
19394258	1046	1078	deplezione del DNA mitocondriale	DISEASEORPHENOTYPICFEATURE	C580039
19394258	1169	1174	DGUOK	GENEORGENEPRODUCT	1716
19394258	1202	1210	pazienti	ORGANISMTAXON	9606
19394258	1396	1418	moderata iperintensità	DISEASEORPHENOTYPICFEATURE	D006973
19394258	1480	1488	pazienti	ORGANISMTAXON	9606
19394258	1893	1896	dGK	GENEORGENEPRODUCT	1716
19394258	1979	1999	deossiribonucleosidi	CHEMICALENTITY	D003853
19394258	2247	2252	DGUOK	GENEORGENEPRODUCT	1716
19394258	2357	2362	DGUOK	GENEORGENEPRODUCT	1716
19394258	2452	2455	dGK	GENEORGENEPRODUCT	1716
19484664	31	70	Enzima di conversione dell'angiotensina	GENEORGENEPRODUCT	1636
19484664	143	152	asmatico 	DISEASEORPHENOTYPICFEATURE	D001249
19484664	180	188	pazienti	ORGANISMTAXON	9606
19484664	233	239	L'asma	DISEASEORPHENOTYPICFEATURE	D001249
19484664	289	311	malattia infiammatoria	DISEASEORPHENOTYPICFEATURE	D007249
19484664	463	467	asma	DISEASEORPHENOTYPICFEATURE	D001249
19484664	510	549	enzima di conversione dell'angiotensina	GENEORGENEPRODUCT	1636
19484664	582	585	ACE	GENEORGENEPRODUCT	1636
19484664	692	695	ACE	GENEORGENEPRODUCT	1636
19484664	748	756	asmatico	DISEASEORPHENOTYPICFEATURE	D001249
19484664	784	792	pazienti	ORGANISMTAXON	9606
19484664	932	940	asmatici	DISEASEORPHENOTYPICFEATURE	D001249
19484664	968	976	pazienti	ORGANISMTAXON	9606
19484664	1257	1261	asma	DISEASEORPHENOTYPICFEATURE	D001249
19484664	1320	1328	atopismo	DISEASEORPHENOTYPICFEATURE	 C566404
19484664	1407	1415	pazienti	ORGANISMTAXON	9606
19484664	1509	1512	ACE	GENEORGENEPRODUCT	1636
19484664	1597	1605	asmatici	DISEASEORPHENOTYPICFEATURE	D001249
19484664	1685	1693	asmatici	DISEASEORPHENOTYPICFEATURE	D001249
19484664	1988	1991	ACE	GENEORGENEPRODUCT	1636
19484664	2076	2084	asmatici	DISEASEORPHENOTYPICFEATURE	D001249
19484664	2164	2172	Asmatici	DISEASEORPHENOTYPICFEATURE	D001249
19484664	2211	2214	ACE	GENEORGENEPRODUCT	1636
19484664	2309	2328	allergie ai farmaci	DISEASEORPHENOTYPICFEATURE	D004342
19484664	2440	2452	Gli asmatici	DISEASEORPHENOTYPICFEATURE	D001249
19484664	2558	2566	asmatico	DISEASEORPHENOTYPICFEATURE	D001249
19484664	2642	2658	infezioni virali	DISEASEORPHENOTYPICFEATURE	D001102
19484664	2764	2772	Pazienti	ORGANISMTAXON	9606
19484664	2821	2825	asma	DISEASEORPHENOTYPICFEATURE	D001249
19484664	2971	2974	ACE	GENEORGENEPRODUCT	1636
19484664	3027	3035	asmatico	DISEASEORPHENOTYPICFEATURE	D001249
19484664	3063	3071	pazienti	ORGANISMTAXON	9606
19484664	3130	3138	asmatici	DISEASEORPHENOTYPICFEATURE	D001249
19484664	3194	3197	ACE	GENEORGENEPRODUCT	1636
19484664	3303	3307	asma	DISEASEORPHENOTYPICFEATURE	D001249
19531695	43	50	Delirio	DISEASEORPHENOTYPICFEATURE	D003693
19531695	84	92	paziente	ORGANISMTAXON	9606
19531695	128	138	flecainide	CHEMICALENTITY	D005424
19531695	245	255	paroxetina	CHEMICALENTITY	D017374
19531695	321	331	flecainide	CHEMICALENTITY	D005424
19531695	386	393	delirio	DISEASEORPHENOTYPICFEATURE	D003693
19531695	472	482	paroxetina	CHEMICALENTITY	D017374
19531695	627	637	confusione	DISEASEORPHENOTYPICFEATURE	D003221
19531695	683	691	paranoia	DISEASEORPHENOTYPICFEATURE	D010259
19531695	758	766	paziente	ORGANISMTAXON	9606
19531695	814	825	carvedilolo	CHEMICALENTITY	C043211
19531695	886	894	warfarin	CHEMICALENTITY	D014 859
19531695	936	948	acido folico	CHEMICALENTITY	D005492
19531695	991	1003	levotiroxina	CHEMICALENTITY	D013974
19531695	1051	1063	pantoprazolo	CHEMICALENTITY	C064276
19531695	1106	1117	paroxetina 	CHEMICALENTITY	D017374
19531695	1161	1171	flecainide	CHEMICALENTITY	D005424
19531695	1231	1241	Flecainide	CHEMICALENTITY	D005424
19531695	1326	1347	fibrillazione atriale	DISEASEORPHENOTYPICFEATURE	D001281
19531695	1498	1508	flecainide	CHEMICALENTITY	D005424
19531695	1639	1649	flecainide	CHEMICALENTITY	D005424
19531695	1683	1693	paroxetina	CHEMICALENTITY	D017374
19531695	1730	1738	paziente	ORGANISMTAXON	9606
19531695	1834	1844	Paroxetina	CHEMICALENTITY	D017374
19531695	1908	1918	flecainide	CHEMICALENTITY	D005424
19531695	2015	2022	delirio	DISEASEORPHENOTYPICFEATURE	D003693
19531695	2095	2105	Flecainide	CHEMICALENTITY	D005424
19531695	2203	2208	sodio	CHEMICALENTITY	D012964
19531695	2268	2275	delirio	DISEASEORPHENOTYPICFEATURE	D003693
19531695	2306	2314	pazienti	ORGANISMTAXON	9606
19531695	2465	2475	flecainide	CHEMICALENTITY	D005424
19531695	2511	2518	 CYP2D6	GENEORGENEPRODUCT	1565
19531695	2562	2572	paroxetina	CHEMICALENTITY	D017374
19531695	2608	2614	CYP2D6	GENEORGENEPRODUCT	1565
19531695	2681	2691	flecainide	CHEMICALENTITY	D005424
19531695	2736	2743	delirio	DISEASEORPHENOTYPICFEATURE	D003693
19531695	2820	2830	flecainide	CHEMICALENTITY	D005424
19531695	2885	2893	paziente	ORGANISMTAXON	9606
19531695	2939	2946	delirio	DISEASEORPHENOTYPICFEATURE	D003693
19531695	3075	3085	flecainide	CHEMICALENTITY	D005424
19531695	3119	3129	paroxetina	CHEMICALENTITY	D017374
19531695	3226	3236	flecainide	CHEMICALENTITY	D005424
19531695	3296	3303	delirio	DISEASEORPHENOTYPICFEATURE	D003693
19531695	3355	3364	tossicità	DISEASEORPHENOTYPICFEATURE	D064420
19531695	3419	3429	flecainide	CHEMICALENTITY	D005424
19531695	3479	3489	paroxetina	CHEMICALENTITY	D017374
19531695	3547	3553	CYP2D6	GENEORGENEPRODUCT	1565
19531695	3597	3607	flecainide	CHEMICALENTITY	D005424
19531695	3739	3745	CYP2D6	GENEORGENEPRODUCT	1565
19565319	30	60	Recettore dell'adenosina A(2A)	GENEORGENEPRODUCT	135
19565319	97	117	 Le varianti ADORA2A	GENEORGENEPRODUCT	135
19565319	180	197	sintomi autistici	DISEASEORPHENOTYPICFEATURE	D001321
19565319	243	248	ansia	DISEASEORPHENOTYPICFEATURE	D001008
19565319	298	330	disturbo dello spettro autistico	DISEASEORPHENOTYPICFEATURE	D000067877
19565319	378	410	Disturbi dello spettro autistico	DISEASEORPHENOTYPICFEATURE	D000067877
19565319	458	462	ASDs	DISEASEORPHENOTYPICFEATURE	D000067877
19565319	573	578	ansia	DISEASEORPHENOTYPICFEATURE	D001008
19565319	618	648	recettore dell'adenosina A(2A)	GENEORGENEPRODUCT	135
19565319	680	687	ADORA2A	GENEORGENEPRODUCT	135
19565319	746	764	disturbo di panico	DISEASEORPHENOTYPICFEATURE	D016584
19565319	857	887	recettore dell'adenosina A(2A)	GENEORGENEPRODUCT	135
19565319	1003	1006	ASD	DISEASEORPHENOTYPICFEATURE	D000067877
19565319	1058	1077	i sintomi autistici	DISEASEORPHENOTYPICFEATURE	D001321
19565319	1156	1185	sindrome da delezione 22q11.2	DISEASEORPHENOTYPICFEATURE	D004062
19565319	1239	1259	22q11.2 eliminazioni	DISEASEORPHENOTYPICFEATURE	D004062
19565319	1345	1348	ASD	DISEASEORPHENOTYPICFEATURE	D000067877
19565319	1442	1445	ASD	DISEASEORPHENOTYPICFEATURE	D000067877
19565319	1576	1584	 ADORA2A	GENEORGENEPRODUCT	135
19565319	1683	1692	rs2236624	SEQUENCEVARIANT	RS2236624
19565319	1770	1773	ASD	DISEASEORPHENOTYPICFEATURE	D000067877
19565319	1844	1853	rs3761422	SEQUENCEVARIANT	RS3761422
19565319	1889	1898	rs5751876	SEQUENCEVARIANT	RS5751876
19565319	1937	1947	rs35320474	SEQUENCEVARIANT	RS35320474
19565319	2006	2013	ADORA2A	GENEORGENEPRODUCT	135
19565319	2070	2075	ansia	DISEASEORPHENOTYPICFEATURE	D001008
19565319	2158	2161	ASD	DISEASEORPHENOTYPICFEATURE	D000067877
19565319	2250	2257	ADORA2A	GENEORGENEPRODUCT	135
19565319	2344	2347	ASD	DISEASEORPHENOTYPICFEATURE	D000067877
19681452	62	98	infarto emorragico del globo pallido	DISEASEORPHENOTYPICFEATURE	D002543,D020520
19681452	136	143	cocaina	CHEMICALENTITY	 D003042
19681452	177	200	intossicazione da alcol	CHEMICALENTITY	D000431
19681452	233	243	La cocaina	CHEMICALENTITY	D003042
19681452	327	356	ictus ischemico ed emorragico	DISEASEORPHENOTYPICFEATURE	D002544,D020521
19681452	411	415	uomo	ORGANISMTAXON	9606
19681452	474	500	ischemia del globo pallido	DISEASEORPHENOTYPICFEATURE	D002545
19681452	565	570	alcol	CHEMICALENTITY	D000431
19681452	604	611	cocaina	CHEMICALENTITY	D003042
19681452	668	697	gli infarti del globo pallido	DISEASEORPHENOTYPICFEATURE	D020520
19681452	778	784	eroina	CHEMICALENTITY	D003932
19681452	840	869	infarti dei gangli della base	DISEASEORPHENOTYPICFEATURE	D020520
19681452	915	922	cocaina	CHEMICALENTITY	D003042
19681452	975	988	uso di eroina	CHEMICALENTITY	D003932
19681452	1057	1065	paziente	ORGANISMTAXON	9606
19681452	1122	1138	aritmia cardiaca	DISEASEORPHENOTYPICFEATURE	D001145
19681452	1185	1209	disfunzione respiratoria	DISEASEORPHENOTYPICFEATURE	D012131
19681452	1253	1260	cocaina	CHEMICALENTITY	D003042
19681452	1296	1303	etanolo	CHEMICALENTITY	D000431
19681452	1385	1408	ipoperfusione cerebrale	DISEASEORPHENOTYPICFEATURE	D002545
19789368	31	75	L'espressione del recettore della vitamina D	GENEORGENEPRODUCT	7421
19789368	121	128	PIK3CA 	GENEORGENEPRODUCT	5290
19789368	162	166	KRAS	GENEORGENEPRODUCT	3845
19789368	223	245	cancro del colon-retto	DISEASEORPHENOTYPICFEATURE	D015179
19789368	279	292	La vitamina D	CHEMICALENTITY	D014807
19789368	383	389	cancro	DISEASEORPHENOTYPICFEATURE	D009369
19789368	443	458	cancro al colon	DISEASEORPHENOTYPICFEATURE	D015179
19789368	494	520	recettore della vitamina D	GENEORGENEPRODUCT	7421
19789368	553	556	VDR	GENEORGENEPRODUCT	7421
19789368	741	744	VDR	GENEORGENEPRODUCT	7421
19789368	778	781	RAS	GENEORGENEPRODUCT	3845
19789368	814	852	proteina chinasi attivata dal mitogeno	GENEORGENEPRODUCT	1432
19789368	885	889	MAPK	GENEORGENEPRODUCT	1432
19789368	924	953	fosfatidilinositolo 3-chinasi	GENEORGENEPRODUCT	5290
19789368	986	990	PI3K	GENEORGENEPRODUCT	5290
19789368	1022	1025	AKT	GENEORGENEPRODUCT	207
19789368	1136	1139	VDR	GENEORGENEPRODUCT	7421
19789368	1194	1200	PIK3CA	GENEORGENEPRODUCT	5290
19789368	1234	1238	KRAS	GENEORGENEPRODUCT	3845
19789368	1319	1341	tumori del colon-retto	DISEASEORPHENOTYPICFEATURE	D015179
19789368	1431	1437	tumori	DISEASEORPHENOTYPICFEATURE	D009369
19789368	1481	1484	VDR	GENEORGENEPRODUCT	7421
19789368	1593	1599	PIK3CA	GENEORGENEPRODUCT	5290
19789368	1633	1637	KRAS	GENEORGENEPRODUCT	3845
19789368	1883	1890	CACNA1G	GENEORGENEPRODUCT	8913
19789368	1924	1930	CDKN2A	GENEORGENEPRODUCT	1029
19789368	1963	1966	p16	GENEORGENEPRODUCT	1029
19789368	2000	2006	CRABP1	GENEORGENEPRODUCT	1381
19789368	2039	2043	IGF2	GENEORGENEPRODUCT	3481
19789368	2076	2080	MLH1	GENEORGENEPRODUCT	4292
19789368	2115	2122	NEUROG1	GENEORGENEPRODUCT	4762
19789368	2154	2159	RUNX3	GENEORGENEPRODUCT	864
19789368	2193	2199	SOCS1 	GENEORGENEPRODUCT	8651
19789368	2268	2271	VDR	GENEORGENEPRODUCT	7421
19789368	2371	2375	KRAS	GENEORGENEPRODUCT	3845
19789368	2482	2488	PIK3CA	GENEORGENEPRODUCT	5290
19789368	2657	2660	VDR	GENEORGENEPRODUCT	7421
19789368	2794	2816	cancro del colon-retto	DISEASEORPHENOTYPICFEATURE	D015179
19789368	2861	2867	tumore	DISEASEORPHENOTYPICFEATURE	D009369
19789368	2951	2957	tumore	DISEASEORPHENOTYPICFEATURE	D009369
19789368	3061	3065	BRAF	GENEORGENEPRODUCT	673
19789368	3098	3101	p53	GENEORGENEPRODUCT	7157
19789368	3134	3137	p21	GENEORGENEPRODUCT	1026
19789368	3170	3183	beta-catenina	GENEORGENEPRODUCT	1499
19789368	3218	3234	ciclossigenasi-2	GENEORGENEPRODUCT	5743
19789368	3267	3270	VDR	GENEORGENEPRODUCT	7421
19789368	3351	3359	paziente	ORGANISMTAXON	9606
19789368	3452	3455	VDR	GENEORGENEPRODUCT	7421
19789368	3519	3541	cancro del colon-retto	DISEASEORPHENOTYPICFEATURE	D015179
19789368	3606	3612	PIK3CA	GENEORGENEPRODUCT	5290
19789368	3646	3650	KRAS	GENEORGENEPRODUCT	3845
19789368	3745	3748	VDR	GENEORGENEPRODUCT	7421
19789368	3781	3784	RAS	GENEORGENEPRODUCT	3845
19789368	3817	3821	MAPK	GENEORGENEPRODUCT	1432
19789368	3855	3859	PI3K	GENEORGENEPRODUCT	5290
19789368	3890	3893	AKT	GENEORGENEPRODUCT	207
19789368	3959	3963	KRAS	GENEORGENEPRODUCT	3845
19789368	3997	4003	PIK3CA	GENEORGENEPRODUCT	5290
19789368	4085	4088	VDR	GENEORGENEPRODUCT	7421
19957053	31	42	fenilefrina	CHEMICALENTITY	D010656
19957053	81	89	efedrina	CHEMICALENTITY	D004809
19957053	187	198	ipotensione	DISEASEORPHENOTYPICFEATURE	D007022
19957053	315	326	ipotensione	DISEASEORPHENOTYPICFEATURE	D007022
19957053	407	418	fenilefrina	CHEMICALENTITY	D010656
19957053	452	460	efedrina	CHEMICALENTITY	D004809
19957053	566	577	ipotensione	DISEASEORPHENOTYPICFEATURE	D007022
19957053	676	684	fentanil	CHEMICALENTITY	D005283
19957053	735	743	propofol	CHEMICALENTITY	D015742
19957053	791	799	pazienti	ORGANISMTAXON	9606
19957053	846	857	fenilefrina	CHEMICALENTITY	D010656
19957053	902	910	pazienti	ORGANISMTAXON	9606
19957053	957	965	efedrina	CHEMICALENTITY	D004809
19957053	1103	1108	ictus	DISEASEORPHENOTYPICFEATURE	D020521
19957053	1407	1418	fenilefrina	CHEMICALENTITY	D010656
19957053	1706	1714	efedrina	CHEMICALENTITY	D004809
19957053	1942	1953	fenilefrina	CHEMICALENTITY	D010656
19957053	2012	2023	ipotensione	DISEASEORPHENOTYPICFEATURE	D007022
19957053	2120	2128	efedrina	CHEMICALENTITY	D004809
20534762	76	84	TSH-beta	GENEORGENEPRODUCT	7252
20534762	141	173	ipotiroidismo centrale congenito	DISEASEORPHENOTYPICFEATURE	D003409
20534762	246	249	TSH	GENEORGENEPRODUCT	7252
20534762	287	296	 Pazienti	ORGANISMTAXON	9606
20534762	332	340	TSH-beta	GENEORGENEPRODUCT	7252
20534762	409	432	ipotiroidismo congenito	DISEASEORPHENOTYPICFEATURE	D003409
20534762	514	517	TSH	GENEORGENEPRODUCT	7252
20534762	730	738	TSH-beta	GENEORGENEPRODUCT	7252
20534762	781	789	pazienti	ORGANISMTAXON	9606
20534762	837	869	ipotiroidismo centrale congenito	DISEASEORPHENOTYPICFEATURE	D003409
20534762	956	962	anemia	DISEASEORPHENOTYPICFEATURE	D0 00740
20534762	1002	1010	Paziente	ORGANISMTAXON	9606
20534762	1067	1073	G to A	SEQUENCEVARIANT	C|SUB|G||A
20534762	1591	1599	paziente	ORGANISMTAXON	9606
20534762	1721	1728	313delT	SEQUENCEVARIANT	C|DEL|313|T
20534762	1771	1782	C105Vfs114X	SEQUENCEVARIANT	P|FS|C|105|V|114
20534762	1882	1929	G per A nella posizione del nucleotide cDNA 323	SEQUENCEVARIANT	C|SUB|G|323|A
20534762	1986	1990	C88Y	SEQUENCEVARIANT	P|SUB| C|88|Y
20534762	2134	2168	glicoproteina ormone-beta subunità	GENEORGENEPRODUCT	122876
20534762	2271	2275	C88Y	SEQUENCEVARIANT	P|SUB|C|88|Y
20534762	2453	2457	C88Y	SEQUENCEVARIANT	P|SUB|C|88|Y
20534762	2549	2563	carenza di TSH	DISEASEORPHENOTYPICFEATURE	D007037
20534762	2679	2705	carenza ipofisaria isolata	DISEASEORPHENOTYPICFEATURE	C566321
20534762	2824	2846	ipotiroidismo centrale	DISEASEORPHENOTYPICFEATURE	D007037
20534762	2959	2965	anemia	DISEASEORPHENOTYPICFEATURE	D000740
20648600	49	59	lamivudina	CHEMICALENTITY	D019259
20648600	126	135	 pazienti	ORGANISMTAXON	9606
20648600	187	217	co-infetti da HIV ed epatite B	DISEASEORPHENOTYPICFEATURE	D006509,D015658
20648600	326	336	lamivudina	CHEMICALENTITY	D019259
20648600	369	372	LAM	CHEMICALENTITY	D019259
20648600	410	419	tenofovir	CHEMICALENTITY	D000068698
20648600	455	458	TDF	CHEMICALENTITY	D000068698
20648600	528	536	pazienti	ORGANISMTAXON	9606
20648600	588	630	co-infezione da HIV e virus dell'epatite B	DISEASEORPHENOTYPICFEATURE	D006509,D015658
20648600	661	664	HBV	ORGANISMTAXON	10407
20648600	741	749	pazienti	ORGANISMTAXON	9606
20648600	782	785	HIV	ORGANISMTAXON	11676
20648600	814	824	I pazienti	ORGANISMTAXON	9606
20648600	911	916	HBsAg	CHEMICALENTITY	D006514
20648600	959	962	HBV	ORGANISMTAXON	10407
20648600	1088	1091	HBV	ORGANISMTAXON	10407
20648600	1208	1215	precore	GENEORGENEPRODUCT	944568
20648600	1310	1318	pazienti	ORGANISMTAXON	9606
20648600	1369	1378	infezione	DISEASEORPHENOTYPICFEATURE	D007239
20648600	1462	1465	HBV	ORGANISMTAXON	10407
20648600	1504	1512	pazienti	ORGANISMTAXON	9606
20648600	1625	1633	pazienti	ORGANISMTAXON	9606
20648600	1689	1692	LAM	CHEMICALENTITY	D019259
20648600	1727	1735	pazienti	ORGANISMTAXON	9606
20648600	1791	1794	LAM	CHEMICALENTITY	D019259
20648600	1833	1836	TDF	CHEMICALENTITY	D000068698
20648600	1898	1901	LAM	CHEMICALENTITY	D019259
20648600	1938	1941	TDF	CHEMICALENTITY	D000068698
20648600	1999	2002	LAM	CHEMICALENTITY	D019259
20648600	2071	2076	L180M	SEQUENCEVARIANT	P|SUB|L|180|M
20648600	2119	2124	M204V	SEQUENCEVARIANT	P|SUB|M|204|V
20648600	2193	2201	pazienti	ORGANISMTAXON	9606
20648600	2249	2256	viremia	DISEASEORPHENOTYPICFEATURE	D014766
20648600	2341	2346	V173L	SEQUENCEVARIANT	P|SUB|V|173|L
20648600	2404	2412	pazienti	ORGANISMTAXON	9606
20648600	2445	2453	pazienti	ORGANISMTAXON	9606
20648600	2501	2511	polimerasi	GENEORGENEPRODUCT	944565
20648600	2578	2583	V173L	SEQUENCEVARIANT	P|SUB|V|173|L
20648600	2626	2631	L180M	SEQUENCEVARIANT	P|SUB|L|180|M
20648600	2674	2679	M204V	SEQUENCEVARIANT	P|SUB|M|204|V
20648600	2751	2759	envelope	GENEORGENEPRODUCT	944569
20648600	2805	2810	E164D	SEQUENCEVARIANT	P|SUB|E|164|D
20648600	2853	2858	I195M	SEQUENCEVARIANT	P|SUB| I|195|M
20648600	2929	2935	A1762T	SEQUENCEVARIANT	G|SUB|A|1762|T
20648600	2977	2983	G1764A	SEQUENCEVARIANT	G|SUB|G|1764| A
20648600	3034	3041	precore	GENEORGENEPRODUCT	944568
20648600	3083	3089	G1896A	SEQUENCEVARIANT	G|SUB|G| 1896|A
20648600	3130	3136	G1899A	SEQUENCEVARIANT	G|SUB|G|1899|A
20648600	3229	3232	TDF	CHEMICALENTITY	D000068698
20648600	3309	3312	LAM	CHEMICALENTITY	D019259
20648600	3397	3400	HBV	ORGANISMTAXON	10407
20648600	3566	3569	TDF	CHEMICALENTITY	D000068698
20648600	3646	3649	TDF	CHEMICALENTITY	D000068698
20705401	31	71	Il gene del recettore della serotonina 6	GENEORGENEPRODUCT	3362
20705401	117	131	metanfetamina 	CHEMICALENTITY	D008694
20705401	186	193	psicosi	DISEASEORPHENOTYPICFEATURE	D011605
20705401	380	398	disturbi psicotici	DISEASEORPHENOTYPICFEATURE	D011605
20705401	448	460	schizofrenia	DISEASEORPHENOTYPICFEATURE	D012559
20705401	496	532	recettore della serotonina 6 (5-HT6)	GENEORGENEPRODUCT	3362
20705401	608	621	antipsicotici	CHEMICALENTITY	D014150
20705401	682	691	clozapina	CHEMICALENTITY	D003024
20705401	728	738	olanzapina	CHEMICALENTITY	D000077152
20705401	773	785	d-anfetamina	CHEMICALENTITY	D003913
20705401	837	849	iperattività	DISEASEORPHENOTYPICFEATURE	D006948
20705401	881	887	 ratti	ORGANISMTAXON	10116
20705401	987	992	5-HT6	CHEMICALENTITY	D012702
20705401	1082	1094	d-amfetamina	CHEMICALENTITY	D003913
20705401	1128	1140	fenciclidina	CHEMICALENTITY	D010622
20705401	1196	1227	antagonista del recettore 5-HT6	CHEMICALENTITY	D012702
20705401	1293	1298	ratti	ORGANISMTAXON	10116
20705401	1421	1433	schizofrenia	DISEASEORPHENOTYPICFEATURE	D012559
20705401	1507	1525	5- I recettori HT6	GENEORGENEPRODUCT	3362
20705401	1608	1626	disturbi psicotici	DISEASEORPHENOTYPICFEATURE	D011605
20705401	1672	1685	metamfetamina	CHEMICALENTITY	D008694
20705401	1718	1722	METH	CHEMICALENTITY	D008694
20705401	1768	1775	psicosi	DISEASEORPHENOTYPICFEATURE	D011605
20705401	1843	1873	schizofrenia di tipo paranoico	DISEASEORPHENOTYPICFEATURE	D012563
20705401	1971	1976	5-HT6	GENEORGENEPRODUCT	3362
20705401	2009	2013	HTR6	GENEORGENEPRODUCT	3362
20705401	2050	2054	METH	CHEMICALENTITY	D008694
20705401	2109	2116	psicosi	DISEASEORPHENOTYPICFEATURE	D011605
20705401	2196	2205	rs6693503	SEQUENCEVARIANT	RS6693503
20705401	2241	2250	rs1805054	SEQUENCEVARIANT	RS1805054
20705401	2287	2296	rs4912138	SEQUENCEVARIANT	RS4912138
20705401	2332	2341	rs3790757	SEQUENCEVARIANT	RS3790757
20705401	2378	2387	rs9659997	SEQUENCEVARIANT	RS9659997
20705401	2506	2510	METH	CHEMICALENTITY	D008694
20705401	2563	2570	psicosi	DISEASEORPHENOTYPICFEATURE	 D011605
20705401	2598	2606	pazienti	ORGANISMTAXON	9606
20705401	2758	2771	metamfetamina	CHEMICALENTITY	D008694
20705401	2810	2818	pazienti	ORGANISMTAXON	9606
20705401	2865	2874	rs6693503	SEQUENCEVARIANT	RS6693503
20705401	2926	2930	METH	CHEMICALENTITY	D008694
20705401	2983	2990	psicosi	DISEASEORPHENOTYPICFEATURE	D011605
20705401	3018	3026	pazienti	ORGANISMTAXON	9606
20705401	3260	3269	rs6693503	SEQUENCEVARIANT	RS6693503
20705401	3306	3315	rs1805054	SEQUENCEVARIANT	RS1805054
20705401	3369	3378	rs6693503	SEQUENCEVARIANT	RS6693503
20705401	3414	3423	rs1805054	SEQUENCEVARIANT	RS1805054
20705401	3461	3470	rs4912138	SEQUENCEVARIANT	RS4912138
20705401	3506	3510	HTR6	GENEORGENEPRODUCT	3362
20705401	3544	3549	 METH	CHEMICALENTITY	D008694
20705401	3601	3608	psicosi	DISEASEORPHENOTYPICFEATURE	D011605
20705401	3636	3644	pazienti	ORGANISMTAXON	9606
20705401	3707	3711	HTR6	GENEORGENEPRODUCT	3362
20705401	3800	3804	METH	CHEMICALENTITY	D008694
20705401	3860	3867	psicosi	DISEASEORPHENOTYPICFEATURE	D011605
20709368	34	55	gamma del fibrinogeno	GENEORGENEPRODUCT	2266
20709368	90	98	10034C>T	SEQUENCEVARIANT	RS2066865
20709368	176	199	Arteriopatia periferica	DISEASEORPHENOTYPICFEATURE	D058729
20709368	256	271	fibrinogeno da 	GENEORGENEPRODUCT	2243,2244,2266
20709368	315	325	la fibrina	GENEORGENEPRODUCT	2243,2244,2266
20709368	444	451	fibrina	GENEORGENEPRODUCT	2243,2244,2266
20709368	501	512	Fibrinogeno	GENEORGENEPRODUCT	2243,2244,2266
20709368	625	641	fibrinogeno alfa	GENEORGENEPRODUCT	2243
20709368	674	677	FGA	GENEORGENEPRODUCT	2243
20709368	711	727	fibrinogeno beta	GENEORGENEPRODUCT	2244
20709368	760	763	FGB	GENEORGENEPRODUCT	2244
20709368	799	816	fibrinogeno gamma	GENEORGENEPRODUCT	 2266
20709368	849	852	FGG	GENEORGENEPRODUCT	2266
20709368	970	973	FGG	GENEORGENEPRODUCT	2266
20709368	1006	1009	FGG	GENEORGENEPRODUCT	2266
20709368	1044	1052	10034C>T	SEQUENCEVARIANT	RS2066865
20709368	1088	1097	rs2066865	SEQUENCEVARIANT	RS2066865
20709368	1162	1186	trombosi venosa profonda	DISEASEORPHENOTYPICFEATURE	D020246
20709368	1232	1253	infarto del miocardio	DISEASEORPHENOTYPICFEATURE	D009203
20709368	1377	1400	arteriopatia periferica	DISEASEORPHENOTYPICFEATURE	D058729
20709368	1445	1448	PAD	DISEASEORPHENOTYPICFEATURE	D058729
20709368	1551	1559	pazienti	ORGANISMTAXON	9606
20709368	1607	1610	PAD	DISEASEORPHENOTYPICFEATURE	D058729
20709368	1683	1686	FGG	GENEORGENEPRODUCT	2266
20709368	1792	1795	FGG	GENEORGENEPRODUCT	2266
20709368	1909	1912	PAD	DISEASEORPHENOTYPICFEATURE	D058729
20709368	1941	1949	pazienti	ORGANISMTAXON	9606
20709368	2174	2181	diabete	DISEASEORPHENOTYPICFEATURE	D003920
20709368	2236	2248	ipertensione	DISEASEORPHENOTYPICFEATURE	D006973
20709368	2294	2312	ipercolesterolemia	DISEASEORPHENOTYPICFEATURE	D006937
20709368	2348	2351	FGG	GENEORGENEPRODUCT	2266
20709368	2387	2406	10034 La variante T	SEQUENCEVARIANT	RS2066865
20709368	2504	2507	PAD	DISEASEORPHENOTYPICFEATURE	D058729
20709368	2623	2626	FGG	GENEORGENEPRODUCT	2266
20709368	2661	2669	10034C>T	SEQUENCEVARIANT	RS2066865
20709368	2761	2764	PAD	DISEASEORPHENOTYPICFEATURE	D058729
20709368	2847	2850	FGG	GENEORGENEPRODUCT	2266
20709368	2885	2892	10034 T	SEQUENCEVARIANT	RS2066865
20709368	2984	2987	PAD	DISEASEORPHENOTYPICFEATURE	D058729
21126715	68	105	lipodistrofia congenita generalizzata	DISEASEORPHENOTYPICFEATURE	D052497
21126715	165	173	Ile262fs	SEQUENCEVARIANT	 P|FS|I|262||
21126715	225	230	BSCL2	GENEORGENEPRODUCT	26580
21126715	275	312	Lipodistrofia congenita generalizzata	DISEASEORPHENOTYPICFEATURE	D052497
21126715	357	360	CGL	DISEASEORPHENOTYPICFEATURE	D052497
21126715	417	446	malattia autosomica recessiva	DISEASEORPHENOTYPICFEATURE	D030342
21126715	613	618	BSCL2	GENEORGENEPRODUCT	26580
21126715	676	680	CGL2	DISEASEORPHENOTYPICFEATURE	D052497
21126715	760	764	CGL1	DISEASEORPHENOTYPICFEATURE	D052497
21126715	886	913	compromissione intellettiva	DISEASEORPHENOTYPICFEATURE	D008607
21126715	970	984	cardiomiopatia	DISEASEORPHENOTYPICFEATURE	D009202
21126715	1158	1174	xantomi eruttivi	DISEASEORPHENOTYPICFEATURE	D014973
21126715	1229	1248	ipertrigliceridemia	DISEASEORPHENOTYPICFEATURE	D015228
21126715	1423	1435	Epatomegalia	DISEASEORPHENOTYPICFEATURE	D006529
21126715	1554	1570	steatosi epatica	DISEASEORPHENOTYPICFEATURE	D005234
21126715	1628	1635	necrosi	DISEASEORPHENOTYPICFEATURE	D009336
21126715	1739	1753	cardiomiopatia	DISEASEORPHENOTYPICFEATURE	D009202
21126715	1815	1842	compromissione intellettiva	DISEASEORPHENOTYPICFEATURE	D008607
21126715	1997	2018	allargamento dei reni	DISEASEORPHENOTYPICFEATURE	D007674
21126715	2104	2111	783insG	SEQUENCEVARIANT	C|INS|783|G
21126715	2151	2169	mutazione Ile262fs	SEQUENCEVARIANT	P|FS|I|262 ||
21126715	2226	2231	BSCL2	GENEORGENEPRODUCT	26580
21126715	2315	2318	CGL	DISEASEORPHENOTYPICFEATURE	D052497
21126715	2408	2413	BSCL2	GENEORGENEPRODUCT	26580
21126715	2492	2495	CGL	DISEASEORPHENOTYPICFEATURE	D052497
21219851	93	134	Sindrome di Ehlers-Danlos, tipo vascolare	DISEASEORPHENOTYPICFEATURE	D004535
21219851	325	366	Sindrome di Ehlers-Danlos, tipo vascolare	DISEASEORPHENOTYPICFEATURE	D004535
21219851	411	415	vEDS	DISEASEORPHENOTYPICFEATURE	D004535
21219851	463	474	MIM #130050	DISEASEORPHENOTYPICFEATURE	D004535
21219851	524	553	disturbo autosomico dominante	DISEASEORPHENOTYPICFEATURE	D030342
21219851	597	618	tipo III procollagene	GENEORGENEPRODUCT	1281
21219851	670	676	COL3A1	GENEORGENEPRODUCT	1281
21219851	746	752	COL3A1	GENEORGENEPRODUCT	1281
21219851	825	833	paziente	ORGANISMTAXON	9606
21219851	1252	1258	COL3A1	GENEORGENEPRODUCT	1281
21219851	1347	1353	COL3A1	GENEORGENEPRODUCT	1281
21219851	1598	1602	vEDS	DISEASEORPHENOTYPICFEATURE	D004535
21219851	1630	1660	pazienti clinicamente sospetti	ORGANISMTAXON	9606
21219851	1734	1740	COL3A1	GENEORGENEPRODUCT	1281
21219851	1902	1908	COL3A1	GENEORGENEPRODUCT	1281
21219851	1970	1981	c. 2187delA	SEQUENCEVARIANT	C|DEL|2187|A
21219851	2051	2060	c.2992C>T	SEQUENCEVARIANT	C|SUB|C|2992|T
21219851	2324	2333	rs1800255	SEQUENCEVARIANT	RS1800255
21219851	2369	2373	G>LA	SEQUENCEVARIANT	 RS1800255
21219851	2409	2418	rs1801184	SEQUENCEVARIANT	RS1801184
21219851	2453	2456	T>C	SEQUENCEVARIANT	RS1801184
21219851	2493	2502	rs2271683	SEQUENCEVARIANT	RS2271683
21219851	2537	2541	LA>G	SEQUENCEVARIANT	RS2271683
21219851	2577	2583	COL3A1	GENEORGENEPRODUCT	1281
21219851	2775	2781	COL3A1	GENEORGENEPRODUCT	1281
21219851	2917	2923	COL3A1	GENEORGENEPRODUCT	1281
21405999	66	72	GUCA1B	GENEORGENEPRODUCT	2979
21405999	103	112	pazienti 	ORGANISMTAXON	9606
21405999	195	238	distrofia del cono e del bastoncello conico	DISEASEORPHENOTYPICFEATURE	D000071700,D000077765
21405999	304	310	GUCA1A	GENEORGENEPRODUCT	2978
21405999	431	456	cone autosomica dominante	DISEASEORPHENOTYPICFEATURE	D000077765
21405999	504	536	distrofia del bastoncello conico	DISEASEORPHENOTYPICFEATURE	D000071700
21405999	582	600	distrofia maculare	DISEASEORPHENOTYPICFEATURE	D008268
21405999	679	685	GUCA1B	GENEORGENEPRODUCT	2979
21405999	735	752	malattia retinica	DISEASEORPHENOTYPICFEATURE	D012164
21405999	862	868	GUCA1B	GENEORGENEPRODUCT	2979
21405999	944	952	pazienti	ORGANISMTAXON	9606
21405999	1083	1097	cone dystrophy	DISEASEORPHENOTYPICFEATURE	D000077765
21405999	1146	1165	cone rod dystrophy 	DISEASEORPHENOTYPICFEATURE	D000071700
21405999	1227	1235	pazienti	ORGANISMTAXON	9606
21405999	1324	1342	distrofia del cono	DISEASEORPHENOTYPICFEATURE	D000077765
21405999	1423	1455	distrofia del bastoncello conico	DISEASEORPHENOTYPICFEATURE	D000071700
21405999	1674	1680	GUCA1B	GENEORGENEPRODUCT	2979
21405999	1896	1904	c.-17T>C	SEQUENCEVARIANT	RS1474867
21405999	1940	1948	c.171T>C	SEQUENCEVARIANT	RS3749921
21405999	1986	1994	c.465G>T	SEQUENCEVARIANT	RS139923590
21405999	2080	2088	c.465G>T	SEQUENCEVARIANT	RS139923590
21405999	2183	2194	p.Glu155Asp	SEQUENCEVARIANT	RS139923590
21405999	2275	2281	calcio	CHEMICALENTITY	D002118
21405999	2316	2321	GCAP2	GENEORGENEPRODUCT	2979
21405999	2524	2532	paziente	ORGANISMTAXON	9606
21405999	2582	2588	GUCA1B	GENEORGENEPRODUCT	2979
21405999	2659	2682	degenerazioni retiniche	DISEASEORPHENOTYPICFEATURE	D012162
21684788	80	107	Sindrome di Sjogren-Larsson	DISEASEORPHENOTYPICFEATURE	D016111
21684788	152	179	Sindrome di Sjogren-Larsson	DISEASEORPHENOTYPICFEATURE	D016111
21684788	224	227	SLS	DISEASEORPHENOTYPICFEATURE	D016111
21684788	278	307	disturbo autosomico recessivo	DISEASEORPHENOTYPICFEATURE	D030342
21684788	369	376	ittiosi	DISEASEORPHENOTYPICFEATURE	D007057
21684788	421	437	ritardo mentale 	DISEASEORPHENOTYPICFEATURE	D008607
21684788	482	492	spasticità	DISEASEORPHENOTYPICFEATURE	D009128
21684788	539	546	ALDH3A2	GENEORGENEPRODUCT	224
21684788	586	613	aldeide grassa deidrogenasi	GENEORGENEPRODUCT	224
21684788	687	701	aldeide grassa	CHEMICALENTITY	C001634
21684788	735	747	acido grasso	CHEMICALENTITY	D005227
21684788	839	842	SLS	DISEASEORPHENOTYPICFEATURE	D016111
21684788	870	878	pazienti	ORGANISMTAXON	9606
21684788	1060	1063	SLS	DISEASEORPHENOTYPICFEATURE	D016111
21684788	1091	1099	pazienti	ORGANISMTAXON	9606
21684788	1220	1227	ALDH3A2	GENEORGENEPRODUCT	224
21684788	1442	1445	SLS	DISEASEORPHENOTYPICFEATURE	D016111
21684788	1504	1527	352-kb di cancellazione	SEQUENCEVARIANT	C|DEL||352K
21684788	1578	1589	ALDH3A2 e 4	GENEORGENEPRODUCT	223,224
21684788	1642	1649	ALDH3A1	GENEORGENEPRODUCT	218
21684788	1774	1791	malattia corneale	DISEASEORPHENOTYPICFEATURE	D003316
21684788	1865	1868	SLS	DISEASEORPHENOTYPICFEATURE	D016111
21684788	2019	2027	paziente	ORGANISMTAXON	9606
21684788	2201	2209	c.407C>T	SEQUENCEVARIANT	C|SUB|C|407|T
21684788	2249	2254	P136L	SEQUENCEVARIANT	P|SUB|P|136|L
21684788	2289	2296	ALDH3A2	GENEORGENEPRODUCT	224
21684788	2453	2456	SLS	DISEASEORPHENOTYPICFEATURE	D016111
21684788	2583	2591	pazienti	ORGANISMTAXON	9606
21684788	2639	2642	SLS	DISEASEORPHENOTYPICFEATURE	D016111
21684788	2694	2726	errori congeniti del metabolismo	DISEASEORPHENOTYPICFEATURE	D008661
21750150	56	61	DACH1	GENEORGENEPRODUCT	1602
21750150	112	118	tumore	DISEASEORPHENOTYPICFEATURE	D009369
21750150	194	200	glioma	DISEASEORPHENOTYPICFEATURE	D005910
21750150	297	303	tumore	DISEASEORPHENOTYPICFEATURE	D009369
21750150	379	391	tumorigenesi	DISEASEORPHENOTYPICFEATURE	D009369
21750150	641	653	glioblastoma	DISEASEORPHENOTYPICFEATURE	D005909
21750150	723	736	Il gene DACH1	GENEORGENEPRODUCT	1602
21750150	868	874	glioma	DISEASEORPHENOTYPICFEATURE	D005910
21750150	954	959	DACH1	GENEORGENEPRODUCT	1602
21750150	1064	1070	glioma	DISEASEORPHENOTYPICFEATURE	D005910
21750150	1128	1133	DACH1	GENEORGENEPRODUCT	1602
21750150	1223	1234	doxiciclina	CHEMICALENTITY	D004318
21750150	1351	1357	tumori	DISEASEORPHENOTYPICFEATURE	D009369
21750150	1401	1405	topi	ORGANISMTAXON	10090
21750150	1501	1506	DACH1	GENEORGENEPRODUCT	1602
21750150	1582	1587	DACH1	GENEORGENEPRODUCT	1602
21750150	1637	1642	DACH1	GENEORGENEPRODUCT	1602
21750150	1762	1767	DACH1	GENEORGENEPRODUCT	1602
21750150	1838	1843	DACH1	GENEORGENEPRODUCT	1602
21750150	1914	1919	CD133	GENEORGENEPRODUCT	8842
21750150	1954	1960	Nestin	GENEORGENEPRODUCT	10763
21750150	2065	2070	DACH1	GENEORGENEPRODUCT	1602
21750150	2172	2177	DACH1	GENEORGENEPRODUCT	1602
21750150	2271	2276	DACH1	GENEORGENEPRODUCT	1602
21750150	2374	2379	DACH1	GENEORGENEPRODUCT	1602
21750150	2468	2474	tumore	DISEASEORPHENOTYPICFEATURE	D009369
21750150	2604	2641	fattore di crescita dei fibroblasti 2	GENEORGENEPRODUCT	2247
21750150	2674	2678	FGF2	GENEORGENEPRODUCT	2247
21750150	2710	2714	bFGF	GENEORGENEPRODUCT	2247
21750150	2780	2785	DACH1	GENEORGENEPRODUCT	1602
21750150	2879	2883	bFGF	GENEORGENEPRODUCT	2247
21750150	3022	3027	DACH1	GENEORGENEPRODUCT	1602
21750150	3100	3105	DACH1	GENEORGENEPRODUCT	1602
21750150	3171	3177	tumore	DISEASEORPHENOTYPICFEATURE	D009369
21750150	3273	3277	bFGF	GENEORGENEPRODUCT	2247
21750150	3342	3347	DACH1	GENEORGENEPRODUCT	1602
21750150	3422	3428	tumore	DISEASEORPHENOTYPICFEATURE	D009369
21750150	3521	3527	tumore	DISEASEORPHENOTYPICFEATURE	D009369
21750150	3575	3579	bFGF	GENEORGENEPRODUCT	2247
21750150	3632	3638	tumore	DISEASEORPHENOTYPICFEATURE	D009369
21750150	3704	3710	glioma	DISEASEORPHENOTYPICFEATURE	D005910
21879313	43	52	rs8099917	SEQUENCEVARIANT	RS8099917
21879313	95	100	IL28B	GENEORGENEPRODUCT	282617
21879313	216	236	virus dell'epatite C	ORGANISMTAXON	11103
21879313	296	317	apolipoproteina B-100	GENEORGENEPRODUCT	338
21879313	379	396	epatite cronica C	DISEASEORPHENOTYPICFEATURE	D019698
21879313	447	467	virus dell'epatite C	ORGANISMTAXON	11103
21879313	497	500	HCV	ORGANISMTAXON	11103
21879313	627	633	lipidi	CHEMICALENTITY	D008055
21879313	696	716	interferone pegilato	GENEORGENEPRODUCT	3439
21879313	752	772	interferone pegilato	GENEORGENEPRODUCT	3439
21879313	809	819	ribavirina	CHEMICALENTITY	D012254
21879313	852	859	PEG-IFN	GENEORGENEPRODUCT	3439
21879313	892	895	RBV	CHEMICALENTITY	D012254
21879313	986	991	umano	ORGANISMTAXON	9606
21879313	1026	1043	interleuchina 28B	GENEORGENEPRODUCT	282617
21879313	1078	1083	IL28B	GENEORGENEPRODUCT	282617
21879313	1184	1187	HCV	ORGANISMTAXON	11103
21879313	1268	1275	PEG-IFN	GENEORGENEPRODUCT	3439
21879313	1308	1319	Terapia RBV	CHEMICALENTITY	D012254
21879313	1366	1381	epatite cronica	DISEASEORPHENOTYPICFEATURE	D006521
21879313	1429	1460	infezione da HCV di genotipo 1b	DISEASEORPHENOTYPICFEATURE	D006526
21879313	1558	1563	lipid	CHEMICALENTITY	D008055
21879313	1641	1648	PEG-IFN	GENEORGENEPRODUCT	3439
21879313	1680	1682	RB	CHEMICALENTITY	D012254
21879313	1745	1767	apolipoproteina B -100	GENEORGENEPRODUCT	338
21879313	1799	1807	apoB-100	GENEORGENEPRODUCT	338
21879313	1872	1897	HCV G1b cronico infezione	DISEASEORPHENOTYPICFEATURE	D006526
21879313	2019	2022	HCV	ORGANISMTAXON	11103
21879313	2059	2068	rs8099917	SEQUENCEVARIANT	RS8099917
21879313	2136	2141	IL28B	GENEORGENEPRODUCT	282617
21879313	2224	2232	apoB-100	GENEORGENEPRODUCT	338
21879313	2266	2323	Lipoproteine a bassa densità (LDL) livelli di colesterolo	CHEMICALENTITY	D008078
21879313	2427	2435	apoB-100	GENEORGENEPRODUCT	338
21879313	2487	2502	colesterolo LDL	CHEMICALENTITY	D008078
21879313	2575	2580	Arg70	SEQUENCEVARIANT	P|ALLELE|R|70
21879313	2724	2733	rs8099917	SEQUENCEVARIANT	RS8099917
21879313	2789	2797	apoB-100	GENEORGENEPRODUCT	338
21879313	2848	2863	Colesterolo LDL	CHEMICALENTITY	D008078
21879313	2948	2956	apoB-100	GENEORGENEPRODUCT	338
21879313	2990	3005	colesterolo LDL	CHEMICALENTITY	D008078
21879313	3134	3137	HCV	ORGANISMTAXON	11103
21879313	3185	3201	infezione da HCV	DISEASEORPHENOTYPICFEATURE	D006526
21879313	3286	3294	apoB-100	GENEORGENEPRODUCT	338
21879313	3392	3395	HCV	ORGANISMTAXON	11103
21879313	3482	3490	pazienti	ORGANISMTAXON	9606
21879313	3539	3548	rs8099917	SEQUENCEVARIANT	RS8099917
21976953	61	65	FBN1	GENEORGENEPRODUCT	2200
21976953	155	173	Sindrome di Marfan	DISEASEORPHENOTYPICFEATURE	D008382
21976953	248	260	fibrillina-1	GENEORGENEPRODUCT	2200
21976953	293	297	FBN1	GENEORGENEPRODUCT	2200
21976953	370	388	Sindrome di Marfan	DISEASEORPHENOTYPICFEATURE	D008382
21976953	433	436	MFS	DISEASEORPHENOTYPICFEATURE	D008382
21976953	474	484	I pazienti	ORGANISMTAXON	9606
21976953	817	821	FBN1	GENEORGENEPRODUCT	2200
21976953	1460	1469	c.3703T>C	SEQUENCEVARIANT	C|SUB|T|3703|C
21976953	1531	1535	FBN1	GENEORGENEPRODUCT	2200
21976953	1646	1679	serina con prolina al codone 1235	SEQUENCEVARIANT	P|SUB|S|1235|P
21976953	1720	1728	p.S1235P	SEQUENCEVARIANT	P|SUB|S|1235|P
21976953	1948	1954	calcio	CHEMICALENTITY	D002118
21976953	1993	2023	fattore di crescita epidermica	GENEORGENEPRODUCT	1956
21976953	2254	2262	p.S1235P	SEQUENCEVARIANT	P|SUB|S|1235|P
21976953	2297	2301	FBN1	GENEORGENEPRODUCT	2200
21976953	2377	2380	MFS	DISEASEORPHENOTYPICFEATURE	D008382
21976953	2486	2490	FBN1	GENEORGENEPRODUCT	2200
21976953	2592	2610	Sindrome di Marfan	DISEASEORPHENOTYPICFEATURE	D008382
22369755	52	55	NNK	CHEMICALENTITY	C016583
22369755	90	98	SLURP-1 	GENEORGENEPRODUCT	57152
22369755	224	262	recettori nicotinici dell'acetilcolina	GENEORGENEPRODUCT	1136
22369755	357	364	tabacco	ORGANISMTAXON	4097
22369755	396	408	nitrosammina	CHEMICALENTITY	D009602
22369755	441	487	4-(metilnitrosamino)-1-(3-piridil)- 1-butanone	CHEMICALENTITY	C016583
22369755	521	524	NNK	CHEMICALENTITY	C016583
22369755	578	589	cancerogeno	DISEASEORPHENOTYPICFEATURE	D009369
22369755	663	666	NNK	CHEMICALENTITY	C016583
22369755	772	845	plasminogeno Ly-6/urochinasi proteina-1 correlata al recettore attivatore	GENEORGENEPRODUCT	57152
22369755	879	886	SLURP-1	GENEORGENEPRODUCT	57152
22369755	956	959	NNK	CHEMICALENTITY	 C016583
22369755	1010	1017	SLURP-1	GENEORGENEPRODUCT	57152
22369755	1099	1111	tumorigenesi	DISEASEORPHENOTYPICFEATURE	D009369
22369755	1142	1147	umano	ORGANISMTAXON	9606
22369755	1343	1346	NNK	CHEMICALENTITY	C016583
22369755	1428	1431	MYB	GENEORGENEPRODUCT	4602
22369755	1466	1472	PIK3CA	GENEORGENEPRODUCT	5290
22369755	1541	1546	ETS1 	GENEORGENEPRODUCT	2113
22369755	1579	1583	NRAS	GENEORGENEPRODUCT	4893
22369755	1617	1620	SRC	GENEORGENEPRODUCT	6714
22369755	1691	1695	AKT1	GENEORGENEPRODUCT	207
22369755	1729	1732	KIT	GENEORGENEPRODUCT	 3815
22369755	1766	1769	RB1	GENEORGENEPRODUCT	5925
22369755	1878	1886	rSLURP-1	GENEORGENEPRODUCT	57152
22369755	1954	1960	cancro	DISEASEORPHENOTYPICFEATURE	D009369
22369755	2019	2022	NNK	CHEMICALENTITY	C016583
22369755	2075	2083	rSLURP-1	GENEORGENEPRODUCT	57152
22369755	2143	2146	EGF	GENEORGENEPRODUCT	1950
22369755	2223	2226	HGF	GENEORGENEPRODUCT	3082
22369755	2329	2335	CDKN2A	GENEORGENEPRODUCT	1029
22369755	2369	2374	STAT3	GENEORGENEPRODUCT	6774
22369755	2448	2451	NNK	CHEMICALENTITY	C016583
22369755	2523	2527	BCL2	GENEORGENEPRODUCT	596
22369755	2629	2632	TNF	GENEORGENEPRODUCT	7124
22369755	2701	2704	BAX	GENEORGENEPRODUCT	581
22369755	2737	2742	CASP8	GENEORGENEPRODUCT	841
22369755	2861	2870	rSLURP- 1	GENEORGENEPRODUCT	57152
22369755	2903	2906	NNK	CHEMICALENTITY	C016583
22369755	2967	2973	CTNNB1	GENEORGENEPRODUCT	1499
22369755	3067	3080	beta-catenina	GENEORGENEPRODUCT	1499
22369755	3169	3189	soppressori tumorali	DISEASEORPHENOTYPICFEATURE	D009369
22369755	3221	3226	CDKN3	GENEORGENEPRODUCT	1033
22369755	3261	3266	FOXD3	GENEORGENEPRODUCT	27022
22369755	3342	3350	SERPINB5	GENEORGENEPRODUCT	5268
22369755	3460	3463	NNK	CHEMICALENTITY	C016583
22369755	3518	3526	rSLURP-1	GENEORGENEPRODUCT	57152
22369755	3581	3586	RUNX3	GENEORGENEPRODUCT	864
22369755	3702	3705	NNK	CHEMICALENTITY	C016583
22369755	3740	3747	SLURP-1	GENEORGENEPRODUCT	57152
22369755	3876	3886	tumorigena	DISEASEORPHENOTYPICFEATURE	D009369
22729903	93	98	STAT4	GENEORGENEPRODUCT	6775
22729903	145	172	lupus eritematoso sistemico	DISEASEORPHENOTYPICFEATURE	D008180
22729903	234	239	STAT4	GENEORGENEPRODUCT	6775
22729903	341	368	lupus eritematoso sistemico	DISEASEORPHENOTYPICFEATURE	D008180
22729903	413	416	LES	DISEASEORPHENOTYPICFEATURE	D008180
22729903	573	576	LES	DISEASEORPHENOTYPICFEATURE	D008180
22729903	653	659	STAT4 	GENEORGENEPRODUCT	6775
22729903	694	699	G > C	SEQUENCEVARIANT	RS7582694
22729903	735	744	rs7582694	SEQUENCEVARIANT	RS7582694
22729903	789	797	pazienti	ORGANISMTAXON	9606
22729903	845	848	LES	DISEASEORPHENOTYPICFEATURE	D008180
22729903	974	982	pazienti	ORGANISMTAXON	9606
22729903	1021	1026	STAT4	GENEORGENEPRODUCT	6775
22729903	1135	1138	LES	DISEASEORPHENOTYPICFEATURE	D008180
22729903	1347	1352	STAT4	GENEORGENEPRODUCT	6775
22729903	1447	1450	LES	DISEASEORPHENOTYPICFEATURE	D008180
22729903	1572	1577	STAT4	GENEORGENEPRODUCT	6775
22729903	1643	1646	SLE	DISEASEORPHENOTYPICFEATURE	D008180
22729903	1674	1682	pazienti	ORGANISMTAXON	9606
22729903	1730	1744	sintomi renali	DISEASEORPHENOTYPICFEATURE	D007674
22729903	1856	1859	LES	DISEASEORPHENOTYPICFEATURE	D008180
22729903	1887	1895	pazienti	ORGANISMTAXON	9606
22729903	2074	2079	STAT4	GENEORGENEPRODUCT	6775
22729903	2147	2152	snRNP	GENEORGENEPRODUCT	57819
22729903	2269	2276	Scl -70	GENEORGENEPRODUCT	7150
22729903	2433	2438	STAT4	GENEORGENEPRODUCT	6775
22729903	2476	2485	rs7582694	SEQUENCEVARIANT	RS7582694
22729903	2549	2552	LES	DISEASEORPHENOTYPICFEATURE	D008180
23069675	49	71	pentraxina neuronale 1	GENEORGENEPRODUCT	18164
23069675	139	173	danno neuronale ipossico-ischemico	DISEASEORPHENOTYPICFEATURE	 D020925
23069675	276	307	lesione ipossico-ischemica (HI)	DISEASEORPHENOTYPICFEATURE	D020925
23069675	369	392	disabilità neurologiche	DISEASEORPHENOTYPICFEATURE	D009461
23069675	515	537	pentraxina neuronale 1	GENEORGENEPRODUCT	266777
23069675	572	575	NP1	GENEORGENEPRODUCT	266777
23069675	703	723	lesione neuronale HI	DISEASEORPHENOTYPICFEATURE	D020925
23069675	851	869	HI morte neuronale	DISEASEORPHENOTYPICFEATURE	D020925
23069675	934	937	NP1	GENEORGENEPRODUCT	18164
23069675	980	983	NP1	GENEORGENEPRODUCT	18164
23069675	1017	1021	topo	ORGANISMTAXON	10090
23069675	1120	1128	ossigeno	CHEMICALENTITY	D010100
23069675	1161	1169	glucosio	CHEMICALENTITY	D005947
23069675	1245	1249	topo	ORGANISMTAXON	10090
23069675	1304	1324	HI lesione cerebrale	DISEASEORPHENOTYPICFEATURE	D020925
23069675	1401	1404	NP1	GENEORGENEPRODUCT	18164
23069675	1533	1536	CA1	GENEORGENEPRODUCT	 12346
23069675	1571	1574	CA3	GENEORGENEPRODUCT	12350
23069675	1715	1719	PTEN	GENEORGENEPRODUCT	19211
23069675	1828	1831	Akt	GENEORGENEPRODUCT	11651
23069675	1871	1877	Ser473	SEQUENCEVARIANT	P|AELLELS|473
23069675	1913	1919	GSK-3b	GENEORGENEPRODUCT	56637
23069675	1957	1961	Ser9	SEQUENCEVARIANT	P|AELLELS|9
23069675	2078	2081	Bad	GENEORGENEPRODUCT	12015
23069675	2121	2127	Ser136	SEQUENCEVARIANT	P|AELLELS|136
23069675	2163	2166	Bax	GENEORGENEPRODUCT	12028
23069675	2362	2365	Bad	GENEORGENEPRODUCT	12015
23069675	2400	2403	Bax	GENEORGENEPRODUCT	12028
23069675	2520	2525	Cyt C	GENEORGENEPRODUCT	13063
23069675	2601	2611	 caspase-3	GENEORGENEPRODUCT	12367
23069675	2645	2648	NP1	GENEORGENEPRODUCT	18164
23069675	2723	2726	Bad	GENEORGENEPRODUCT	12015
23069675	2762	2765	Bax	GENEORGENEPRODUCT	12028
23069675	2855	2858	NP1	GENEORGENEPRODUCT	18164
23069675	2895	2898	Bad	GENEORGENEPRODUCT	12015
23069675	2934	2937	Bax	GENEORGENEPRODUCT	12028
23069675	3112	3115	NP1	GENEORGENEPRODUCT	18164
23069675	3201	3212	citocromo C	GENEORGENEPRODUCT	13063
23069675	3247	3252	Cyt C	GENEORGENEPRODUCT	13063
23069675	3314	3323	caspase-3	GENEORGENEPRODUCT	12367
23069675	3458	3461	NP1	GENEORGENEPRODUCT	18164
23069675	3529	3532	Bad	GENEORGENEPRODUCT	12015
23069675	3567	3570	Bax	GENEORGENEPRODUCT	12028
23069675	3680	3685	Cyt C	GENEORGENEPRODUCT	13063
23069675	3729	3738	caspase-3	GENEORGENEPRODUCT	12367
23069675	3864	3879	morte neuronale	DISEASEORPHENOTYPICFEATURE	D009410
23069675	3963	3966	NP1	GENEORGENEPRODUCT	18164
23069675	4002	4005	Bad	GENEORGENEPRODUCT	12015
23069675	4039	4079	Rilascio mitocondriale dipendente da Bax	GENEORGENEPRODUCT	12028
23069675	4115	4120	Cyt C	GENEORGENEPRODUCT	13063
23069675	4156	4165	caspase-3	GENEORGENEPRODUCT	 12367
23069675	4288	4291	NP1	GENEORGENEPRODUCT	18164
23069675	4400	4403	NP1	GENEORGENEPRODUCT	18164
23069675	4492	4512	HI lesione cerebrale	DISEASEORPHENOTYPICFEATURE	D020925
24114426	43	54	Depressione	DISEASEORPHENOTYPICFEATURE	D003866
24114426	99	110	impulsività	DISEASEORPHENOTYPICFEATURE	D010554
24114426	199	229	3,4-metilendiossimetanfetamina	CHEMICALENTITY	D018817
24114426	262	267	MDMA 	CHEMICALENTITY	D018817
24114426	300	307	ecstasy	CHEMICALENTITY	D018817
24114426	352	359	Ecstasy	CHEMICALENTITY	D018817
24114426	392	422	3,4-metilendiossimetanfetamina	CHEMICALENTITY	D018817
24114426	456	460	MDMA	CHEMICALENTITY	D018817
24114426	573	578	umana	ORGANISMTAXON	9606
24114426	816	819	5HT	CHEMICALENTITY	D012701
24114426	901	908	ecstasy	CHEMICALENTITY	D018817
24114426	1199	1204	alcol	CHEMICALENTITY	D000431
24114426	1237	1245	nicotina	CHEMICALENTITY	D009538
24114426	1286	1288	AN	CHEMICALENTITY	D000431,D009538
24114426	1322	1331	cannabis 	CHEMICALENTITY	D002188
24114426	1363	1369	alcool	CHEMICALENTITY	D000431
24114426	1401	1409	nicotina	CHEMICALENTITY	D009538
24114426	1459	1462	CAN	CHEMICALENTITY	D000431,D002188,D009538
24114426	1500	1507	ecstasy	CHEMICALENTITY	D018817
24114426	1563	1570	ecstasy	CHEMICALENTITY	D018817
24114426	1635	1639	MDMA	CHEMICALENTITY	D018817
24114426	1693	1697	MDMA	CHEMICALENTITY	D018817
24114426	2015	2018	CAN	CHEMICALENTITY	D000431,D002188,D0 09538
24114426	2145	2149	MDMA	CHEMICALENTITY	D018817
24114426	2188	2201	I gruppi MDMA	CHEMICALENTITY	D018817
24114426	2458	2465	ecstasy	CHEMICALENTITY	D018817
24114426	2568	2575	ecstasy	CHEMICALENTITY	D018817
24114426	2807	2826	memoria compromessa	DISEASEORPHENOTYPICFEATURE	D008569
24114426	2910	2921	depressione	DISEASEORPHENOTYPICFEATURE	D003866
24114426	2967	2978	impulsività	DISEASEORPHENOTYPICFEATURE	D010554
24114426	3024	3042	disturbi del sonno	DISEASEORPHENOTYPICFEATURE	D020920
24114426	3130	3137	ecstasy	CHEMICALENTITY	D018817
24671324	43	64	Fascite necrotizzante	DISEASEORPHENOTYPICFEATURE	D019115
24671324	104	114	bortezomib	CHEMICALENTITY	D000069286
24671324	148	178	regime contenente desametasone	CHEMICALENTITY	D003907
24671324	212	220	paziente	ORGANISMTAXON	9606
24671324	275	307	Macroglobulinemia di Waldenstrom	DISEASEORPHENOTYPICFEATURE	D008258
24671324	343	353	Bortezomib	CHEMICALENTITY	D000069286
24671324	387	399	desametasone	CHEMICALENTITY	D003907
24671324	512	532	infezioni batteriche	DISEASEORPHENOTYPICFEATURE	D001424
24671324	563	571	pazienti	ORGANISMTAXON	9606
24671324	629	636	maligne	DISEASEORPHENOTYPICFEATURE	D009369
24671324	722	730	pazienti	ORGANISMTAXON	9606
24671324	806	810	uomo	ORGANISMTAXON	9606
24671324	869	901	Macroglobulinemia di Waldenstrom	DISEASEORPHENOTYPICFEATURE	D008258
24671324	964	985	fascite necrotizzante	DISEASEORPHENOTYPICFEATURE	D019115
24671324	1035	1046	neutropenia	DISEASEORPHENOTYPICFEATURE	D009503
24671324	1116	1126	bortezomib	CHEMICALENTITY	D000069286
24671324	1176	1188	desametasone	CHEMICALENTITY	D003907
24671324	1226	1235	rituximab	CHEMICALENTITY	D000069283
24671324	1428	1448	infezioni batteriche	DISEASEORPHENOTYPICFEATURE	D001424
24671324	1495	1505	bortezomib	CHEMICALENTITY	D000069286
24671324	1552	1564	desametasone	CHEMICALENTITY	D003907
24671324	1596	1604	pazienti	ORGANISMTAXON	9606
24717468	78	93	dexmedetomidina	CHEMICALENTITY	D020927
24717468	128	136	propofol	CHEMICALENTITY	D015742
24717468	205	213	pazienti	ORGANISMTAXON	9606
24717468	257	272	Dexmedetomidina	CHEMICALENTITY	D020927
24717468	306	314	propofol	CHEMICALENTITY	D015742
24717468	664	672	pazienti	ORGANISMTAXON	9606
24717468	717	732	dexmedetomidina	CHEMICALENTITY	D020927
24717468	766	774	propofol	CHEMICALENTITY	D015742
24717468	1039	1047	PAZIENTI	ORGANISMTAXON	9606
24717468	1071	1079	pazienti	ORGANISMTAXON	9606
24717468	1338	1353	dexmedetomidina	CHEMICALENTITY	D020927
24717468	1387	1395	propofol	CHEMICALENTITY	D015742
24717468	1472	1480	pazienti	ORGANISMTAXON	9606
24717468	1517	1532	dexmedetomidina	CHEMICALENTITY	D020927
24717468	1570	1578	propofol	CHEMICALENTITY	D015742
24717468	1780	1791	ipotensione	DISEASEORPHENOTYPICFEATURE	D007022
24717468	1876	1888	 bradicardia	DISEASEORPHENOTYPICFEATURE	D001919
24717468	2251	2262	ipotensione	DISEASEORPHENOTYPICFEATURE	D007022
24717468	2308	2319	bradicardia	DISEASEORPHENOTYPICFEATURE	D001919
24717468	2420	2431	ipotensione	DISEASEORPHENOTYPICFEATURE	D007022
24717468	2477	2488	bradicardia	DISEASEORPHENOTYPICFEATURE	D001919
24717468	2582	2590	pazienti	ORGANISMTAXON	9606
24717468	2635	2650	dexmedetomidina	CHEMICALENTITY	D020927
24717468	2684	2693	 propofol	CHEMICALENTITY	D015742
24717468	2809	2820	ipotensione	DISEASEORPHENOTYPICFEATURE	D007022
24717468	2866	2877	bradicardia	DISEASEORPHENOTYPICFEATURE	D001919
24739405	42	63	deidroepiandrosterone	CHEMICALENTITY	D003687
24739405	98	108	anfetamina	CHEMICALENTITY	D000661
24739405	160	172	schizofrenia	DISEASEORPHENOTYPICFEATURE	D012559
24739405	212	216	topi	ORGANISMTAXON	10090
24739405	285	306	deidroepiandrosterone	CHEMICALENTITY	D003687
24739405	339	343	DHEA	CHEMICALENTITY	D003687
24739405	410	422	schizofrenia	DISEASEORPHENOTYPICFEATURE	D012559
24739405	493	497	topi	ORGANISMTAXON	10090
24739405	570	580	anfetamine	CHEMICALENTITY	D000661
24739405	631	641	anfetamina	CHEMICALENTITY	D000661
24739405	689	694	DHEA 	CHEMICALENTITY	D003687
24739405	730	734	DHEA	CHEMICALENTITY	D003687
24739405	832	842	Anfetamina	CHEMICALENTITY	D000661
24739405	907	923	iper locomozione	DISEASEORPHENOTYPICFEATURE	D006948
24739405	957	967	apomorfina	CHEMICALENTITY	D001058
24739405	1064	1075	aloperidolo	CHEMICALENTITY	D006220
24739405	1139	1148	catalessi	DISEASEORPHENOTYPICFEATURE	D002375
24739405	1233	1245	schizofrenia	DISEASEORPHENOTYPICFEATURE	D012559
24739405	1561	1577	iper locomozione	DISEASEORPHENOTYPICFEATURE	D006948
24739405	1669	1679	catalessia	DISEASEORPHENOTYPICFEATURE	D002375
24739405	1759	1769	anfetamine	CHEMICALENTITY	D000661
24739405	1875	1885	anfetamine	CHEMICALENTITY	D000661
24739405	1936	1940	DHEA	CHEMICALENTITY	D003687
24739405	2074	2117	gruppo di locomozione indotto da anfetamine	CHEMICALENTITY	D000661
24739405	2207	2218	aloperidolo	CHEMICALENTITY	D006220
24739405	2262	2272	catalessia	DISEASEORPHENOTYPICFEATURE	D002375
24739405	2457	2467	apomorfina	CHEMICALENTITY	D001058
24739405	2544	2548	DHEA	CHEMICALENTITY	D003687
24739405	2638	2647	catalessi	DISEASEORPHENOTYPICFEATURE	D002375
24739405	2780	2784	DHEA	CHEMICALENTITY	D003687
24739405	2914	2926	schizofrenia	DISEASEORPHENOTYPICFEATURE	D012559
24840785	31	40	Aconitina	CHEMICALENTITY	D000157
24840785	80	84	Ca2+	CHEMICALENTITY	D002118
24840785	152	159	aritmia	DISEASEORPHENOTYPICFEATURE	D001145
24840785	243	251	p38 MAPK	GENEORGENEPRODUCT	81649
24840785	292	297	ratti	ORGANISMTAXON	10116
24840785	330	339	Aconitina	CHEMICALENTITY	D000157
24840785	538	543	Na(+)	CHEMICALENTITY	D012964
24840785	638	653	cardiotossicità	DISEASEORPHENOTYPICFEATURE	D066126
24840785	688	697	aconitina	CHEMICALENTITY	D000157
24840785	783	789	Ca(2+)	CHEMICALENTITY	D002118
24840785	824	833	aconitina	CHEMICALENTITY	D000157
24840785	877	890	avvelenamento	DISEASEORPHENOTYPICFEATURE	D011041
24840785	1005	1011	Ca(2+)	CHEMICALENTITY	D002118
24840785	1046	1055	aconitina	CHEMICALENTITY	D000157
24840785	1099	1112	avvelenamento	DISEASEORPHENOTYPICFEATURE	D011041
24840785	1204	1210	Ca(2+)	CHEMICALENTITY	D002118
24840785	1246	1249	rat	ORGANISMTAXON	10116
24840785	1370	1377	aritmia	DISEASEORPHENOTYPICFEATURE	D001145
24840785	1410	1447	ratti in movimento cosciente e libero	ORGANISMTAXON	10116
24840785	1508	1517	aconitina	CHEMICALENTITY	D000157
24840785	1564	1580	danno miocardico	DISEASEORPHENOTYPICFEATURE	D009202
24840785	1643	1656	citotossicità	DISEASEORPHENOTYPICFEATURE	D064420
24840785	1732	1735	rat	ORGANISMTAXON	10116
24840785	1780	1811	livello di lattato deidrogenasi	GENEORGENEPRODUCT	24533
24840785	1916	1921	ratti	ORGANISMTAXON	10116
24840785	1985	1994	aconitina	CHEMICALENTITY	D000157
24840785	2051	2067	danno miocardico	DISEASEORPHENOTYPICFEATURE	D009202
24840785	2406	2413	biotina	CHEMICALENTITY	D001710
24840785	2511	2520	aconitina	CHEMICALENTITY	D000157
24840785	2633	2639	Ca(2+)	CHEMICALENTITY	D002118
24840785	2716	2725	aconitina	CHEMICALENTITY	D000157
24840785	2766	2772	Ca(2+)	CHEMICALENTITY	D002118
24840785	2859	2865	Ca(2+)	CHEMICALENTITY	D002118
24840785	3118	3123	BCL-2	GENEORGENEPRODUCT	24224
24840785	3239	3243	MAPK	GENEORGENEPRODUCT	81649
24840785	3298	3301	P38	GENEORGENEPRODUCT	81649
24840785	3335	3350	Il rapporto P38	GENEORGENEPRODUCT	81649
24840785	3464	3473	aconitina	CHEMICALENTITY	D000157
24840785	3532	3538	Ca(2+)	CHEMICALENTITY	D002118
24840785	3605	3612	aritmia	DISEASEORPHENOTYPICFEATURE	D001145
24840785	3718	3759	P38 protein chinasi attivata dal mitogeno	GENEORGENEPRODUCT	81649
25006961	43	52	PKC-alpha	GENEORGENEPRODUCT	18750
25006961	92	97	litio	CHEMICALENTITY	D008094
25006961	149	177	diabete insipido nefrogenico	DISEASEORPHENOTYPICFEATURE	D018500
25006961	210	215	Litio	CHEMICALENTITY	D008094
25006961	294	320	diabete insipido nefrogeno	DISEASEORPHENOTYPICFEATURE	D018500
25006961	367	370	NDI	DISEASEORPHENOTYPICFEATURE	D018500
25006961	411	419	pazienti	ORGANISMTAXON	9606
25006961	526	531	litio	CHEMICALENTITY	D008094
25006961	592	596	cAMP	CHEMICALENTITY	D000242
25006961	653	674	trasportatore di urea	GENEORGENEPRODUCT	27411
25006961	708	713	UT-A1	GENEORGENEPRODUCT	27411
25006961	764	768	AQP2	GENEORGENEPRODUCT	11827
25006961	909	912	PKC	GENEORGENEPRODUCT	18750
25006961	997	1002	litio	CHEMICALENTITY	D008094
25006961	1054	1062	poliuria	DISEASEORPHENOTYPICFEATURE	D011141
25006961	1096	1105	PKC-alpha	GENEORGENEPRODUCT	18750
25006961	1139	1143	topi	ORGANISMTAXON	10090
25006961	1178	1182	PKCa	GENEORGENEPRODUCT	 18750
25006961	1277	1282	litio	CHEMICALENTITY	D008094
25006961	1335	1339	topi	ORGANISMTAXON	10090
25006961	1498	1502	PKCa	GENEORGENEPRODUCT	18750
25006961	1534	1538	topi	ORGANISMTAXON	10090
25006961	1698	1702	AQP2	GENEORGENEPRODUCT	11827
25006961	1791	1798	topi WT	ORGANISMTAXON	10090
25006961	1842	1846	AQP2	GENEORGENEPRODUCT	11827
25006961	1902	1906	PKCa	GENEORGENEPRODUCT	18750
25006961	1999	2004	UT-A1	GENEORGENEPRODUCT	27411
25006961	2079	2084	litio	CHEMICALENTITY	D008094
25006961	2133	2138	Litio	CHEMICALENTITY	D008094
25006961	2169	2173	topi	ORGANISMTAXON	10090
25006961	2290	2294	PKCa	GENEORGENEPRODUCT	18750
25006961	2394	2398	AQP2	GENEORGENEPRODUCT	11827
25006961	2433	2438	UT-A1	GENEORGENEPRODUCT	27411
25006961	2516	2521	Litio	CHEMICALENTITY	D008094
25006961	2583	2587	PKCa	GENEORGENEPRODUCT	18750
25006961	2620	2624	topi	ORGANISMTAXON	10090
25006961	2658	2662	AQP2	GENEORGENEPRODUCT	11827
25006961	2729	2749	 L'espressione UT-A1	GENEORGENEPRODUCT	27411
25006961	2814	2819	sodio	CHEMICALENTITY	D012964
25006961	2852	2860	potassio	CHEMICALENTITY	D011188
25006961	2895	2901	calcio	CHEMICALENTITY	D002118
25006961	2950	2955	litio	CHEMICALENTITY	D008094
25006961	3000	3005	litio	CHEMICALENTITY	D008094
25006961	3042	3046	PKCa	GENEORGENEPRODUCT	18750
25006961	3078	3082	topi	ORGANISMTAXON	10090
25006961	3158	3162	PKCa	GENEORGENEPRODUCT	18750
25006961	3204	3208	AQP2	GENEORGENEPRODUCT	11827
25006961	3244	3249	UT-A1	GENEORGENEPRODUCT	27411
25006961	3328	3333	litio	CHEMICALENTITY	D008094
25006961	3386	3389	NDI	DISEASEORPHENOTYPICFEATURE	D018500
25006961	3469	3477	poliuria	DISEASEORPHENOTYPICFEATURE	D011141
25006961	3522	3527	litio	CHEMICALENTITY	D008094
25874935	60	71	neuroserpin	GENEORGENEPRODUCT	116459
25874935	106	114	ossigeno	CHEMICALENTITY	D010100
25874935	146	154	glucosio	CHEMICALENTITY	D005947
25874935	156	159	rat	ORGANISMTAXON	10116
25874935	291	302	Neuroserpin	GENEORGENEPRODUCT	116459,5274
25874935	342	345	NSP	GENEORGENEPRODUCT	116459,5274
25874935	451	469	ischemia cerebrale	DISEASEORPHENOTYPICFEATURE	D002545
25874935	515	523	pazienti	ORGANISMTAXON	9606
25874935	683	686	NSP	GENEORGENEPRODUCT	116459
25874935	750	759	ischemico	DISEASEORPHENOTYPICFEATURE	D007511
25874935	856	861	ratti	ORGANISMTAXON	10116
25874935	927	935	ossigeno	CHEMICALENTITY	D010100
25874935	968	992	deprivazione di glucosio	CHEMICALENTITY	D005947
25874935	1114	1117	NSP	GENEORGENEPRODUCT	116459
25874935	1214	1234	lattato deidrogenasi	GENEORGENEPRODUCT	24533
25874935	1268	1271	LDH	GENEORGENEPRODUCT	24533
25874935	1409	1418	Annexin V	GENEORGENEPRODUCT	25673
25874935	1494	1497	NSP	GENEORGENEPRODUCT	116459
25874935	1545	1559	ossido nitrico	CHEMICALENTITY	D009569
25874935	1593	1595	NO	CHEMICALENTITY	D009569
25874935	1631	1640	TNF-alpha	GENEORGENEPRODUCT	24835
25874935	1686	1712	La somministrazione di NSP	GENEORGENEPRODUCT	116459
25874935	1834	1843	NF-kappaB	GENEORGENEPRODUCT	309165
25874935	1881	1887	ERK1/2	GENEORGENEPRODUCT	5594,5595
25874935	1925	1929	PI3K	GENEORGENEPRODUCT	298947
25874935	1962	1965	Akt	GENEORGENEPRODUCT	24185
25874935	2128	2137	NF-kappaB	GENEORGENEPRODUCT	309165
25874935	2175	2185	NF-kappaB 	GENEORGENEPRODUCT	309165
25874935	2242	2248	sc3060	CHEMICALENTITY	C118258
25874935	2329	2332	NSP	GENEORGENEPRODUCT	116459
25874935	2412	2415	NSP	GENEORGENEPRODUCT	116459
25874935	2535	2538	LDH	GENEORGENEPRODUCT	24533
25874935	2638	2640	NO	CHEMICALENTITY	D009569
25874935	2673	2682	TNF-alpha	GENEORGENEPRODUCT	24835
25874935	2783	2797	IKKBalpha/beta	GENEORGENEPRODUCT	309361,84351
25874935	2833	2836	P65	GENEORGENEPRODUCT	309165
25874935	2996	2999	NSP	GENEORGENEPRODUCT	116459
25874935	3058	3061	NSP	GENEORGENEPRODUCT	116459
25874935	3172	3181	NF-kappaB	GENEORGENEPRODUCT	309165
25874935	3236	3242	sc3060	CHEMICALENTITY	C118258
25874935	3301	3305	ERK1	GENEORGENEPRODUCT	50689
25874935	3342	3346	ERK2	GENEORGENEPRODUCT	116590
25874935	3383	3386	AKT	GENEORGENEPRODUCT	24185
25874935	3539	3542	NSP	GENEORGENEPRODUCT	116459
25874935	3651	3654	NSP	GENEORGENEPRODUCT	116459
25874935	3701	3710	ischemici	DISEASEORPHENOTYPICFEATURE	D007511
25874935	3816	3818	NO	CHEMICALENTITY	D009569
25874935	3851	3860	TNF-alpha	GENEORGENEPRODUCT	24835
25874935	3934	3943	NF-kappaB	GENEORGENEPRODUCT	309165
25874935	4019	4022	NSP	GENEORGENEPRODUCT	116459
25874935	4083	4087	MAPK	GENEORGENEPRODUCT	116590,50689
25874935	4123	4127	PI3K	GENEORGENEPRODUCT	298947
25874935	4160	4163	Akt	GENEORGENEPRODUCT	24185
26110643	41	45	Trap	GENEORGENEPRODUCT	436725
26110643	132	141	Zebrafish	ORGANISMTAXON	 7955
26110643	211	224	Neuregulin 2a	GENEORGENEPRODUCT	100006951
26110643	271	276	 ErbB	GENEORGENEPRODUCT	386635,386966
26110643	406	428	I disturbi della pelle	DISEASEORPHENOTYPICFEATURE	D012871
26110643	673	682	Zebrafish	ORGANISMTAXON	7955
26110643	855	866	Danio rerio	ORGANISMTAXON	7955
26110643	895	906	pesce zebra	ORGANISMTAXON	7955
26110643	1167	1172	fras1	GENEORGENEPRODUCT	563428
26110643	1207	1212	grip1	GENEORGENEPRODUCT	558006
26110643	1248	1253	hmcn1	GENEORGENEPRODUCT	559150
26110643	1287	1291	msxc	GENEORGENEPRODUCT	30526
26110643	1326	1332	col4a4	GENEORGENEPRODUCT	554270
26110643	1367	1372	ahnak	GENEORGENEPRODUCT	559276
26110643	1407	1413	capn12	GENEORGENEPRODUCT	799247
26110643	1453	1458	nrg2a	GENEORGENEPRODUCT	100006951
26110643	1564	1573	arhgef25b	GENEORGENEPRODUCT	569561
26110643	1609	1616	fkbp10b	GENEORGENEPRODUCT	324381
26110643	1652	1658	megf6a	GENEORGENEPRODUCT	565108
26110643	1797	1810	neuregulin 2a	GENEORGENEPRODUCT	100006951
26110643	1848	1853	nrg2a	GENEORGENEPRODUCT	100006951
26110643	1932	1945	Neuregulin 2a	GENEORGENEPRODUCT	100006951
26110643	1983	1988	Nrg2a	GENEORGENEPRODUCT	100006951
26110643	2031	2038	ErbB2/3	GENEORGENEPRODUCT	386635,386966
26110643	2075	2078	AKT	GENEORGENEPRODUCT	101910198
26110643	2281	2286	nrg2a	GENEORGENEPRODUCT	100006951
26110643	2436	2448	AKT ridotti 	GENEORGENEPRODUCT	101910198
26110643	2769	2774	Nrg2a	GENEORGENEPRODUCT	100006951
26110643	2837	2888	recettore della tirosina chinasi del recettore ErbB	GENEORGENEPRODUCT	386635,386966
26110643	3004	3010	tumore	DISEASEORPHENOTYPICFEATURE	D009369
26110643	3056	3060	lgl2	GENEORGENEPRODUCT	795670
26110643	3114	3119	nrg2a	GENEORGENEPRODUCT	100006951
26110643	3190	3194	Lgl2	GENEORGENEPRODUCT	795670
26110643	3251	3256	Nrg2a	GENEORGENEPRODUCT	100006951
26110643	3410	3414	Lgl2	GENEORGENEPRODUCT	795670
26615423	48	73	proteina centrosomiale 55	GENEORGENEPRODUCT	55165
26615423	155	161	tumore	DISEASEORPHENOTYPICFEATURE	D009369
26615423	221	249	carcinoma ovarico epiteliale	DISEASEORPHENOTYPICFEATURE	D000077216
26615423	283	310	La proteina centrosomale 55	GENEORGENEPRODUCT	55165
26615423	344	349	CEP55	GENEORGENEPRODUCT	55165
26615423	465	471	cancro	DISEASEORPHENOTYPICFEATURE	D009369
26615423	551	556	CEP55	GENEORGENEPRODUCT	55165
26615423	644	649	umano	ORGANISMTAXON	9606
26615423	696	724	carcinoma ovarico epiteliale	DISEASEORPHENOTYPICFEATURE	D000077216
26615423	772	775	EOC	DISEASEORPHENOTYPICFEATURE	D000077216
26615423	889	894	CEP55	GENEORGENEPRODUCT	55165
26615423	925	933	pazienti	ORGANISMTAXON	9606
26615423	984	987	EOC	DISEASEORPHENOTYPICFEATURE	D000077216
26615423	1081	1118	metastasi di linee cellulari ovariche	DISEASEORPHENOTYPICFEATURE	D010051
26615423	1152	1157	CEP55	GENEORGENEPRODUCT	55165
26615423	1398	1403	CEP55	GENEORGENEPRODUCT	55165
26615423	1479	1487	paziente	ORGANISMTAXON	9606
26615423	1548	1553	CEP55	GENEORGENEPRODUCT	55165
26615423	1772	1777	CEP55	GENEORGENEPRODUCT	55165
26615423	1865	1879	cancro ovarico	DISEASEORPHENOTYPICFEATURE	D010051
26615423	2031	2034	EOC	DISEASEORPHENOTYPICFEATURE	D000077216
26615423	2077	2082	CEP55	GENEORGENEPRODUCT	55165
26615423	2214	2235	metastasi linfonodali	DISEASEORPHENOTYPICFEATURE	D008207
26615423	2292	2318	metastasi intraperitoneali	DISEASEORPHENOTYPICFEATURE	D009362
26615423	2375	2381	tumore	DISEASEORPHENOTYPICFEATURE	D009369
26615423	2495	2501	tumore	DISEASEORPHENOTYPICFEATURE	D009369
26615423	2569	2575	ascite	DISEASEORPHENOTYPICFEATURE	D001201
26615423	2626	2632	tumore	DISEASEORPHENOTYPICFEATURE	D009369
26615423	2692	2697	CA153	GENEORGENEPRODUCT	4582
26615423	2754	2762	pazienti	ORGANISMTAXON	9606
26615423	2831	2836	CEP55	GENEORGENEPRODUCT	55165
26615423	3071	3079	paziente	ORGANISMTAXON	9606
26615423	3141	3147	CA125 	GENEORGENEPRODUCT	94025
26615423	3181	3186	CA199	GENEORGENEPRODUCT	94025
26615423	3220	3225	CA724	GENEORGENEPRODUCT	94025
26615423	3259	3262	NSE	GENEORGENEPRODUCT	2026
26615423	3295	3298	CEA	GENEORGENEPRODUCT	1084
26615423	3333	3339	 b-HCG	GENEORGENEPRODUCT	93659
26615423	3376	3384	Pazienti	ORGANISMTAXON	9606
26615423	3448	3453	CEP55	GENEORGENEPRODUCT	55165
26615423	3620	3625	CEP55	GENEORGENEPRODUCT	55165
26615423	3695	3700	CEP55	GENEORGENEPRODUCT	55165
26615423	3792	3795	EOC	DISEASEORPHENOTYPICFEATURE	D000077216
26615423	3824	3832	pazienti	ORGANISMTAXON	9606
26615423	3907	3912	CEP55	GENEORGENEPRODUCT	55165
26615423	3959	3973	cancro ovarico	DISEASEORPHENOTYPICFEATURE	D010051
26615423	4092	4097	CEP55	GENEORGENEPRODUCT	55165
26615423	4185	4188	EOC	DISEASEORPHENOTYPICFEATURE	D000077216
26615423	4217	4225	pazienti	ORGANISMTAXON	9606
26615423	4347	4361	cancro ovarico	DISEASEORPHENOTYPICFEATURE	D010051
26615423	4405	4410	CEP55	GENEORGENEPRODUCT	55165
26615423	4516	4519	EOC	DISEASEORPHENOTYPICFEATURE	D000077216
26847345	31	41	Transgelin	GENEORGENEPRODUCT	6876
26847345	122	144	cancro del colon-retto	DISEASEORPHENOTYPICFEATURE	D015179
26847345	272	282	Transgelin	GENEORGENEPRODUCT	6876
26847345	326	351	proteina legante l'actina	GENEORGENEPRODUCT	21345,6876
26847345	451	461	transgelin	GENEORGENEPRODUCT	6876
26847345	508	514	cancro	DISEASEORPHENOTYPICFEATURE	D009369
26847345	671	677	tumore	DISEASEORPHENOTYPICFEATURE	D009369
26847345	811	821	transgelin	GENEORGENEPRODUCT	6876
26847345	902	912	transgelin	GENEORGENEPRODUCT	6876
26847345	967	989	cancro del colon-retto	DISEASEORPHENOTYPICFEATURE	D015179
26847345	1034	1037	CRC	DISEASEORPHENOTYPICFEATURE	D015179
26847345	1184	1187	CRC	DISEASEORPHENOTYPICFEATURE	D015179
26847345	1253	1263	transgelin	GENEORGENEPRODUCT	6876
26847345	1404	1408	topo	ORGANISMTAXON	10090
26847345	1513	1523	transgelin	GENEORGENEPRODUCT	6876
26847345	1680	1690	transgelin	GENEORGENEPRODUCT	6876
26847345	2003	2022	metastasi polmonari	DISEASEORPHENOTYPICFEATURE	D008175
26847345	2055	2060	mouse	ORGANISMTAXON	10090
26847345	2186	2196	transgelin	GENEORGENEPRODUCT	6876
26847345	2344	2353	metastasi	DISEASEORPHENOTYPICFEATURE	D009362
26847345	2494	2504	transgelin	GENEORGENEPRODUCT	6876
26847345	2652	2658	actina	GENEORGENEPRODUCT	60
26847345	2710	2735	proteine citoscheletriche	GENEORGENEPRODUCT	51361,55740,7145
26847345	2805	2810	HOOK1	GENEORGENEPRODUCT	51361
26847345	2844	2851	SDCCAG8	GENEORGENEPRODUCT	10806
26847345	2886	2890	ENAH	GENEORGENEPRODUCT	55740
26847345	2923	2927	Mena	GENEORGENEPRODUCT	55740
26847345	2961	2965	TNS1	GENEORGENEPRODUCT	7145
26847345	3015	3018	EMB	GENEORGENEPRODUCT	133418
26847345	3052	3058	BCL11B	GENEORGENEPRODUCT	64919
26847345	3093	3098	PTPRD	GENEORGENEPRODUCT	5789
26847345	3186	3196	transgelin	GENEORGENEPRODUCT	6876
26847345	3267	3273	tumore	DISEASEORPHENOTYPICFEATURE	D009369
26900322	31	34	CFI	GENEORGENEPRODUCT	3426
26900322	69	78	rs7356506	SEQUENCEVARIANT	RS7356506
26900322	147	179	Sindrome di Vogt-Koyanagi-Harada	DISEASEORPHENOTYPICFEATURE	D014607
26900322	219	246	Il fattore di complemento I	GENEORGENEPRODUCT	3426
26900322	279	282	CFI	GENEORGENEPRODUCT	3426
26900322	435	441	uveite	DISEASEORPHENOTYPICFEATURE	D014605
26900322	558	561	CFI	GENEORGENEPRODUCT	3426
26900322	629	664	Vogt-Koyanagi-Harada sindrome (VKH)	DISEASEORPHENOTYPICFEATURE	D014607
26900322	718	726	pazienti	ORGANISMTAXON	9606
26900322	786	798	sindrome VKH	DISEASEORPHENOTYPICFEATURE	D014607
26900322	983	986	CFI	GENEORGENEPRODUCT	3426
26900322	1021	1030	rs7356506	SEQUENCEVARIANT	RS7356506
26900322	1211	1219	pazienti	ORGANISMTAXON	9606
26900322	1375	1384	cataratta	DISEASEORPHENOTYPICFEATURE	D002386
26900322	1418	1426	steroide	CHEMICALENTITY	D013256
26900322	1545	1548	CFI	GENEORGENEPRODUCT	3426
26900322	1583	1592	rs7356506	SEQUENCEVARIANT	RS7356506
26900322	1652	1664	Sindrome VKH	DISEASEORPHENOTYPICFEATURE	D014607
26900322	1703	1711	pazienti	ORGANISMTAXON	9606
26900322	1759	1771	sindrome VKH	DISEASEORPHENOTYPICFEATURE	D014607
26900322	1863	1866	CFI	GENEORGENEPRODUCT	3426
26900322	1901	1910	rs7356506	SEQUENCEVARIANT	RS7356506
26900322	2212	2215	CFI	GENEORGENEPRODUCT	3426
26900322	2250	2259	rs7356506	SEQUENCEVARIANT	RS7356506
26900322	2290	2298	pazienti	ORGANISMTAXON	9606
26900322	2346	2358	Sindrome VKH	DISEASEORPHENOTYPICFEATURE	D014607
26900322	2417	2426	cataratta	DISEASEORPHENOTYPICFEATURE	D002386
26900322	2623	2631	pazienti	ORGANISMTAXON	9606
26900322	2679	2691	sindrome VKH	DISEASEORPHENOTYPICFEATURE	D014607
26900322	2727	2776	sono stati rilevati stati sensibili agli steroidi	CHEMICALENTITY	D013256
26900322	2812	2815	CFI	GENEORGENEPRODUCT	3426
26900322	2851	2860	rs7356506	SEQUENCEVARIANT	 RS7356506
26900322	2967	2970	CFI	GENEORGENEPRODUCT	3426
26900322	3054	3066	Sindrome VKH	DISEASEORPHENOTYPICFEATURE	D014607
26900322	3161	3164	CFI	GENEORGENEPRODUCT	3426
26900322	3190	3197	7356506	SEQUENCEVARIANT	RS7356506
26900322	3254	3266	Sindrome VKH	DISEASEORPHENOTYPICFEATURE	D014607
26900322	3373	3382	cataratta	DISEASEORPHENOTYPICFEATURE	D002386
26900322	3433	3441	steroide	CHEMICALENTITY	D013256
26937641	43	61	Amiloide sierica A	GENEORGENEPRODUCT	20208,20210,6288
26937641	201	219	Amiloide sierica A	GENEORGENEPRODUCT	20208,20210,6288
26937641	264	267	SAA	GENEORGENEPRODUCT	20208,20210,6288
26937641	445	472	danno epatico e fibrogenesi	DISEASEORPHENOTYPICFEATURE	D008107
26937641	598	601	SAA	GENEORGENEPRODUCT	20208,20210,6288
26937641	738	756	Amiloide sierica A	GENEORGENEPRODUCT	20208,20210,6288
26937641	816	831	IkappaB chinasi	GENEORGENEPRODUCT	84351,9641
26937641	871	896	c-Jun N-terminale chinasi	GENEORGENEPRODUCT	116554,5599
26937641	936	939	JNK	GENEORGENEPRODUCT	116554,5599
26937641	981	984	Erk	GENEORGENEPRODUCT	116590,5594
26937641	1023	1026	Akt	GENEORGENEPRODUCT	207,24185
26937641	1078	1113	Attività della luciferasi NF-kappaB	GENEORGENEPRODUCT	4790,81736
26937641	1155	1160	umano	ORGANISMTAXON	9606
26937641	1192	1195	rat	ORGANISMTAXON	10116
26937641	1244	1262	Amiloide sierica A	GENEORGENEPRODUCT	20208,20210,6288
26937641	1330	1335	MCP-1	GENEORGENEPRODUCT	24770,6347
26937641	1374	1380	RANTES	GENEORGENEPRODUCT	6352,81780
26937641	1420	1424	MMP9	GENEORGENEPRODUCT	4318,81687
26937641	1469	1478	NF-kappaB	GENEORGENEPRODUCT	4790,81736
26937641	1520	1523	JNK	GENEORGENEPRODUCT	116554,5599
26937641	1591	1600	NF-kappaB	GENEORGENEPRODUCT	4790,81736
26937641	1656	1667	citotossico	DISEASEORPHENOTYPICFEATURE	D064420
26937641	1723	1726	SAA	GENEORGENEPRODUCT	20208,20210,6288
26937641	1805	1814	caspase 3	GENEORGENEPRODUCT	25402,836
26937641	1853	1857	PARP	GENEORGENEPRODUCT	142,25591
26937641	1906	1915	Annexin V	GENEORGENEPRODUCT	25673,308
26937641	1972	1992	L'amiloide sierica A	GENEORGENEPRODUCT	20208,20210,6288
26937641	2085	2088	JNK	GENEORGENEPRODUCT	116554,5599
26937641	2128	2131	Erk	GENEORGENEPRODUCT	116590,5594
26937641	2170	2173	Akt	GENEORGENEPRODUCT	207,24185
26937641	2252	2255	SAA	GENEORGENEPRODUCT	20208,20210,6288
26937641	2331	2342	MAP chinasi	GENEORGENEPRODUCT	116554,116590,207,24185,5594,5599
26937641	2430	2439	NF-kappaB	GENEORGENEPRODUCT	4790,81736
26937641	2513	2532	fibrogenesi epatica	DISEASEORPHENOTYPICFEATURE	D008107
26937641	2565	2569	CCl4	GENEORGENEPRODUCT	6351
26937641	2673	2677	SAA1	GENEORGENEPRODUCT	20208
26937641	2712	2716	SAA3	GENEORGENEPRODUCT	20210
26937641	2809	2812	SAA	GENEORGENEPRODUCT	20208,20210,6288
26991973	33	37	MOL1	GENEORGENEPRODUCT	835209
26991973	107	119	Arabidopsis 	ORGANISMTAXON	3702
26991973	453	464	peptide CLE	GENEORGENEPRODUCT	820713,821957,832170
26991973	508	561	chinasi simile al recettore ripetuto ricco di leucina	GENEORGENEPRODUCT	835209,836269
26991973	603	610	LRR-RLK	GENEORGENEPRODUCT	835209,836269
26991973	839	846	LRR-RLK	GENEORGENEPRODUCT	835209,836269
26991973	880	884	MOL1	GENEORGENEPRODUCT	835209
26991973	949	969	Arabidopsis thaliana	ORGANISMTAXON	3702
26991973	1062	1066	MOL1	GENEORGENEPRODUCT	835209
26991973	1166	1171	CLE41	GENEORGENEPRODUCT	822075
26991973	1205	1208	PXY	GENEORGENEPRODUCT	836269
26991973	1298	1302	MOL1	GENEORGENEPRODUCT	835209
26991973	1365	1370	CLE41	GENEORGENEPRODUCT	822075
26991973	1404	1407	PXY	GENEORGENEPRODUCT	836269
26991973	1492	1496	MOL1	GENEORGENEPRODUCT	835209
26991973	1636	1640	MOL1	GENEORGENEPRODUCT	835209
26991973	1676	1679	PXY	GENEORGENEPRODUCT	836269
26991973	1731	1738	LRR-RLK	GENEORGENEPRODUCT	835209,836269
26991973	1879	1883	MOL1	GENEORGENEPRODUCT	835209
26991973	1924	1927	PXY	GENEORGENEPRODUCT	836269
26991973	1984	1988	CLV1	GENEORGENEPRODUCT	843915
26991973	2124	2128	mol1	GENEORGENEPRODUCT	835209
26991973	2179	2183	MOL1	GENEORGENEPRODUCT	835209
26991973	2275	2282	etilene	CHEMICALENTITY	D005030
26991973	2316	2331	acido jasmonico	CHEMICALENTITY	C011006
26991973	2448	2459	Arabidopsis	ORGANISMTAXON	3702
27384305	40	48	11b-HSD1	GENEORGENEPRODUCT	15483
27384305	86	90	Topi	ORGANISMTAXON	10090
27384305	126	136	Trans-Fats	CHEMICALENTITY	D044242
27384305	170	179	Fruttosio	CHEMICALENTITY	D005632
27384305	244	263	Sindrome metabolica	DISEASEORPHENOTYPICFEATURE	D008659
27384305	309	345	Malattia epatica grassa non alcolica	DISEASEORPHENOTYPICFEATURE	D065626
27384305	390	422	La steatosi epatica non alcolica	DISEASEORPHENOTYPICFEATURE	D065626
27384305	467	472	NAFLD	DISEASEORPHENOTYPICFEATURE	D065626
27384305	568	576	steatosi	DISEASEORPHENOTYPICFEATURE	D005234
27384305	622	648	steatoepatite non alcolica	DISEASEORPHENOTYPICFEATURE	D065626
27384305	694	698	NASH	DISEASEORPHENOTYPICFEATURE	D065626
27384305	745	752	cirrosi	DISEASEORPHENOTYPICFEATURE	D005355
27384305	845	865	 sindrome metabolica	DISEASEORPHENOTYPICFEATURE	D008659
27384305	898	915	I glucocorticoidi	CHEMICALENTITY	D005938
27384305	978	986	steatosi	DISEASEORPHENOTYPICFEATURE	D005234
27384305	1075	1094	acido grasso libero	CHEMICALENTITY	D005230
27384305	1180	1197	I glucocorticoidi	CHEMICALENTITY	D005938
27384305	1278	1317	11b-idrossisteroide deidrogenasi tipo 1	GENEORGENEPRODUCT	15483
27384305	1352	1360	11b-HSD1	GENEORGENEPRODUCT	15483
27384305	1431	1439	11b-HSD1	GENEORGENEPRODUCT	15483
27384305	1533	1538	NAFLD	DISEASEORPHENOTYPICFEATURE	D065626
27384305	1596	1600	topi	ORGANISMTAXON	10090
27384305	1646	1654	11b-HSD1	GENEORGENEPRODUCT	15483
27384305	1728	1736	11b-HSD1	GENEORGENEPRODUCT	15483
27384305	1924	1929	NAFLD	DISEASEORPHENOTYPICFEATURE	D065626
27384305	2097	2105	glucosio	CHEMICALENTITY	D005947
27384305	2157	2165	11b-HSD1	GENEORGENEPRODUCT	15483
27384305	2202	2206	topi	ORGANISMTAXON	10090
27384305	2272	2291	malattia metabolica	DISEASEORPHENOTYPICFEATURE	D008659
27384305	2373	2385	trigliceridi	CHEMICALENTITY	D014280
27384305	2480	2485	NAFLD	DISEASEORPHENOTYPICFEATURE	D065626
27384305	2558	2566	steatosi	DISEASEORPHENOTYPICFEATURE	D005234
27384305	2616	2624	11b-HSD1	GENEORGENEPRODUCT	15483
27384305	2672	2676	topi	ORGANISMTAXON	10090
27384305	2843	2851	11b-HSD1	GENEORGENEPRODUCT	15483
27384305	2906	2910	topi	ORGANISMTAXON	 10090
27384305	2987	2991	NASH	DISEASEORPHENOTYPICFEATURE	D065626
27384305	3140	3152	infiammatori	DISEASEORPHENOTYPICFEATURE	D007249
27384305	3211	3219	11b-HSD1	GENEORGENEPRODUCT	15483
27384305	3256	3260	topi	ORGANISMTAXON	10090
27384305	3325	3344	malattia metabolica	DISEASEORPHENOTYPICFEATURE	D008659
27384305	3390	3403	epatosteatosi	DISEASEORPHENOTYPICFEATURE	D005234
27384305	3460	3482	Dieta che induce NAFLD	DISEASEORPHENOTYPICFEATURE	D065626
27384305	3548	3556	11b-HSD1	GENEORGENEPRODUCT	15483
27384305	3628	3649	infiammazione epatica	DISEASEORPHENOTYPICFEATURE	D008107
27384305	3721	3729	11b-HSD1	GENEORGENEPRODUCT	15483
27384305	3803	3807	NASH	DISEASEORPHENOTYPICFEATURE	D065626
27464336	86	92	Alcool	CHEMICALENTITY	D000438
27464336	168	172	S6K1	GENEORGENEPRODUCT	72508
27464336	331	337	alcool	CHEMICALENTITY	D000438
27464336	470	484	 lipodistrofia	DISEASEORPHENOTYPICFEATURE	D008060
27464336	637	643	alcool	CHEMICALENTITY	D000438
27464336	826	866	bersaglio della rapamicina nei mammiferi	GENEORGENEPRODUCT	56717
27464336	900	905	mTOR 	GENEORGENEPRODUCT	56717
27464336	961	965	topi	ORGANISMTAXON	10090
27464336	1049	1055	alcool	CHEMICALENTITY	D000438
27464336	1448	1453	alcol	CHEMICALENTITY	D000438
27464336	1652	1656	mTOR	GENEORGENEPRODUCT	56717
27464336	1690	1696	4E-BP1	GENEORGENEPRODUCT	13685
27464336	1731	1734	Akt	GENEORGENEPRODUCT	11651
27464336	1769	1775	PRAS40	GENEORGENEPRODUCT	67605
27464336	1877	1881	S6K1	GENEORGENEPRODUCT	72508
27464336	1944	1946	S6	GENEORGENEPRODUCT	20104
27464336	1981	1986	eIF4B	GENEORGENEPRODUCT	75705
27464336	2038	2044	alcool	CHEMICALENTITY	D000438
27464336	2089	2093	topi	ORGANISMTAXON	10090
27464336	2126	2132	Alcool	CHEMICALENTITY	D000438
27464336	2181	2186	eEF2K	GENEORGENEPRODUCT	13631
27464336	2247	2251	eEF2	GENEORGENEPRODUCT	13629
27464336	2355	2361	Alcool	CHEMICALENTITY	D000438
27464336	2410	2417	Atg12-5	GENEORGENEPRODUCT	11793,67526
27464336	2452	2464	LC3B-I e -II	GENEORGENEPRODUCT	67443
27464336	2499	2503	ULK1	GENEORGENEPRODUCT	22241
27464336	2544	2548	S555	SEQUENCEVARIANT	P|ALLELE |S|555
27464336	2682	2696	caspase-3 e -9	GENEORGENEPRODUCT	12367,12371
27464336	2731	2735	PARP	GENEORGENEPRODUCT	11545
27464336	2816	2820	ATGL	GENEORGENEPRODUCT	66853
27464336	2855	2858	HSL	GENEORGENEPRODUCT	16890
27464336	2956	2965	PPARgamma	GENEORGENEPRODUCT	19016
27464336	3000	3009	C/EBAlpha	GENEORGENEPRODUCT	12606
27464336	3073	3079	alcool	CHEMICALENTITY	D000438
27464336	3120	3126	alcool	CHEMICALENTITY	D000438
27464336	3173	3182	TNF-alpha	GENEORGENEPRODUCT	21926
27464336	3217	3221	IL-6	GENEORGENEPRODUCT	16193
27464336	3256	3264	IL-1beta	GENEORGENEPRODUCT	16176
27464336	3349	3354	NLRP3	GENEORGENEPRODUCT	216799
27464336	3402	3407	NLRP3	GENEORGENEPRODUCT	216799
27464336	3441	3444	ACS	GENEORGENEPRODUCT	66824
27464336	3479	3488	caspase-1	GENEORGENEPRODUCT	12362
27464336	3549	3554	alcol	CHEMICALENTITY	D000438
27464336	3627	3635	insulina	GENEORGENEPRODUCT	16334
27464336	3755	3761	alcool	CHEMICALENTITY	D000438
27464336	3998	4002	S6K1	GENEORGENEPRODUCT	72508
27798239	32	65	Fosfatidilinositolo 4-chinasi IIb	GENEORGENEPRODUCT	55300
27798239	199	239	fosfatidilinositolo 4-chinasi di tipo II	GENEORGENEPRODUCT	55300,55361
27798239	279	285	PI4KII	GENEORGENEPRODUCT	55300,55361
27798239	345	350	lipid	CHEMICALENTITY	D008055
27798239	382	411	fosfatidilinositolo 4-fosfato	CHEMICALENTITY	C037178
27798239	445	451	PI(4)P	CHEMICALENTITY	C037178
27798239	572	580	clatrina	GENEORGENEPRODUCT	1213
27798239	777	784	PI4KIIa	GENEORGENEPRODUCT	55361
27798239	819	826	PI4KIIb	GENEORGENEPRODUCT	55300
27798239	906	912	actina	GENEORGENEPRODUCT	60
27798239	976	983	PI4KIIb	GENEORGENEPRODUCT	55300
27798239	1072	1122	metalloproteinasi di matrice di tipo I di membrana	GENEORGENEPRODUCT	4323
27798239	1155	1162	MT1-MMP	GENEORGENEPRODUCT	4323
27798239	1232	1238	PI4KII	GENEORGENEPRODUCT	55300,55361
27798239	1352	1359	PI(4) P	CHEMICALENTITY	C037178
27798239	1413	1420	PI4KIIb	GENEORGENEPRODUCT	55300
27798239	1490	1497	MT1-MMP	GENEORGENEPRODUCT	4323
27798239	1641	1648	MT1-MMP	GENEORGENEPRODUCT	4323
27798239	1728	1732	Rab5	GENEORGENEPRODUCT	5868
27798239	1768	1772	Rab7	GENEORGENEPRODUCT	338382
27798239	1853	1857	Rab8	GENEORGENEPRODUCT	4218
27798239	1908	1915	PI4KIIb	GENEORGENEPRODUCT	55300
27798239	2172	2178	PI4K2B	GENEORGENEPRODUCT	55300
27798239	2236	2243	PI4KIIb	GENEORGENEPRODUCT	55300
27798239	2297	2302	umano	ORGANISMTAXON	9606
27798239	2346	2352	cancro	DISEASEORPHENOTYPICFEATURE	D009369
27798239	2445	2452	PI4KIIb	GENEORGENEPRODUCT	55300
27798239	2569	2576	PI4KIIb	GENEORGENEPRODUCT	55300
27798239	2630	2636	PI(4)P	CHEMICALENTITY	C037178
27798239	2693	2700	MT1-MMP	GENEORGENEPRODUCT	4323
27959387	107	122	 cancro al seno	DISEASEORPHENOTYPICFEATURE	D001943
27959387	164	171	etanolo	CHEMICALENTITY	D000431
27959387	242	248	Alcool	CHEMICALENTITY	D000438
27959387	331	345	cancro al seno	DISEASEORPHENOTYPICFEATURE	D001943
27959387	438	449	acetaldeide	CHEMICALENTITY	D000079
27959387	483	491	estrogen	CHEMICALENTITY	D004967
27959387	634	641	etanolo	CHEMICALENTITY	D000431
27959387	681	687	alcool	CHEMICALENTITY	D000438
27959387	767	772	umano	ORGANISMTAXON	9606
27959387	966	971	umano	ORGANISMTAXON	9606
27959387	1015	1029	cancro al seno	DISEASEORPHENOTYPICFEATURE	D001943
27959387	1139	1146	etanolo	CHEMICALENTITY	D000431
27959387	1345	1352	etanolo	CHEMICALENTITY	D000431
27959387	1430	1435	alcol	CHEMICALENTITY	D000438
27959387	1563	1567	Ott4	GENEORGENEPRODUCT	5460
27959387	1603	1608	Nanog	GENEORGENEPRODUCT	79923
27959387	1743	1750	etanolo	CHEMICALENTITY	D000431
27959387	1802	1806	Oct4	GENEORGENEPRODUCT	5460
27959387	1841	1846	Nanog	GENEORGENEPRODUCT	79923
27959387	1917	1926	malignità	DISEASEORPHENOTYPICFEATURE	D009369
27959387	1966	1973	Ceacam6	GENEORGENEPRODUCT	4680
27959387	2123	2138	metallotioneina	GENEORGENEPRODUCT	4501
27959387	2186	2190	MT1X	GENEORGENEPRODUCT	4501
27959387	2321	2330	malignità	DISEASEORPHENOTYPICFEATURE	D009369
27959387	2364	2370	STEAP4	GENEORGENEPRODUCT	79689
27959387	2401	2409	SERPINA3	GENEORGENEPRODUCT	12
27959387	2443	2448	SAMD9	GENEORGENEPRODUCT	54809
27959387	2481	2487	 GDF15	GENEORGENEPRODUCT	9518
27959387	2520	2525	KRT15	GENEORGENEPRODUCT	3866
27959387	2558	2563	ITGB6	GENEORGENEPRODUCT	3694
27959387	2596	2600	TP63	GENEORGENEPRODUCT	8626
27959387	2634	2637	PGR	GENEORGENEPRODUCT	5241
27959387	2678	2684	CEACAM	GENEORGENEPRODUCT	4680
27959387	2719	2730	interferone	GENEORGENEPRODUCT	282617
27959387	2774	2777	HLA	GENEORGENEPRODUCT	3123
27959387	2979	2983	Oct4	GENEORGENEPRODUCT	5460
27959387	3069	3078	malignità	DISEASEORPHENOTYPICFEATURE	D009369
27959387	3142	3151	estrogeni	CHEMICALENTITY	D004967
27959387	3206	3213	etanolo	CHEMICALENTITY	D000431
27959387	3405	3416	acetaldeide	CHEMICALENTITY	D000079
27959387	3508	3515	etanolo	CHEMICALENTITY	D000431
27959387	3625	3631	alcool	CHEMICALENTITY	D000438
27959387	3742	3748	alcool	CHEMICALENTITY	D000438
27959387	3854	3868	cancro al seno	DISEASEORPHENOTYPICFEATURE	D001943
27993978	32	37	CenpH	GENEORGENEPRODUCT	26886
27993978	120	129	APC/CCdh1	GENEORGENEPRODUCT	 56371
27993978	163	188	percorso della ciclina B1	GENEORGENEPRODUCT	268697
27993978	419	424	CenpH	GENEORGENEPRODUCT	26886
27993978	559	563	topo	ORGANISMTAXON	 10090
27993978	620	625	CenpH	GENEORGENEPRODUCT	26886
27993978	669	679	morpholino	CHEMICALENTITY	D060172
27993978	734	755	livelli di ciclina B1	GENEORGENEPRODUCT	268697
27993978	822	861	fattore di promozione della maturazione	GENEORGENEPRODUCT	268697
27993978	897	900	MPF	GENEORGENEPRODUCT	 268697
27993978	989	994	CenpH	GENEORGENEPRODUCT	26886
27993978	1037	1047	ciclina B1	GENEORGENEPRODUCT	268697
27993978	1126	1131	APC/C	GENEORGENEPRODUCT	56371
27993978	1164	1168	Cdh1	GENEORGENEPRODUCT	56371
27993978	1234	1239	CenpH	GENEORGENEPRODUCT	26886
27993978	1331	1341	ciclina B1	GENEORGENEPRODUCT	268697
27993978	1414	1419	CenpH	GENEORGENEPRODUCT	26886
27993978	1633	1638	CenpH	GENEORGENEPRODUCT	26886
27993978	1736	1742	APC/C 	GENEORGENEPRODUCT	56371
27993978	1775	1779	Cdh1	GENEORGENEPRODUCT	56371
27993978	1814	1824	ciclina B1	GENEORGENEPRODUCT	268697
28068934	47	53	PIK3CA	GENEORGENEPRODUCT	5290
28068934	180	217	carcinoma a cellule squamose esofagee	DISEASEORPHENOTYPICFEATURE	D000077277
28068934	290	296	PIK3CA	GENEORGENEPRODUCT	5290
28068934	385	422	carcinoma a cellule squamose esofagee	DISEASEORPHENOTYPICFEATURE	D000077277
28068934	470	474	ESCC	DISEASEORPHENOTYPICFEATURE	D000077277
28068934	566	572	PIK3CA	GENEORGENEPRODUCT	5290
28068934	761	767	PIK3CA	GENEORGENEPRODUCT	5290
28068934	805	810	E542K	SEQUENCEVARIANT	RS121913273
28068934	848	853	E545K	SEQUENCEVARIANT	RS104886003
28068934	893	898	E546K	SEQUENCEVARIANT	P|SUB|E|546|K
28068934	937	943	H1047R	SEQUENCEVARIANT	RS121913279
28068934	982	988	H1047L	SEQUENCEVARIANT	RS121913279
28068934	1024	1064	 sezioni di tessuto fissate in formalina	CHEMICALENTITY	D005557
28068934	1109	1118	paraffina	CHEMICALENTITY	D010232
28068934	1224	1232	pazienti	ORGANISMTAXON	9606
28068934	1315	1319	ESCC	DISEASEORPHENOTYPICFEATURE	D000077277
28068934	1644	1650	PIK3CA	GENEORGENEPRODUCT	5290
28068934	1962	1970	pazienti	ORGANISMTAXON	9606
28068934	2020	2026	PIK3CA	GENEORGENEPRODUCT	5290
28068934	2148	2154	PIK3CA	GENEORGENEPRODUCT	5290
28068934	2301	2307	PIK3CA	GENEORGENEPRODUCT	5290
28068934	2535	2541	PIK3CA	GENEORGENEPRODUCT	5290
28068934	2609	2615	PIK3CA	GENEORGENEPRODUCT	5290
28068934	2747	2755	paziente	ORGANISMTAXON	9606
28068934	2900	2906	PIK3CA	GENEORGENEPRODUCT	5290
28068934	2906	2907	 	ORGANISMTAXON	9606
28068934	2998	3002	ESCC	DISEASEORPHENOTYPICFEATURE	D000077277
28481876	55	94	mantenimento cromosomico in miniatura 8	GENEORGENEPRODUCT	84515
28481876	126	131	umano	ORGANISMTAXON	9606
28481876	175	182	maligne	DISEASEORPHENOTYPICFEATURE	D009369
28481876	216	255	Manutenzione dei cromosomi in miniatura	GENEORGENEPRODUCT	84515
28481876	289	292	MCM	GENEORGENEPRODUCT	84515
28481876	432	436	MCM8	GENEORGENEPRODUCT	84515
28481876	489	492	MCM	GENEORGENEPRODUCT	84515
28481876	703	708	umano	ORGANISMTAXON	9606
28481876	752	759	maligne	DISEASEORPHENOTYPICFEATURE	D009369
28481876	808	812	MCM8	GENEORGENEPRODUCT	84515
28481876	901	906	umani	ORGANISMTAXON	9606
28481876	950	956	tumori	DISEASEORPHENOTYPICFEATURE	D009369
28481876	1017	1021	MCM8	GENEORGENEPRODUCT	84515
28481876	1068	1088	cancro alla prostata	DISEASEORPHENOTYPICFEATURE	D011471
28481876	1146	1152	cancro	DISEASEORPHENOTYPICFEATURE	D009369
28481876	1218	1222	MCM8	GENEORGENEPRODUCT	84515
28481876	1460	1464	MCM8	GENEORGENEPRODUCT	84515
28481876	1682	1688	tumore	DISEASEORPHENOTYPICFEATURE	D009369
28481876	1770	1786	immunodeficienza	DISEASEORPHENOTYPICFEATURE	D007153
28481876	1816	1820	topi	ORGANISMTAXON	10090
28481876	1944	1948	MCM8	GENEORGENEPRODUCT	84515
28481876	1986	1996	ciclina D1	GENEORGENEPRODUCT	595
28481876	2040	2042	Rb	GENEORGENEPRODUCT	 5925
28481876	2107	2135	chinasi 4 ciclino-dipendente	GENEORGENEPRODUCT	1019
28481876	2200	2210	ciclina D1	GENEORGENEPRODUCT	595
28481876	2243	2247	MCM8	GENEORGENEPRODUCT	84515
28481876	2296	2298	Rb	GENEORGENEPRODUCT	5925
28481876	2392	2398	cancro	DISEASEORPHENOTYPICFEATURE	D009369
28481876	2544	2548	MCM8	GENEORGENEPRODUCT	84515
28481876	2610	2615	umano	ORGANISMTAXON	9606
28481876	2659	2678	sviluppo del cancro	DISEASEORPHENOTYPICFEATURE	D009369
28684635	45	62	Diabete di tipo 2	DISEASEORPHENOTYPICFEATURE	D003924
28684635	183	188	ADCY5	GENEORGENEPRODUCT	111
28684635	376	393	diabete di tipo 2	DISEASEORPHENOTYPICFEATURE	D003924
28684635	462	479	diabete di tipo 2	DISEASEORPHENOTYPICFEATURE	D003924
28684635	523	531	glucosio	CHEMICALENTITY	D005947
28684635	589	594	ADCY5	GENEORGENEPRODUCT	111
28684635	651	670	adenilato ciclasi 5	GENEORGENEPRODUCT	111
28684635	702	723	L'adenilato ciclasi 5	GENEORGENEPRODUCT	111
28684635	782	793	AMP ciclico	CHEMICALENTITY	D000242
28684635	947	955	insulina	GENEORGENEPRODUCT	3630
28684635	1045	1062	diabete di tipo 2	DISEASEORPHENOTYPICFEATURE	D003924
28684635	1137	1142	ADCY5	GENEORGENEPRODUCT	111
28684635	1185	1190	umani	ORGANISMTAXON	9606
28684635	1290	1300	rs11708067	SEQUENCEVARIANT	RS11708067
28684635	1419	1436	diabete di tipo 2	DISEASEORPHENOTYPICFEATURE	D003924
28684635	1480	1490	rs11708067	SEQUENCEVARIANT	RS11708067
28684635	1574	1579	umano	ORGANISMTAXON	9606
28684635	1690	1693	rat	ORGANISMTAXON	10116
28684635	1758	1763	mouse	ORGANISMTAXON	10090
28684635	1899	1909	rs11708067	SEQUENCEVARIANT	RS11708067
28684635	2119	2125	 Adcy5	GENEORGENEPRODUCT	64532
28684635	2185	2191	Sec22a	GENEORGENEPRODUCT	117513
28684635	2251	2274	 secrezione di insulina	GENEORGENEPRODUCT	24506
28684635	2349	2359	rs11708067	SEQUENCEVARIANT	RS11708067
28684635	2439	2456	diabete di tipo 2	DISEASEORPHENOTYPICFEATURE	D003924
28684635	2575	2580	ADCY5	GENEORGENEPRODUCT	111
28684635	2626	2656	ridotta secrezione di insulina	DISEASEORPHENOTYPICFEATURE	D003920
